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Abstract 
 
 
Endothelial cells form the inner lining of a blood vessel and their structure and 
functional integrity are important in maintenance of the vessel wall and circulatory 
function. 
These cells play key roles in immune and inflammatory reactions by regulating 
lymphocyte and leukocyte movement into tissues; they are also main targets for 
antivascular agents in cancer therapy. 
Endothelial cell responses to different stimuli have been previously investigated using 
conventional approaches, ‘HUVEC in vitro culture system’. 
In this study an ex vivo perfusion model was constructed and utilized using whole 
human umbilical cords, in attempts to replicate a more accurate in vivo 
microenvironment. 
Assessment of the proportion and duration of endothelial cell viability in the ex vivo 
model was undertaken using a  MTT 3, (4,5-dimethylthiazol-2-yl) 2, 5-diphenyl-
tetrazolium bromide viability assay. A time baseline was successfully established for 
all experimental perfusions. 
Endothelial cell immune response was assessed through intravenous perfusion of the 
endotoxin, Lipopolysaccharide (LPS). Gene expression profiles revealed a significant 
increase in expression levels of E-Selctin (E-Sel), Intracellular adhesion molecule (I-
CAM) and Tissue Factor (TF) relative to the housekeeping gene Beta 2 
Microglobulin. When LPS was administered in combination with Hypertonic Saline  
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Solution (HSS), expression levels declined indicating HSS interferes with the 
activation pathway of LPS ultimately suppressing its effectiveness on endothelial 
cells. 
HSS impact was also recognized from perfusion experiments on resting endothelial 
cells. All identified genes were suppressed by HSS apart from inducible nitric oxide 
synthase (iNOS). 
As a potential target for antivascular agents, HUVEC were then stimulated with 
DMXAA and gene responses of Tumour Necrosis Factor-α (TNF-α) was analysed. 
DMXAA demonstrates excellent antivascular acivity in experimental tumours, so 
tumour conditioned media (TCM) was administered intravenously through umbilical 
cord segments to replicate a tumour microenvironment prior to DMXAA addition. 
When cells were stimulated with Tumour conditioned media then administered 
DMXAA, TNF-α expression was significantly upregulated; relative to the 
housekeeping gene Human Proteosome subunit Y, however, when the cells were 
exposed to tumour conditioned media in absence of DMXAA gene expression 
significantly decreased. Thus, the antitumour action of DMXAA is capable of 
inhibiting the gene response of TNF-α replicated in a tumour environment. 
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Chapter One 
Introduction and Literature Review 
 
 
 
1.1 Background to Research 
The potential of the tumour vasculature as a target for cancer therapy has been 
increasingly recognized in recent years. While much effort is being directed at 
developing angiogenesis inhibitors, there are two drugs currently in clinical trial 
which induce acute tumour blood flow reduction, and thus offer different therapeutic 
potential (Rewcastle et al, 1991). 
One of these is 5, 6-Dimethylxanthenone-4-acetic acid (DMXAA), an experimental 
anticancer drug that selectively reduces tumour blood flow and induces tumouricidal 
cytokine responses (Baguely et al, 1997).  This drug is currently in clinical 
development in phase I/II studies in combination with chemotherapy in New Zealand 
and United Kingdom. 
 
1.2 Endothelial Cells 
Blood vessel walls provide a selective barrier for the transport of molecules between 
blood and tissues. The endothelial lining presents a surface area for the exchange of 
materials between blood and tissues (Baldwin and Thurston, 2001). 
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All blood vessels are lined by endothelial cells, the layer being called the endothelium. 
The endothelium is a continuous monolayer formed from endothelial cells linked 
together by cell-to-cell junctions. These are very complex structures formed by 
transmembrane adhesive molecules linked to a network of cytoplasmic proteins. 
Three types of junctions have been described in endothelial cells: tight junctions, 
adheren junctions and gap junctions (Dejana et al, 1995; Schnittler, 1998).  
Tight junctions are formed from closely apposed neighboring plasma membrane and 
have over lapping regions that seal the endothelial cell layer (Michiels C, 2003). 
Toxic substances are capable of opening up these junctions and allowing larger 
molecules to pass through the walls leading to degenerative changes in the blood 
vessel. 
Endothelial cells are flat, with a central nucleus, and form a pavement like pattern on 
the inside of blood vessel cells; they play important roles in the formation of blood 
vessels and their degeneration (Miao et al.1996).  
Endothelial cell permeability changes are associated with redistribution of surface 
cadherins, stabilization of adhesion bonds and activation of matrix metalloproteinases 
(Alexander and Elrod, 2002). Loss of this barrier function can lead to extravasation of 
intracellular material. 
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The endothelium itself plays a role in pathological states such as tumour angiogenesis 
and thrombotic events (Schreiber et al, 1985). The surface of a healthy endothelium is 
both anticoagulant and antithrombotic. Endothelial cells secrete a variety of important 
molecules for regulation of blood coagulation and platelet functions. Damage to the 
vessel or exposure to certain cytokines or proinflammatory stimuli shifts balance 
towards a more procoagulant/prothrombotic phenotype of the endothelial cell 
(Pearson, 1999). Studies of endothelial cell biology have been prompted by the 
establishment of in vitro culture conditions, the definition of endothelial cell 
phenotypes and the identification of growth factors that interact with endothelial cells 
(Shreiber et al. 1985). 
Endothelial cells lining tumour blood vessels are the main targets for antivascular 
agents. Two changes that are induced by these agents are rearrangement of 
cytoskeletal network and the alteration of junctions that lie in between endothelial 
cells. Further investigation of this process includes the induction of apoptosis, leading 
to rupture of the vessel and extravasation of erythrocytes into the surrounding tissue 
(Baguley B, 2003) as shown in Figure 1.1. 
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Figure 1.1. Antivascular Action 
The antivascular agent causes damage or distortion to the vascular endothelial cell 
and the resulting exposure of basement membrane allows platelets to aggregate and 
release 5-hydroxytryptamine. Further disruption to the vascular endothelial cell 
results in rupture of the capillary, extravasations of erythrocytes, induction of hypoxia, 
and cessation of blood flow. 
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Changes in vascular endothelial cells result in the exposure of basement membrane 
components, which promote activation of platelets. 
It is important to emphasize that there is phenotypic variation between endothelial 
cells in different parts of the human vasculature tree, between both the arterial and 
venous cells. Cells from different locations will not only express different markers 
but can also generate different responses to the same stimulus (Gallagher G et al,. 
1997). 
 
1.3 Human Umbilical Vein Endothelial Cells (HUVEC) 
For many years research has focused on endothelial cell physiology and pathology. 
Endothelial cells cultured from human umbilical veins of cords are the mostly widely 
used cell model in vitro (Gerritsen M et al, 1993). 
Cell Biologists rely on in vivo cell cultures for studies of the effects of compounds 
and other parameters on cells (Mulder P, 2004). 
It is clear, however, that cells raised in culture flasks with medium in incubators are 
themselves in an environment that little resembles that of its natural situation. A 
result of this that cells are subjected to more stress, which will affect their growth and 
response to applied stimuli (Mulder P, 2004). The information obtained from in vitro 
studies has, however furthered the understanding of the molecular processes that take 
place. 
A more accurate cell response would result if in vitro conditions could be made to 
resemble the in vivo environment (Mulder P, 2004). 
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This research project will use whole Human Umbilical Cords for ex vivo studies. The 
umbilical cord is flexible and can be easily manipulated with in the chamber setup. 
The ready availability of cords and also relative ease of isolation will contribute to the  
in vitro studies. Employing an ex vivo model will give a more accurate re-creation of 
the cells microenvironment, made possible with the tubing and a peristaltic pump, 
allowing continuous solution perfusion through the umbilical vein. Also liquid 
handling will be more controlled, so cells are exposed to minimal chemical and 
mechanical stress. 
 
1.4 Cytokines 
Cytokines are low molecular weight proteins. Secreted primarily from leukocytes, 
they function as messengers providing communication between leukocytes and 
endothelial cells. Cytokines stimulate the humoral and cellular immune responses, as 
well as the activation of phagocytic cells. Endothelial response to cytokines and 
bacterial products result in adhesion molecule expression and chemokine production, 
which mediate increased binding and transmigration of leukocytes across the vascular 
wall.  
Many cytokines are initially given descriptive names but as their basic structure is 
identified they are renamed “interleukins” (IL). Interleukins are not only secreted by 
leukocytes but also able to affect the cellular responses of leukocytes. Specifically, 
interleukins are growth factors targeted to cells of hematopoietic origin. 
In vitro, endothelial cells characteristically respond to proinflammatory stimuli like 
LPS and Interleukin-1 by induction of the expression of intracellular cell adhesion  
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molecule 1(ICAM-1)(Dustin and Springer, 1998), vascular endothelial cell adhesion 
molecule-1 (VCAM-1) (Bevilacque et al, 1987), and E-Selectin (E-Sel) (Osborne et  
al, 1998) on the cell surface, and secretion of proinflammatory cytokines such as 
Interleukin-6 (IL-6) (May et al, 1989) and Interleukin-8 (IL-8) (Gimbrone et al, 1989). 
IL-6 is produced by macrophages, fibroblasts, endothelial cells and activated T-helper 
cells and acts in synergy with IL-1 and TNF. Unlike IL-1, IL-2 and TNF-α, IL-6 does 
not induce cytokine expression; its main effect, therefore, is to augment the responses 
of immune cells to other cytokines.  
 
1.4.1 Lipopolysaccharide (LPS) 
Lipopolysaccharide is a complex glycoprotein constituent of the outer cell wall of 
Gram-negative bacteria. (Munshi et al, 2002). 
LPS is recognized by Toll-like receptor 4 (TL4) leading to the induction of immune 
and inflammatory genes in myeloid, leukocytes and endothelial cells (Baldwin, 1996 
& Siebenlist et al, 1994). 
The pro-inflammatory effects seem to be mediated by the transcription factor NF-κB 
(Nuclear Factor- κB). NF-κB is a heterodimer consisting of p50 and p65 subunits. It 
is isolated in the cytoplasm bound to inhibitory protein IκB. Upon LPS stimulation 
IκB is phosphorylated, ubiquininated and degraded. The free NF-κB translocates to 
the nucleus where it is involved in activation of genes encoding inflammatory 
mediators, adhesion molecules and anti-apoptotic proteins in endothelial cells (Lush 
et al, 2000). 
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LPS is also responsible for endothelial cell responses including 1) increased 
production of nitric acid and tissue factor; 2) loss of monolayer integrity and barrier 
function; and 3) apoptosis (Bannerman et al, 2001). The mechanism in which LPS  
activates apoptosis is unknown. Human endothelial cells sensitive to LPS induced 
apoptosis are dependent on new protein or mRNA synthesis inhibition, suggesting  
that either an inducible or constitutively expressed protein is responsible for 
protection (Hu et al, 1998). 
 
1.4.2. Tumour Necrosis Factor–α (TNF-α) 
Tumour necrosis factor (TNF-α) is a cytokine that contributes to a variety of 
inflammatory responses. The most important source of this cytokine is 
monocytes/macrophages (Rothe et al, 1993). 
In vivo TNF is a mediator of systemic inflammation and immune responses. A major 
site of these effects is the vascular endothelium (Pober et al, 1995) where it is capable 
of inducing inflammatory responses by enhancing adhesion molecule expression and 
cytokine secretion. 
These processes involve the translocation of transcription factor NF-κB from the 
cytoplasm to the nucleus. This translocation helps stimulate transcription of adhesion 
molecules E-Sel, ICAM-1 and VCAM-1 and the cytokines IL-6 and IL-8 which all 
posses the NF-κB elements (Collins T, 1995). 
When cells are stimulated with appropriate agonists messenger RNA for TNF-α is 
induced and also the membrane bound precursor is produced (Imaizumi T et al, 2000). 
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In addition TNF-α induces the expression of other autocrine growth factors, increases 
cellular responsiveness to growth factors and induces signaling pathways that lead to 
proliferation. 
The role of endothelial cells as a source of TNF-α is not yet known (Imaizumi et al, 
2000). 
 
1.5. Vascular Targeting Agents (VTAs) 
The vascular endothelium of tumours differs physiologically from the endothelium of 
normal tissue; therefore it may be potentially exploited as a target for anticancer 
drugs (Matthews et al, 2006). 
The initial observation that physical obstruction of the blood vessels of solid tumours 
led to tumour regression in mice suggested that VTAs might be created and altered to 
cause occulation of blood vessels (Thorpe, 2004). 
Destroying the endothelium of solid tumours would result in death of tumour cells 
from lack of oxygen and nutrients leading to occulation of blood-transporting vessels 
as well as the capillary sprouts. This action leads to widespread necrosis of 
established tumours. 
There are two types of VTAs; small molecule VTAs and ligand directed VTAs, they 
each have an individual approach in targeting blood vessels of solid tumours. 
Small molecule VTAs are further placed into two categories; microtubule 
destabilizing agents and cytokine inducers. 
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1.5.1 Flavone Acetic Acid (FAA) 
Flavone Acetic Acid is derived from the flavones group of compounds called 
flavonoids. Flavonoids have many roles which include influencing cell wall  
permeability, ion fluxes, altering enzyme activity, inducing interferons, and inducing 
gene expression (Havsteen, 1983; Redmond et al, 1986; Schneider and Zrenner, 1986; 
Wiltrout and Hornung, 1988). 
Two hundred different flavones were chosen to be screened in the National Cancer 
Institute programme; however, none demonstrated antitumour activity in vivo against 
the current tumour cell lines in use (Plowman et al, 1986). 
A new in vivo screening technique was developed using P388 leukaemia as a 
prescreen. From these results FAA was selected as the lead compound and was then 
taken into Phase I and Phase II clinical trials. Results from these clinical trials 
showed limited significant activity compared to potent antitumour activity against a 
wide range of murine tumours. This result suggested there may be a species 
difference in the biochemical target of FAA (Smith et al, 1987 & Finlay et al, 1989). 
The Auckland Cancer Society Research Centre initiated a chemistry programme to 
synthesise analogues of FAA and screen them for induction of haemorrhagic necrosis 
in a transplanted colon short-term histology assay (Baguley et al, 1989; Gamage et al, 
1992; Rewcastle et al, 1989). Significant activity was seen in analogues of 
xanthenone-4- acetic acid (XAA) and one of these, DMXAA, was selected as a lead 
compound for further clinical trials. 
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1.5.2. 5,6 –dimethylxanthenone-4-acetic acid (DMXAA) 
 
Phase I clinical trials of the investigational anti-cancer drug 5,6 dimethyl xanthenone 
- 4- acetic acid (DMXAA) developed by the Auckland Cancer Society Research 
Centre (ACSRC) have been recently completed in New Zealand and United Kingdom. 
The structure of this compound is shown in Figure 1.2. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.2  Structure of DMXAA 
 
 
DMXAA acts by disrupting the tumour vasculature, directly and indirectly, causing 
apoptosis of tumour vasculature endothelial cells and a tumoural induction of 
cytokines (Baguley B, 2002). 
In vitro and murine in vivo studies have indicated three major pharmological effects 
that DMXAA has; antivascular, anti-angiogenetic and immuno-modulating effects. 
(Zhou et al, 2002). These are dramatically represented in Figure 1.3. 
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Figure 1.3 The proposed mechanism of action of DMXAA 
 
 
The antivascular activity is the drugs ability to inhibit blood flow in selective tissues. 
In murine tumours DMXAA was shown to selectively arrest blood flow within 30 
minutes of administration (Zwi L, 1994 & Lash C, 1998). 
Blood modification induces tumour vascular collapse, leading to tumour necrosis 
(Bibby M et al, 1991 & Zwi L et al, 1989). 
However, hemorrhagic necrosis induction is not capable of maintaining tumour 
regression long term and it is believed that stimulated immune response, in particular 
involvement of T cells, is essential (Hornung R, Bibby M & Pratesi G). 
The immuno-modulating effects of DMXAA induce production of many cytokines 
and chemokines, in particular TNF-α, and Interferons (IFNs). INF-α and INF-β  
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activate natural killer cell activity and IFN-α and INF-β activate natural killer cell 
activity, IFN-γ stimulates T cell immune response (Hornung R, Sayers T & Ching L).  
The ability of DMXAA to induce cytokines such as Interleukin-6 and inflammatory 
protein-10 can also influence endothelial cell permeability and leukocyte migration. 
The overall antitumour effect of DMXAA is considered to be mediated by both 
antivascular and immuno-modulatory effects. 
 
Physiological Action: 
A possible reason for the efficiency of DMXAA, is its ability to induce a cascade of 
antivascular events in tumour tissue. Necrosis of tumour tissue requires sustained 
inhibition of blood flow to the tumour. DMXAA may be the most effective drug in 
achieving this. If a cascade of events is generated within the tumour tissue then 
reduction in blood flow will reduce the removal rate of the agent (DMXAA) and 
increase the effectiveness of its action in the tissue.  
 
Molecular Action: 
The biochemical target of DMXAA is still unknown but there is evidence that its 
action involves the activation of the NFκB pathway in monocytes, vascular 
endothelial cells and various tumour cells. 
This finding is taken from the observed range of cytokines and chemokines produced 
in response to DMXAA which is consistent with the involvement of NFκB. 
Also, the induction of early changes observed in vascular endothelial cells (apoptosis) 
supports the idea that they could be the initial target (Ching L et al, 2002).  
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1.5.3. Lessons from the Clinical Trials  
The two clinical trials of DMXAA have demonstrated reduction in tumour blood flow 
(measured with gadolinium-enhanced MRI). In addition, dose-limiting toxicity is non-
overlapping with that of cytotoxic drugs. At higher dose levels in these trials, a rapid 
increase in the plasma concentration of the serotonin metabolite 5-hydroxyindole-acetic 
acid (5HIAA) was found to occur within 20 minutes of DMXAA administration, with 
peak levels at 4 hours. In the absence of emesis the most likely source of serotonin is 
platelets. This concurs with evidence from preclinical studies which suggests that acute 
activation of platelets may be involved in the mechanism for the tumour blood flow 
reduction.  
Endothelial cell responses to DMXAA may therefore be an important component of the 
tumour blood flow changes. Evidence for a direct effect of DMXAA on endothelial 
cells comes from the two research groups associated with the clinical trials. Work by 
the Auckland Cancer Society Research Centre with a human endothelial cell line 
(ECV304) has shown firstly that DMXAA inhibits angiogenesis in vivo (Matrigel assay) 
and in cell culture (Cao Z et al., 1999). Furthermore DMXAA also induces endothelial 
cell apoptosis in vitro; however, the concentrations required to achieve this effect are 
much higher than those achieved in vivo and the time course is much slower than for 
the changes in tumour blood flow. In conjunction with the observation that platelet 
aggregation after DMXAA is restricted to the vasculature of tumours and spleen, this 
evidence suggests that the microenvironment of endothelial cells may determine their 
response to this class of drugs.  
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Ongoing studies at the ACSRC and at other centres have demonstrated synergistic 
antitumour activity between DMXAA and several standard cytotoxic drugs, 
bioreductive drugs and radiotherapy (Lash et al., 1998, Wilson et al., 1998, Siemann et 
al., 1999). Part of the synergy may lie in the blood flow shutdown causing trapping of 
the cytotoxin in the tumour, thus increasing the tumour exposure to the drug (Pruijn et 
al., 1997). However, for some drugs such as paclitaxel, which is known to have 
antiangiogenic activity in its own right, it is possible that part of the antitumour synergy 
with DMXAA occurs at the level of the endothelial cell.  
If the mechanisms by which DMXAA reduces tumour blood flow can be determined, a 
rational basis would be provided to optimise its therapeutic use in further clinical trials. 
In addition, if current work in the ACSRC on the identification of the cellular target of 
DMXAA is successful, exciting opportunities will be presented for the design of new 
analogues. Such work, which might use the existing combinatorial chemistry facilities 
at the ACSRC, could generate a new range of compounds aimed specifically at 
exploiting this mechanism.  
In general terms, the combination of agents with different and possibly 
complementary mechanisms of action offers the hope of more effective treatments for 
patients with cancer. A better understanding of the novel mechanisms of the 
antitumour activity of DMXAA may facilitate rational exploitation of these to 
maximise interactions with standard anticancer therapies. 
While the murine in vivo models for examining mechanisms of DMXAA-induced 
tumour blood flow reduction are well developed, there is an urgent need to develop  
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robust human preclinical models, as they may bear more relevance to the antivascular 
activity of DMXAA in humans.  
Attempts to study the effects of DMXAA using human umbilical vein endothelial 
cells (HUVEC), the usual human endothelial cell model, do not demonstrate the 
expected cellular responses, even when using co-culture with tumour-conditioned 
media (to replicate factors found in the tumour microenvironment. An ex-vivo model 
using human endothelial cells has been published (AD Blann et al., A new whole-
cord model for assessing endothelial cell physiology ex-vivo. XVIIth Congress of the 
International Society on thrombosis and haemostasis 1999). This study employed 
perfusion of the vein within an intact human umbilical cord, and offers the 
opportunity to examine responses of endothelial cells in their normal vascular 
anatomical relationships to other tissues, which plausibly may differ to those of cells 
when harvested and grown in vitro (HUVEC). Endothelial cell responses to damaging 
and activating agents was preserved in this model. 
 
1.6. Polymerase Chain Reaction 
 
Polymerase Chain Reaction (PCR) is a technique used to amplify the number of 
copies of a specific region of DNA, in order to produce enough DNA to be 
adequately tested. PCR has revolutionized the detection of RNA and DNA molecules. 
Traditional PCR has advanced from detection at end point of the reaction to detection 
while the reaction is occurring, in the technique known as Real Time PCR. 
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1.6.1 Reverse Transcriptase PCR (Traditional) 
Traditional methods for detection of PCR products use agarose gels for detection of 
PCR amplification at the end point of the PCR reaction. This type of agarose gel 
based analysis of cDNA products of reverse transcriptase - PCR does not allow 
accurate quantitation, since ethidium bromide fluoresces only when irradiated in the 
UV part of the spectrum. However, fluorescence is not very bright making it 
sometimes hard to visualize, and analysis software must be used to derive 
comparative estimates of the amount of product present. 
 
1.6.2. Real Time PCR 
This technique is fast, precise and accurate because it monitors the amplification of 
products during the reaction. 
Real Time PCR monitors the fluorescence emitted during the reaction as an indicator 
of amplicon production during each PCR cycle (ie. Real Time) as opposed to end 
point detection (Freeman et al, 1999). The signal increases in direct proportion to the 
amount of PCR product in a reaction. By monitoring the amount of fluorescence at 
each cycle, it is possible to monitor PCR reaction at exponential phase. This 
advantage can give a true representation of initial amount of starting material.  
Other techniques in use for the quantification of mRNA include Northern Blotting or 
Ribonuclease Protection Assay (RPA). These two techniques require no amplification  
and work very well; however, they sometimes require more RNA than is made 
available. 
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1.7. Aim of Research 
The main aim of this research project is to characterise the response of endothelial 
cells in the intact human umbilical cord to inflammatory stimuli and DMXAA. 
 
 
1.8. Study Objectives 
 
1. To confirm the viability of endothelial cells within the intact human umbilical 
vein when perfused over different time periods directly after delivery. 
 
2. To characterise the response of umbilical vein endothelial cells to inflammatory 
stimuli and DMXAA in the presence and absence of tumour conditioned media 
using real time PCR 
 
3. To compare endothelial cell responses to inflammatory stimuli and DMXAA 
in the intact umbilical vein with those of human umbilical vein endothelial 
cells cultured in vitro. 
 
1.9. Maori Advisory Group Kaumatua Kaunihera Support 
The investigator recognizes the importance of the collected information as Taonga 
and that knowledge belongs to the Tangata Whenua and must not be removed or 
handed on without their express approval. The Kaumatua Kunihera group have given 
their support and approval for this research to go ahead. 
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Chapter Two 
Materials and Methods 
 
 
 
2.1 General Information 
 
2.1.1 Supplier Information 
 
A list of all the suppliers used to source products and the reference names are listed in 
table 2.1. Thereafter, the suppliers are referred to only by their referred name. 
 
Table 2.1 Supplier List 
 
Supplier Referred Name Address 
Invitrogen Life 
Technologies 
Invitrogen Carlsbad,CA,USA 
Roche Applied Science Roche Penzberg, Germany 
Promega Corporation Promega CA, USA 
Antisoma Research 
Laboratories 
Antisoma London, England 
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2.2. General Reagents and Solutions 
 
All chemicals used in this research, unless otherwise stated, were of analytical 
reagent grade. 
 
2.2.1. General Buffers 
 
The general buffers used in this thesis research are listed in Table 2.2. 
 
Table 2.2. General Buffers 
 
Buffer reference name Components 
Phosphate Buffer Solution 8.00g NaCl, 0.20g KCl, 
0.25g KH2PO4, 1.15g 
Na2HPO4, double distilled 
water to make 1 litre 
TE(10:1) 10mM Tris-HCL pH 7.5, 
1.0mM EDTA 
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2.3. General Solutions 
 
The general solutions used in this thesis research are listed in Table 2.3. 
 
Table 2.3. General Solutions 
 
Solution reference name Components 
Cell Lysing Solution 20% w/v sodium dodecyl 
sulfate (SDS;Invitrogen 
15525-017) was dissolved 
into a solution of 50% N,N-
dimethyl formamide (DMF; 
May & Baker D86/18/67) 
and 50% double distilled 
deionised water. The pH 
was adjusted to 4.7 by 
adding 2.5% of 80% acetic 
acid and 2.5% 1M HCL 
Lactated Ringers Solution 0.3g KCL, 6.0g NaCl, 3.0g 
Sodium Lactate, 0.2g 
CaCl2, Adjusted to pH6.5-
6.6 and double distilled de-
ionised water to make 1L 
was added 
Collagenase A Solution From Clostridium 
histolyticam,  
Working concentration = 
1mg/ml(0.1% w/v) 
Hypertonic Saline Solution 7.5% NaCl 
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2.3.1. RNA Extraction Reagents 
 
Table 2.4 lists all the reagents used in RNA extraction method unless otherwise stated.  
 
Table 2.4. RNA Extraction Reagents 
 
RNA Extraction reference 
name 
Components 
5 M Guanidinium 
Thiocyanate (GiTC) 
__ 
 
2 M Sodium Acetate 2 M Sodium Acetate, 
adjusted to pH 4.6 using 
glacial acetic acid 
Phenol Saturated with 10mM Tris 
HCL,pH 8.0, 1 mM EDTA 
Phenol phase is pH 6.7 
Chloroform Chloroform/ethyl alcohol 
Isopropanol __ 
Triozol Reagent Phenol/guanidine 
isothiocyanate 
 
2.3.2. Electrophoresis Reagents 
 
The reagents used in the Gel Electrophoresis are listed in Table 2.5. 
 
Table 2.5. Gel Electrophoresis Reagents 
 
Reagent reference name Components 
10 x SDS Buffer 56g Boric Acid, 10g NaOH 
make up to 2 litres, pH 8.5 
100bp 
Ladder(size:250μg~1.0μg/μl)
50μl ladder, 850μl TE, 
100μl loading Dye 
Loading Dye 10ml glycerol, 4.0 ml 
EDTA, 2.0 ml 10% SDS, 
2.0 ml Tris, 1.5 ml H2O 
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2.3.3. Dyes 
 
The dye used for this research are listed in Table 2.6. 
 
Table 2.6. General Dyes 
 
Reference Name Components 
Ethidium Bromide Stock solution was made as 
25mg ethidium bromide in 
500ml distilled water 
 
2.3.4. Culture Medium 
The bacterial growth mediums and the components used in this research are listed in 
Table 2.7. 
Table 2.7. Bacterial Growth Medium 
 
Media Reference Name Components 
M199 (100ml) 0.98g Medium 199, 20.0mls 
Fetal Calf Serum, 2.5mls 
NaHCO3, 0.48g Hepes, 
3.0mls GAV, 1.5mls 1N 
NaOH, 73ml double 
distilled water 
HUVEC Complete (100ml) 0.98g Medium 199, 20.0mls 
Fetal Calf Serum, 2.5mls 
NaHCO3, 0.48g Hepes, 
3.0mls GAV, 0.2mls ECGF, 
40μl Heparin, 1.5mls 1N 
NaOH, 76.5ml double 
distilled water 
RPMI 1640 (100ml) 1.026g RPMI 1640, 20.0ml 
Fetal Calf Serum, 2.5mls 
NaHCO3, 0.48g Hepes, 
3.0mls GAV, 1.5mls 1N 
NaOH, 73ml double 
distilled water 
 
 
 
 
 
 
 
 
 
 
 
 
 
Materials and Methods 24
 
2.4. Polymerase Chain Reaction (PCR) Reagents 
 
Table 2.8 lists the reagents used in all PCR reactions unless otherwise stated. All 
reagents were supplied by Invitrogen. 
 
 
Table 2.8. PCR Reagents 
 
 
PCR Reference Name Reaction Concentrations 
Platinum Taq 
Polymerase(5U/μl) 
1 Unit (U) of Platinum Taq 
per reaction 
10 x Platinum Taq Buffer Tris-HCl, (NH4)2 
SO4,0.625μl of Taq and ~ 
25μl of H2O 
 
2.4.1. complementry DNA (cDNA) Production Reagents 
 
The reagents used in production of cDNA from isolated RNA are listed in Table 2.9. 
 
 
Table 2.9. cDNA Reagents 
 
cDNA Reference Name Reaction Concentrations 
Oligo dt ____ 
5 x RT Buffer 100mM Tris-
HCl(pH8.4),250mM KCl 
10mM dNTPs 10mM each of 
dATP,dCTP,dGTP,dTTP in 
double distilled water at 
neutral pH. 
0.1 M DTT 250mM Tris-HCL(pH8.3 at 
room temp.),375mM 
KCl,15mM MgCl2) 
Superscript III 200 units/μl 
Double distilled water ___ 
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Table 2.10. Real Time PCR Primer List 
 
Primer Name Forward Sequence Reverse Sequence 
Intercellular 
adhesion molecule-1 
(I-CAM1) 
CTGCAGACAGTGACCATC 
(892-909) 
GTCCAGTTTCCCGGACA
A   (1211-1228) 
HS E-Selectin (E-S) CGTTGGTGAGGTGTGCTC 
 
(7-24) 
TGATCTTTCCCGGAACT
GC 
(199-216) 
Interleukin -1β (IL-
1β) 
TACGAATCTCCGACCACC
A (235-253) 
GTTGCTCCATATCCTGT
CCC(549-530) 
Interleukin-6 (IL-6) ATGTAGCCGCCCCACAG CATCATCTTTTTCAGCC
AT 
Interleukin-8 (IL-8) ATGACTTCCAAGCTGGCC
GTGGCT 
TCTCAGCCCTCTTCAAA
AACTTCTC 
Tumour Necrosis 
Factor α (TNFα) 
CCTCCTCTCTGCCATCAA
G 
GAGGCGTTTGGGAAGGT
T 
Human proteosome 
subunit Y (HPSY) 
CAGAACAACCACTGGGTC
CT 
CCCGGTATCGGTAACAC
ATC 
Tissue Factor (TF) GGAACCCAAACCCGTCAA TGCTTCACATCCTTCAC
AATCT 
RNA Polymerase II 
(RNA Pol II) 
GCACCACGTCCAATGACA
T 
GTGCGGCTGCTTCCATA
A 
Beta 2 Globulin 
(B2M) 
AGCGTACTCCAAAGATTC
AGGTT 
TACATGTCTCGATCCCA
CTTAACTAT 
Inducible nitric 
oxide synthase 
(iNOS) 
AGGAAGTGGGCAGGAGG
ATG 
GAAGGACTCTGAGGCTG
TGTG 
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Table  2.11. Genes regulated in endothelial cells in response to 
injury and inflammation stimuli 
 
 
Gene Gene Function 
Intercellular adhesion 
molecule-1 (I-CAM1) 
Adhesion molecule of immunoglobulin supergene 
family. Binds ligands, monocytes and lymphocytes 
HS E-Selectin (E-S) Adhesion molecule of selectin family 
 
Interleukin -1β (IL-1β) Inflammatory Cytokoine 
Interleukin-6 (IL-6) B cell growth factor 
Interleukin-8 (IL-8) Neutrophil chemotatic Factor 
Tumour Necrosis Factor α 
(TNFα) 
Upregulated cytokine 
Human proteosome subunit 
Y (HPSY) 
Housekeeping  
Tissue Factor (TF) Co factor for activation of extrinsic pathway of 
coagulation 
RNA Polymerase II (RNA 
Pol II) 
Housekeeping 
Βeta-Actin (β-Actin) Housekeeping 
Beta 2 Globulin (B2M) Housekeeping 
Inducible nitric oxide 
synthase (iNOS) 
Synthesis of NO  
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2.5. Sample Collection 
Whole human umbilical cords were kindly donated, with informed consent from 
women undergoing elective caesarians at Waikato Hospital. Ethical approval was 
granted from the Northern Y Ethical committee and the University of Waikato 
Human Ethical Committee. Umbilical cords were collected immediately after 
delivery. To minimise blood clot formation the vein was flushed with iced PBS then 
transported in a PBS filled container compacted with ice, back to the Molecular 
Genetics laboratory at Waikato University. In the Molecular Genetics Lab the 
umbilical cord vein was cannulated using modified 18 gauge IV catheter hubs and 
placed into a perfusion chamber. The perfusion chamber was attached to a perfusate 
reservoir via luer lock tubing and a peristaltic pump (Eyela Microtube Pump MP-3) 
producing a flow rate through the umbilical vein of 3ml.minֿ¹. The dissolved gas 
content was maintained in perfusate by pumping air into reservoir through a syringe 
filter (Millex-HV 0.45μm Filter Unit,SLHV025LS). All perfusion equipment was 
maintained at 37°C by containment within an air incubator (Ratek Orbital Mixer 
Incubator). 
 
2.6. General Methods 
 
2.6.1. HUVEC Viability Assays 
After the desired perfusion period, 0.1mg.mL¯¹ tetrazolium bromide (3,(4,5-
dimethylthiazol-2-yl) 2,5-diphenyl-tetrazolium bromide; MTT; AppliChem 298-93-1)  
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was added to the perfusate reservoir and the chamber system perfused for a further 
two hours. To each umbilical cord segment; the vein was flushed with PBS and filled  
with cell lysing solution and incubated for 12 hours. Cell lysate solution was added to 
dissolve the insoluble purple formazan product into a coloured solution. The resultant 
solution was collected and absorbance analysed using a spectrophotometer (Bio-Rad 
SmartSpec 3000) at a wavelength of 570nm. 
 
2.6.2. Immune Response Induction 
LPS solution was prepared by Joe Cursons. Briefly, E.Coli (DH5α) was cultured on 
agar plates, then suspended in Lactated Ringers Solution and pasteurized at 65°C for 
30 minutes. The pasteurized E.Coli was added to the perfusate reservoir and the 
umbilical vein was perfused for 4 hours to induce an immune response. 
 
2.6.3. Hypertonic Saline Solution 
For Hypertonic Saline Solution (HSS) treatment 2.5ml of 7.5% NaCl solution was 
added to perfusate reservoir. 
 
2.6.4. DMXAA Requirements 
DMXAA requirements are described in Appendix I. DMXAA working concentration 
for perfusion studies was 250 μM (peak plasma free drug concentration at higher 
doses used in trials) (Jameson et al, 2000) in 100mls PBS. Then 7.6 mg was 
accurately measured out and dissolved in 100mls of warm 37°C incubated PBS. This 
perfusate solution was used for DMXAA perfusion studies. 
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2.7. RNA Extraction and Isolation 
 
To extract mRNA from umbilical vein after desired perfusion period, the vein was 
filled with 500μL of 5M guanidinium thiocyanate (GiTC) and left for 1 minute to 
lyse the HUVECs. The lysate solution was then flushed out (~400μL) and collected in 
an eppendorf tube. A further 100μL of 5M GiTC was added to the suspension to 
bring final volume to 500μL. To this, 50μL of 2M Sodium Acetate (pH 4.0) was 
added followed by 500μL of Phenol (pH4.0) and then mixed by vortexing and placed 
on ice for 5 minutes. 200μL of Chloroform was added, mixed by vortexing then left 
on ice for 5 minutes. The suspension was then centrifuged at 12000G for 10 minutes 
and the aqueous layer was pipetted off into another tube and precipitated using an 
equal volume of isoproponal and incubated at -20°C for 20 minutes. The suspension 
was then centrifuged at 12000G for 10 minutes and the isopropanol was decanted off. 
The RNA pellet was resuspended in 0.5ml of TRI reagent (MRC TR118) and left on 
ice for 5 minutes and followed by another extraction. Once isopropanol was decanted 
off from the second extraction, the RNA pellet was washed in 1.0ml of 70% ethanol 
and then centrifuged 12000G for 1 minute. The ethanol was decanted off and the 
pellet was resuspended in 20μL of 10mM Tris-HCl (pH 7.8),0.66mM MnCl2. The 
RNA was then purified of DNA by adding 2μL of RQ1 RNase free DNase (1 unit/μL; 
Promega M610A) and the solution incubated at 37°C for 30 minutes; the DNase was 
then inactivated by adding 2.0μL of RQ1 stop solution (20mM EGTA; Promega 
M199A) followed by an incubation at 65°C for 10 minutes.  
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2.8. RNA Quality 
The purified RNA was quantitated and purity assessed using an electrophoretic gel 
analysis and a Nanodrop ND-1000 spectrometer with software ND-1000 v3.1.0. 
High quality RNA should exhibit sharp 18s and 28s rRNA bands in an agarose gel 
stained with ethidium bromide. The proportion of ribosomal bands has been viewed 
as the primary indicator of RNA integrity. One disadvantage of checking RNA purity 
using an agarose gel is sample consumption. Only small amounts of RNA were able 
to be extracted from each umbilical cord segment so the agarose gel technique needed 
to be reconsidered. More successful results were observed with the Nanodrop 
spectrometer. 
Briefly, the Nanodrop is a full spectrum (220-750nm) spectrometer that is a capable 
of measuring 1μl samples. It employs surface tension alone to hold the sample in 
place. This advantage eliminates the need for curvettes and other sample contaminant 
devices. Good quality RNA will have an OD 260/280 ratio higher than 1.50 and an 
OD 260/230 close to 1.0. This is because nucleic acid is detected at 260nm, whereas; 
protein, salts and solvents are detected at 230nm and 280nm. A high OD260/280 and 
OD 260/230 means that the RNA was extracted successfully without any of these 
contaminants (Auburn R, 2004). If the OD260/280 results are considerably low the 
RNA was repurified and another reading taken. 
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2.9. cDNA Production 
To produce cDNA, tube A was prepared with 5μl of RNA and added 1μl of OligodT 
and 4μl H2O. The sample was then heated at 65°C – 70°C (PTC -200 Peltier Thermal 
Cycler) for 7 minutes to remove any secondary structure from the RNA and allow the 
oligo dT to bind to the Poly A tail, acting as a reverse transcriptase template. The 
mixture was then cooled on ice for 2-5 minutes. 
In a separate tube 4μl of 5xRT Buffer, 1μl 10mMdntps, 1μl 0.1M TT, 1μl SS III and 
3μl H2O were combined. This solution was added to tube A and heated to  
50°C for 60 minutes and then 85°C for a futher 5 minutes, to inactivate the reverse 
transcriptase. The cDNA quality was confirmed by performing a PCR reaction with 
two known housekeeping genes on endothelial cells, β-Actin and RNA Polymerase II. 
 
2.9.1. Electrophoretic Analysis 
Gel electrophoresis was a technique used to separate DNA fragments. The DNA 
sequences used were stained by mixing 8μl of the DNA with 2μl of loading Dye and 
the entire sample loaded into a single well of an agarose gel. Multiple samples were 
loaded next to each other for easy comparison. The agarose gels were prepared by 
boiling 0.50g of agarose in 35ml of 1XSDS Buffer for 10 seconds before adding 15μl  
of 10mg/ml Ethidium Bromide then poured into a small mould with desired well 
spacers and left to set. As a molecular weight standard, 0.4μl of a 100bp ladder 
(Invitrogen) was loaded into a single well on each gel. The electrophoresis was  
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conducted at a constant voltage of 120V for 35 minutes and then gels were analysed 
under UV light (Life Technologies TFX-35m). Images were captured using a CCD 
camera and intergrating image over 15 frames. The resultant image was modified 
using Scion imaging to improve visibility. 
 
2.9.2. Polymerase Chain Reaction (PCR) 
All Primers used for this research are listed in section 3.0, and detailed where 
appropriate. In general PCR reactions were carried out using a PTC-200 Peltier 
Thermal Cycler and the genes of interest along with the housekeeping gene were 
amplified out using a specified PCR programme. The volume of the PCR reactions 
were 20μl. In general 100μl of SYBER green master mix, 0.5μl Taq and 2μl 
forward/reverse primer were combined in one tube, 20μl were dispensed out into each 
tube including one negative control (5 tubes). Then 0.5μl of cDNA for each sample 
was dispensed into four of the five tubes as shown in figure 2.1. The PCR programme 
was as follows: 95°C for 2 mins, 55°c for 20 sec, 68°C for 35 sec, 95°C for 20 sec, 
55°C for 20 sec, 68°C for 35 sec, 39 quantification cycles of; 95°C for 20 sec, 68°C 
for 5 mins, End. 
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     Primer Tube      Sample 1    Sample 2   Sample 3  Sample 4                 Control        Master Mix 
      20.5μ            20.5μl        20.5μl       20.5μl                    20μl 
 
 
Figure 2.1. PCR reaction with 4 samples & 1 control 
 
 
 
 
2.10. HUVEC Isolation 
 
Umbilical cords were collected from Waikato hospital and brought back to the 
molecular genetics lab, the cord vein was then cannulated at either end. The vein was 
flushed with cold PBS and then further air flushed. The vein was then filled with 8ml 
of Collagenase A (1mg/ml) and sealed at either end with 10ml syringes. The cord was 
then placed in a 37°C incubator oven and left for 30 minutes. Incubator flasks were 
prepared by coating base with 1% gelatin to allow then endothelial cells to attach. 
The cord was then removed from the incubator and the vein was massaged by hand to 
loosen any endothelial cells still attached to the vein wall. The collagenase A solution 
was then flushed out with a 10ml syringe and the effluent collected in a 50ml conical 
centrifuge tube. 10ml of M199 medium was then flushed through the cord to collect  
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any further cells left behind. The resultant solution was then spun at 20,000 rpm for 
10 mins (Multifuge 1 S-R, Heraeus, Kendro). The supernatant was tipped off leaving 
a pellet of cells at the bottom of centrifuge tube. This cell pellet was resuspended in 
fresh M199 media and transferred to a culture flask. The flask was then incubated at 
37°C and the cells were checked daily. The M199 media was replaced on day 2 with 
5mls of fresh complete HUVEC media. Media was changed every three to four days 
until cell confluence was reached. 
 
2.10.1. HUVEC Culture Media 
 
Isolated human umbilical vein endothelial cells were routinely maintained on 
HUVEC complete medium after observed cell growth on either RPMI 1640 or M199 
Medium. Both M199 and HUVEC complete media were prepared by adding 0.98g 
M199 media, 0.48g Hepes and 76.5mls double distilled H2O into a sterile 250ml 
bottle. This content was filter sterilized into another sterile 250ml bottle. To this 
NaHCO3, GAV and Fetal Calf Serum was added, the media was then adjusted to pH 
7.3 with 1 N NaOH. In HUVEC media at this stage both Heparin and endothelial cell 
growth factors were added as stated in table 2.7. 
RPMI 1640 medium was prepared in a similar method except RPMI 1640, Hepes and 
double distilled H20 were autoclaved on liquid cycle at 121°C instead of filter 
sterilized. 
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2.10.2. Subculturing 
 
HUVEC cells were subcultured once grown to confluence, old media was removed 
from flask, 3.0ml of trypsin was added and the flask was returned to the 37°C 
incubator for 5 minutes or until cells had loosened from the base of the flask. 10mls 
of fresh HUVEC media was added to original flask and then 5mls removed and 
pipetted into a new flask. Cells were checked daily and fresh HUVEC media replaced 
when needed. 
 
2.10.3. Human Melanoma Cells 
 
Human Melanoma Cancer Cells (NZM3) were kindly donated from patients at the 
Auckland Cancer Society Research. These were received in ITS growth medium and 
were passaged as previously stated in section 2.10.2 with two flasks allowed to grow 
to confluence. Once cell confluence was reached, cells were passaged and the media 
was collected in 50ml centrifuge tubes and frozen at -80°C until required for 
experimental purposes.  
 
2.10.4. Freezing cells 
Both HUVEC cells and NZM3 cells were allow to grow to confluence in flasks. Both 
cell types were frozen for bulk storage and experimental use later in the year. The 
cells media was removed from flasks, 3ml of trypsin/EDTA was added and it was 
then incubated at 37°C. Once all cells were loosened from flask base, cell suspension  
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was transferred to 10ml centrifuge tubes and centrifuged (Multifuge 1 S-R, Heraeus 
Kendro) at 10,000 rpm for 5 minutes. The supernatant was removed and the 
remaining cell pellet was resuspended in 1ml of Fetal Calf Serum/Dimethyl Sulfoxide. 
This solution was then transferred to a cryogenic vial and placed in a cryocontainer, 
then placed in -80°C freezer. Cryopreservation enabled stocks of cells to be stored, 
preventing the cell line to be in continuous culture during other experimental 
procedures. 
 
2.10.5. Thawing Cells 
 
Cells were thawed when required for experimental purposes. Briefly, cells were 
removed from the -80°C freezer and fast thawed in a heated water bath maintained at 
30°C. The cells were then transferred to a 10ml centrifuge tube containing 5mls of 
appropriate media and then centrifuged for 5 minutes at 10,000rpm. This was to 
remove all DMSO present. The supernatant was tipped off and cells were 
resuspended in fresh media (complete HUVEC media for HUVEC cells or ITS media 
for human melanoma cells) and transferred to a culture flask. The culture flasks were 
incubated at 37°C to allow cells to once again reach confluence. 
 
2.11. Real -Time Polymerase Chain Reaction  
 
All primers used for this research are listed in table 3.0 and detailed where 
appropriate. In general, Real-time PCR was performed using a Corbett RG-3000 with 
Rotor-Gene (v6.0.27) software and genes the of interest were amplified out of the 
cDNA library using a specified PCR programme.  
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In general 400μl of master mix (Sybr Green), 2.5μl Taq and were combined in one 
tube, 35μl was dispensed in 9 tubes. Then 0.4μl of each primer was dispensed into the 
9 tubes. Each tube was mixed and 10μl was dispensed from each different primer 
tube to two new tubes (includes replicates). The control tubes (primer tubes) were 
closed. To the remaining tubes 1μl of the cDNA sample was added. The PCR was run 
in duplicates. Please refer to Figure 2.2. for details. 
 
PCR TEMPLATE 
   
Lane 1 
 
Lane 2 
 
Lane 3 
 1    2    3    4    5    6    7    8    9 
Figure. 2.2. Setup PCR Plate: Lane 1 has the nine individual primers. Lane 2 
& 3; each tube contains each of the different primers and 1μl of 
cDNA sample 
 
The PCR was cycled with an initial inactivation step of 7.5 minutes at 95°C followed 
by 40 quantification cycles of; 94°C for 10 seconds, 55°C for 10 seconds, 68°C for 30 
seconds and 80°C for 20 seconds. Relative quantification was achieved by analyzing 
the Ct value, with data quality examined through a regression model. The approach 
identified the correlation between the Ct value and logrithm (Base 2) transformed 
concentration of template, giving a significant linear relationship for each standard 
curve.
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Chapter Three 
Results 
 
 
 
3.1. Ex Vivo Perfusion Model 
The perfusion chamber was designed previously in a summer studentship but further 
modified by Joe Cursons to minimise experimental variables and to also allow within 
cord comparison which is clearly shown in Figure 3.3. 
           Perfusate 
           Reservoirs 
 
 
 
Air Filter 
Peristaltic 
               Pump 
          
            
 
 
Perfusion  
Chambers 
 
 
 
Figure 3.1 Modified Ex vivo perfusion model 
Perfusion equipment maintained at 37°C by containment within an air 
incubator (Ratek Orbital Mixer Incubator). 
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Figure 3.2. Ex vivo perfusion model: Three chambers are set up running 
along side each other,  peristaltic pump( Eyela Microtube Pump MP-3) 
producing a flow rate through the umbilical vein of 3ml.minֿ¹, dissolved gas 
content was maintained by pumping air into reservoir through a syringe filter 
(Millex-HV 0.45μm Filter Unit,SLHV025LS).  
 
 
 
 
 
 
 
 
 
 
 
Figure 3.3. Perfusion chambers: Umbilical cord divided into 3 segments and 
perfused separately, to allow within cord comparison. 
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3.2. MTT Viability Assay.  
 
Table 3.1. Summary of umbilical cord segment OD absorbance 
readings 
Experiment Cord 1 Cord 2 Cord 3 Cord 4 
Section 1 2 1 2 1 2 1 2 
OD Absorbance 
(AU) at 570nm 
1.440 2.735 0.608 0.406 0.474 
(1:4) 
0.784 
(1:4) 
0.052  0.083 
Time 
Perfused(hrs) 
2 2 2 2.5 2.25 2 2.5 5 
Volume of 
Solution(ml) 
1.9 3.0 1.5 2.5 3.0 0.9 0.15 3.0 
Length(mm) 80 60 80 65 40 40 45 40 
Weight(g) 10.73 9.2 11.3 11.7 10.32 5.77 5.25 9.80 
OD/mm(x10ֿ³) 18 45 7.6 6.2 11.8 19.6 1.15 2.1 
 
Experiment Cord 5 Cord 6 Cord 7 Cord 8 
Section 1 2 1 2 1 2 1 2 
OD Absorbance 
(AU) at 570nm 
0.123 0.049 0.223 0.149 0.078 0.090 0.120 0.080 
Time 
Perfused(hrs) 
3 4 2.5 4 4 5 5 5 
Volume of 
Solution(ml) 
1.5 1.0 .9 1.0 1.5 1.5 1.0 1.0 
Length(mm) 50 40 60 50 50 50 60 55 
Weight(g) 10.73 9.2 9.8 6.0 6.5 5.8 6.0 5.8 
OD/mm(x10ֿ
 
³) 2.46 1.225 3.7 2.9 1.56 1.8 1.5 1.45 
The umbilical cord segments were perfused as described in section 2.6.1.  
When MTT solution was intravenously perfused through each segment the 
tetrazolium salts were converted to a purple formazan dye by only the active cells. 
The lysate solution from each segment was collected and measured using a 
spectrophotometer set at wavelength 570nm.  
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Figure 3.4. Optical Density absorbance measurements of HUVEC 
 
Table 3.2. HUVEC Viability Over Time 
 
 
 
 
 
 
 
In Figure 3.4. the x-axis represents hours each cord segment was perfused, the  
% Cell 
Viability 
Hours 
perfused
100 0 
90 1 
80 2 
60 3 
40 4 
30 5 
10 6 
0 7 
0 8 
0 9 
0 10 
ֿy-axis represents the  OD/mm (x10 ³) measurement. At 0 hours resting endothelial 
cells within the cord vein are presumed to be 100% viable.  
The minimum perfusion time was 2 hours, after this time the cells would expect to be 
losing their viable state. With this assumption, 80% of cells are still viable after 2 
hours. A general decreasing trend was seen in Figure 3.4., an estimation of % cell 
viability over time was possible. Based on the results in Table 3.1 only an estimation  
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of cell viability was possible. The differences in OD absorbance readings in cord 4, 
questioned the reliability of the results. It was shown in Table 3.1 that after 5 hours 
perfusion a significantly low OD absorbance reading of 0.083 is produced; however 
in the same cord after 2 hours perfusion a lower OD absorbance reading of 0.052 is 
recorded. The expected results of a longer perfusion time, decreases cell viability is 
clearly not displayed with cord 4. However, observation of the other perfused cords 
do support the general trend of, increasing time reduces cell viability, and a time 
frame of 2 hours perfusion was concluded. 
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3.3. Immune Response Induction: Cord 1 
 
Table 3.3. Summary of umbilical cord 1 information: Segment weights, 
lengths, perfusate solutions used and time period. 
 
 
Experiment 
Section Perfused Time Length(mm) Weight(g) 
1 Unperfused 
(control) 
4 hours 57 10.4 
2 PBS 4 hours 46 8.6 
3 LPS (1μg/ml) 4 hours 50 8.9 
 
Table 3.4. Nanodrop Spectrometer Data: RNA quality check for each cord 
segment (cord 1) 
 
Experiment – Nanodrop Data 
Sample ID concentration
ng/μL 
A260 260/230 260/280 
 
Const. 
control 373.04 9.326 0.57 1.65 40 
PBS 230.44 5.761 0.37 1.51 40 
LPS 414.37 10.359 0.62 1.61 40 
 
 
The gene expression was measured in response to PBS and LPS. 
The results from the Nanodrop spectrometer in Table 3.4, indicate that the RNA 
isolation procedure was successful and produced RNA of an accepted quality as 
indicated by the (260/280) ratio values >1.50. The purified RNA from PBS and LPS 
samples was then used to produce cDNA as described in section 2.9. Real Time PCR 
was used for gene expression analysis. 
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Quantitation data for SYBR Green ford cord 1 
 
 
 
 
 
 
 
 
 
Figure 3.5. Quantitation Data for SYBR Green (cord 1) 
 
Table 3.5. Summary of Genes and Threshold cycles Ct (cord 1) 
 
 
 
 
 
 
 
 
 
 
Name Ct 
B2M-neg - 
B2M-LPS 39.76 
B2M-PBS 32.32 
IL1B-neg - 
IL1B-LPS 37.55 
IL1B-PBS - 
IL6-neg - 
IL6-LPS - 
IL6-PBS 37.18 
IL8-neg 34.44 
IL8-LPS 34.18 
IL8-PBS 33.56 
IL12-neg - 
IL12-LPS - 
IL12-PBS 39.41 
iNOS-neg - 
iNOS-LPS 37.02 
iNOS-PBS 36.49 
Name Ct 
PAI1-neg - 
PAI1-LPS 37.29 
PAI1-PBS 37.55 
TLR4-neg - 
TLR4-LPS - 
TLR4-PBS - 
TNFα-neg - 
TNFα-LPS 39.34 
TNFα-PBS 36.55 
TF-neg - 
TF-LPS 37.45 
TF-PBS 34.62 
ICAM-neg - 
ICAM-LPS - 
ICAM-PBS - 
ESEL-neg - 
ESEL-LPS - 
ESEL-PBS - 
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Melt data for cord 1
 
 
Figure 3.6. Melt Data (cord 1) 
 
 
 
 
Table 3.6. Summary of Genes and Melt temperatures (cord 1) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Name Melt temp° 
PAI1-neg - 
PAI1-LPS - 
PAI1-PBS 83.2 
TLR4-neg 78.8 
TLR4-LPS 80.2 
TLR4-PBS - 
TNFα-neg 80.3 
TNFα-LPS 81 
TNFα-PBS 81.3 
TF-neg 77.5 
TF-LPS 80 
TF-PBS 85 
ICAM-neg - 
ICAM-LPS - 
ICAM-PBS - 
ESEL-neg 79 
ESEL-LPS 79.5 
ESEL-PBS 78.7 
Name Melt temp° 
B2M-neg - 
B2M-LPS 80 
B2M-PBS 86.3 
IL1B-neg 78.5 
IL1B-LPS 81.5 
IL1B-PBS - 
IL6-neg 80.7 
IL6-LPS 80.5 
IL6-PBS 82 
IL8-neg 82.2 
IL8-LPS 82 87.5 
IL8-PBS 81 87.8 
IL12-neg 81.5 
IL12-LPS 81.2 
IL12-PBS - 
iNOS-neg - 
iNOS-LPS - 
iNOS-PBS 84 
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The internal control standard (housekeeping gene) used in this Real Time PCR was 
Beta 2 Microglobulin (B2M). The background threshold was set to give a threshold 
cycle (Ct) for each gene. The results in Table 3.5 show very little amounts of cDNA, 
this made it difficult to measure gene expression. 
A dissociation curve (melt curve) was produced for each sample, this was to ensure 
that only the desired product was detected. The melt temperatures for each sample 
should be within 0.5-1°C of each other. The results in Table 3.6 indicate possible 
DNA contamination or primer dimer taking place where two peaks appear from one 
sample. 
Due to the inadequate amounts of cDNA detected for each gene and a non reliable Ct 
reading for B2M (housekeeping gene), gene expression evaluation was inconclusive. 
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3.4. Immune Response Induction: Cord 2 
 
Table 3.7. Summary of umbilical cord 2 information: Segment weights, 
lengths, perfusate solutions used and time period. 
 
Experiment 
Section Perfused Time Length(mm) Weight(g) 
1 PBS (control) 4 hours 105 16.057 
2 LPS (1μg/ml) 4 hours 120 9.943 
3 LPS + HSS 4 hours 110 10.997 
 
Table 3.8. Nanodrop Spectrometer Data: RNA quality check for each 
cord segment (cord 2) 
 
Experiment – Nanodrop Data 
Sample ID ng/μL 
Concentration
A260 260/230 260/280 
 
Const. 
PBS(control) 551.55 13.789 0.89 1.67 40 
LPS 340.94 8.524 0.52 1.52 40 
LPS + HSS 228.12 5.703 0.41 1.51 40 
 
 
Gene expression was measured in response to LPS and combination LPS+HSS. 
The isolated RNA from each sample was quality checked with the Nanodrop 
spectrometer and results presented in Table 3.8. All perfused segments resulted in 
good RNA purity with 260/280 ratio values of >1.50.readings >1.50. RNA samples 
were then used to produce cDNA as described in section 2.9. Real Time PCR was 
performed for gene expression analysis.  
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Quantitation data for SYBR Green for Cord 2 
 
 
 
 
 
 
 
 
Figure 3.7. Quantitation Data for SYBR Green (cord 2) 
 
Table 3.9. Summary of Genes and Threshold cycle Ct (cord 2) 
 
 
 
 
 
 
 
 
 
 
 
 
 
Name Ct 
TNF-αneg - 
TNF-α-PBS 33.61 
TNF-α-LPS 30.12 
TNFα-LPS+HSS 28.75 
TF-neg - 
TF-PBS - 
TF-LPS 22.88 
TF-LPS+HSS 29.78 
ICAM-neg - 
ICAM-PBS - 
ICAM-LPS 29.78 
ICAM-LPS+HSS - 
ESEL-neg - 
ESEL-PBS - 
ESEL-LPS 20.01 
ESEL-LPS+HSS 28.30 
Name Ct 
B2M-neg - 
B2M-PBS 28.21 
B2M-LPS 26.80 
B2M-LPS+HSS 28.08 
IL1B-neg - 
IL1B-PBS 33.02 
IL1B-LPS 26.91 
IL1B-LPS+HSS 29.67 
iNOS-neg - 
iNOS-PBS 33.43 
iNOS-LPS 31.00 
iNOS-LPS+HSS 32.54 
TLR4-neg - 
TLR4-PBS - 
TLR4-LPS - 
TLR4-LPS+HSS - 
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Melt data for cord 2 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.8. Melt Data (cord 2) 
 
Table 3.10. Summary of Genes and Melt Temperatures (cord 2) 
 
 
 Name Melt temp° 
B2M-neg - 
B2M-PBS 87.2 
B2M-LPS 87.3 
B2M-LPS+HSS 87.3 
IL1B-neg - 
IL1B-PBS - 
IL1B-LPS 90.5 
IL1B-LPS+HSS 91 
iNOS-neg - 
iNOS-PBS - 
iNOS-LPS - 
iNOS-LPS+HSS - 
TLR4-neg - 
TLR4-PBS - 
TLR4-LPS - 
TLR4-LPS+HSS - 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Name Melt temp° 
TNF-αneg - 
TNF-αPBS - 
TNF-αLPS 92 
TNFα-LPS+HSS 92.8 
TF-neg - 
TF-PBS - 
TF-LPS 85.8 
TF-LPS+HSS 86.3 
ICAM-neg - 
ICAM-PBS - 
ICAM-LPS - 
ICAM-LPS+HSS - 
ESEL-neg - 
ESEL-PBS 88 
ESEL-LPS 88 
ESEL-LPS+HSS - 
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Table 3.11. Summary of Gene Expression Profile Data (cord 2)  
 
 
 
Gene 
Normalised 
ICN Gene 
Normalised 
ICN 
ESel-Control 0 TF-Control 0 
ESel-LPS 25.41882 TF-LPS 1.105642 
ESel-
LPS+HSS 0.958857
TF-
LPS+HSS 0.158604 
ICAM-Control 0
TLR4-
Control 0 
ICAM-LPS 0.762643 TLR4-LPS 0 
ICAM-
LPS+HSS 0
TLR4-
LPS+HSS 0 
IL1B-Control 0.084054
TNFa-
Control 0.503114 
IL1B-LPS 2.18183 TNFa-LPS 0.248113 
IL1B-
LPS+HSS 2.378788
TNFa-
LPS+HSS 0.811941 
iNOS-Control 0.121137   
iNOS-LPS 0.005642   
iNOS-
LPS+HSS 0.175089   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.9. Gene Expression Profile (cord 2) 
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The internal control standard (housekeeping gene) used for this Real Time PCR was 
Beta 2 Microglobulin (B2M). 
After normalizing the expression of each gene to that of the housekeeping gene, B2M, 
it was observed that LPS stimulated endothelial cells have unregulated ESEL 
expression greater than 8 - fold than that of the control (PBS). In the presence of HSS, 
ESEL has decreased expression to 2-fold to that of the control. LPS has also 
increased regulation of ICAM 2-fold, IL1B 4-fold and TF 2-fold. The impact of HSS 
on LPS activation is evident in gene expression of ESEL, ICAM and TF, ultimately 
suppressing the up regulation of these genes. ESEL, ICAM and TF cytokines are 
known to be induced in endothelial cells in the presence of inflammatory stimuli like 
LPS.  
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3.5. Immune Response Induction: Cord 3 
 
Table 3.12. Summary of umbilical cord 3 information. Segment weights, 
lengths, perfusate solutions used and time period 
Experiment 
Section Perfused Time Length(mm) Weight(g) 
1 PBS (control) 4 hours 45 15.67 
2 LRS 4 hours 49 15.0 
3 LPS (1μg/ml) 4 hours 40 12.92 
4 LPS + HSS 2 hours +   
     2 hours 
50 12.0 
 
 
 
Table 3.13. Nanodrop Spectrometer Data: RNA quality check for each 
cord segment (cord 3) 
Experiment 
ng/μL A260 260/230 260/280 Const. Sample ID 
Concentration  
Control(PBS) 330.35 8.259 0.50 1.56 40 
LRS 284.62 7.116 0.44 1.48 40 
LPS 217.13 5.428 0.35 
 
1.42 40 
LPS + HSS 208.66 5.217 0.33 1.39 40 
 
 
 
 
Gene expression was measured in response to LRS, LPS and combination LPS+HSS. 
Isolated RNA from each sample was quantified using a nanodrop spectrometer. The 
concentrations were recorded in Table 3.13. The 260/280 ratio values are low with 
LPS isolated RNA sample recorded at 1.42.  All RNA samples were used to produce 
cDNA for Real Time PCR. 
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Quantitation data for SYBR Green for cord 3 
 
 
 
 
Figure 3.10. Quantitation data for SYBR Green (cord 3) 
 
 
 
 
Table 3.14. Summary of genes and threshold cycle (cord 3) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Name Ct 
B2M-PBS 24.28 
B2M-LPS 28.39 
B2M-LPS+HSS 28.33 
B2M-LRS 26.40 
IL1β-PBS 32.94 
IL1β-LPS 29.22 
IL1β-LPS+HSS 30.26 
IL1β-LRS 29.54 
iNOS-PBS 31.73 
iNOS-LPS - 
iNOS-LPS+HSS 33.03 
iNOS-LRS - 
TLR4-PBS - 
TLR4-LPS - 
TLR4-LPS+HSS - 
TLR4-LRS - 
Name Ct 
TNFα-PBS - 
TNFα-LPS 32.50 
TNFα-LPS+HSS - 
TNFα-LRS - 
TF-PBS 30.84 
TF-LPS 23.89 
TF-LPS+HSS 26.65 
TF-LRS 25.24 
ESEL-PBS 31.24 
ESEL-LPS 21.63 
ESEL-LPS+HSS 22.78 
ESEL-LRS 22.72 
ICAM-PBS 33.53 
ICAM-LPS 27.87 
ICAM-LPS+HSS 28.10 
ICAM-LRS 29.86 
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Melt Data for cord 3 
 
 
 
Figure 3.11. Melt data (cord 3) 
 
 
 
 
Table 3.15. Summary of genes and melt temperatures (cord 3) 
 
Name Melt 
temp° 
B2M-PBS 87 
B2M-LPS 87.2 
 
 
 
 
 
Name Melt 
temp° 
TNFα-PBS - 
TNFα-LPS - 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
B2M-LPS+HSS 87.2 
B2M-LRS 87 
TNFα-LPS+HSS - 
IL1β-PBS - 
TNFα-LRS - 
IL1β-LPS 88.8 
TF-PBS 83.7 
TF-LPS 85.5 
IL1β-LPS+HSS 88.5 
IL1β-LRS 88.7 
TF-LPS+HSS 85.7 
iNOS-PBS - 
TF-LRS 85.7 
iNOS-LPS - 
ICAM-PBS - 
ICAM-LPS - 
iNOS-LPS+HSS - 
iNOS-LRS - 
TLR4-PBS - 
ICAM-LPS+HSS - 
ICAM-LRS - 
TLR4-LPS - 
ESEL-PBS 88 
ESEL-LPS 
TLR4-LPS+HSS - 
TLR4-LRS - 
87.7 
ESEL-LPS+HSS 87.5 
ESEL-LRS 87.7 
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Table 3.16. Summary of Gene Expression Profile Data (cord 3) 
 
 
Gene 
Normalised 
ICN 
 
Gene 
Normalised 
ICN 
ESel-Control 0.063638
 
iNOS-LPS 0 
ESel-LPS 134.1575
 
iNOS-
LPS+HSS 11.57995 
ESel-
LPS+HSS 566.1752
 
 
 iNOS-LRS 0 
ESel-LRS 17.62928 TF-Control 0.003004 
ICAM-Control 0.030681 TF-LPS 26.156 
ICAM-LPS 8.351366
 TF-
LPS+HSS 514766.9 
ICAM-
LPS+HSS 29.85016
 
 
TF-LRS 2.749562  
TLR4-
Control 
 
ICAM-LRS 4.863645 0  
IL1B-Control 0.003997 TLR4-LPS 0  
TLR4-
LPS+HSS  
 
 
 
 
 
 
IL1B-LPS 0.812339 0 
IL1B-
LPS+HSS 7.200989 TLR4-LRS 0 
TNFa-
Control IL1B-LRS 0.421942 0 
iNOS-Control 0.021249 TNFa-LPS 0.041572 
 
 
 
 
 
Figure 3.12. Gene Expression Profile (cord 3) 
 
 
  
TNFa-
LPS+HSS 0 
  TNFa-LRS 0 
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Beta-2 Microglobulin (B2M) was the internal control standard (housekeeping gene) 
used for Real Time PCR. 
Ideally the melt temperature for each primer pair should be the same or within 0.5-
1°C of each other. The recorded melt readings recorded and listed in Table 3.15 were 
successful results, indicating that the specific gene product is being detected with no 
interference or contamination. 
Endothelial cell stimulation from LPS has shown an 8-fold up regulation of E-SEL, I-
CAM and TF genes. The introduction of HSS also shows a positive 8-fold increase of 
each of these genes.  
IL1B is unregulated 2-fold compared to that in the presence of HSS it is unregulated 
8-fold. Inducible NOS (iNOS) had also been unregulated 8-fold with HSS but in LPS 
stimulation alone there is no expression of this gene. 
The overall results showed that HSS contributes entirely to the gene expression of 
iNOS, and increases the up regulation of IL1B. 
The known cytokines of endothelial cells, ESEL, ICAM and TF gene expressions 
have not been affected by HSS in this cord. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Results 57
 
3.6. Immune Response Induction: Cord 4 
 
Table 3.17. Summary of umbilical cord 4 information. Segment weights, 
lengths, perfusate solutions used and time period 
 
Experiment 
Perfused Time Length(mm) Weight(g) Section 
1 PBS (control) 4 hours 90 9.8 
2 LPS (1μg/ml) 4 hours 110 10.5 
3 LPS+HSS 2 hours + 
2hours 
70 7.9 
 
 
Table 3.18.  RNA quality check: Nanodrop spectrometer data for each 
cord segment (cord 4) 
Experiment – Nanodrop Data 
Sample ID ng/μL A260 260/230 260/280 
 
Const. 
Control(PBS) 192.47 4.812 .32 1.48 40 
LPS 447.15 11.179 .78 1.70 40 
LPS+HSS 340.01 8.500 .60 1.58 40 
 
 
Gene expression was measured in response to LPS and combination LPS+HSS. 
RNA isolated from samples was purity assessed using the Nanodrop spectrometer. 
The 260/280 ratio values were recorded in table 3.18. Only PBS had the lowest 
260/280 ratio value of 1.48. All RNA samples were used to produce quality cDNA 
for Real Time PCR.   
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Quantitation data for SYBR Green for cord 4 
 
 
 
 
 
 
 
 
 
Figure 3.13. Quantitation data for SYBR Green (cord 4) 
 
 
Table 3.19. Summary of genes and the threshold cycle (cord 4) 
 
Name Ct 
B2M-PBS 18.99 
B2M-LPS 20.53 
B2M-LPS+HSS 16.63 
IL-1β-PBS 32.48 
IL-1β-LPS 24.68 
IL-1β-LPS+HSS 19.53 
iNOS-PBS 29.73 
iNOS-LPS 35.94 
iNOS-LPS+HSS 32.06 
TLR4-PBS 33.09 
TLR4-LPS - 
Name  
 
 
Ct 
TNFα-PBS 30.75 
TNFα-LPS 
 
- 
TNFα-LPS+HSS 
 
 
29.20 
TF-PBS 33.83 
TF-LPS  23.90 
TF-LPS+HSS  
 
19.50 
 
 
 
 
 
 
ICAM-PBS 31.99 
ICAM-LPS 27.38 
ICAM-LPS+HSS 20.95 
ESEL-PBS 32.51 
ESEL-LPS 19.79 
ESEL-LPS+HSS 16.21 TR4-LPS+HSS 30.05 
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Melt Data for cord 4 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.14. Melt data (cord 4) 
 
 
 
Table 3.20. Summary of Genes and Melt Temperatures (cord 4) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Name Melt temp° Name Melt temp° 
B2M-PBS 86.5 
B2M-LPS 86.5 
TNFα-PBS 84 
TNFα-LPS 85.2 
B2M-LPS+HSS 86.5 
IL-1β-PBS - 
TNFα-LPS+HSS 86 
IL-1β-LPS 90 
TF-PBS - 
TF-LPS - 
IL-1β-LPS+HSS 90 
iNOS-PBS 86.3 
TF-LPS+HSS 85 
iNOS-LPS 88.5 
ICAM-PBS - 
ICAM-LPS - 
iNOS-LPS+HSS - 
TLR4-PBS - 
ICAM-LPS+HSS - 
TLR4-LPS - 
ESEL-PBS 87.7 
ESEL-LPS 87.3 
ESEL-LPS+HSS 87.3 TLR4-LPS+HSS 87.7 
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Table 3.21. Summary of Gene Expression Profile Data (cord 4) 
 
 
 Gene 
Normalised 
ICN  Gene 
Normalised 
ICN 
ESel-Control 736.1406 TF-Control 8158.893 
ESel-LPS 2.298194 
 
 
 
 
TF-LPS 0.16943 
ESel-
LPS+HSS 1.718896
TF-
LPS+HSS 0.442395 
ICAM-Control 2566.006
TLR4-
Control 0.003426 
ICAM-LPS 0.039796 TLR4-LPS 0  
ICAM-
LPS+HSS 
TLR4-
LPS+HSS   
 
 
 
0.265375 0.007323 
TNFa-
Control IL1B-Control 0.155308 0.078705 
IL1B-LPS 0.276012 TNFa-LPS 0 
IL1B-
LPS+HSS 
TNFa-
LPS+HSS  0.229002 0.001428 
 
 
 
 
 
iNOS-Control 0.021249   
iNOS-LPS 0.104472   
iNOS-
LPS+HSS 0.000294   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
. 
 
 
Figure 3.15. Gene expression profile (cord 4) 
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The internal control standard (housekeeping gene) used for this Real Time PCR was 
Beta 2 Microglobulin (B2M). 
It was observed from the gene expression results in Figure 3.15 that ESEL, ICAM 
and TF have been up regulated 8-fold in the control (PBS) samples. The result of this 
gives evidence that ESEL, ICAM and TF expressions are induced in resting 
endothelial cells without any inflammatory stimuli. The large 8-fold increase may be 
due to individual cord heterogeneity. LPS has up regulated gene expression of ESEL 
6-fold but in combination stimulation with HSS, ESEL falls to less than 4-fold. 
HSS interferes with the stimulation of LPS on endothelial cells. 
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3.7. Immune Response Induction: Cord 5 
 
 
Table 3.22. Summary of umbilical cord 5 information. Segment weights, 
lengths, perfusate solutions used and time period 
 
 
 
Table 3.23. Nanodrop Spectrometer Data: RNA quality check for each 
cord segment (cord 5) 
 
 
 
Gene expression was measured  in response to HSS and LRS perfusion. 
The isolated RNA samples were quantified using the Nanodrop spectrometer. Results 
were recorded in Table 3.23. The 260/230 ratio values were >1.5, but of low quality. 
The highest 260/280 ratio value was 1.63 for the Lactated Ringers (LRS) perfused 
segment. All RNA samples were used to produce cDNA for Real Time PCR. 
 
 
 
 
Experiment 
Perfused Time Length(mm) Weight(g) Section 
1 PBS (control) 4 hours 70 8.7 
2 HSS 4 hours 95 12.8 
3 LRS 2 hours  92 7.9 
Experiment – Nanodrop Data 
Sample ID ng/μL A260 260/230 260/280 Const. 
 
Control(PBS) 334.44 8.361 0.55 1.51 40 
HSS 370.85 9.271 0.57 1.53 40 
LRS 502.24 12.556 0.96 1.63 40 
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Quantitation data for cord 5 
 
 
 
 
 
 
 
 
Figure 3.16. Quantitation data for SYBR Green (cord 5) 
 
Table 3.24. Summary of genes and threshold cycle Ct (cord 5) 
 
Name Ct 
B2M-neg - 
B2M-PBS 17.81 
B2M-LRS 30.82 
B2M-HSS 24.46 
IL1B-neg - 
Name 
 
 
Ct 
TNFα-neg - 
TNFα-PBS 
 
29.23 
TNFα-LRS  
 
32.45 
TNFα-HSS - 
TF-neg  - 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
IL1B-PBS 27.57 TF-PBS 27.49 
TF-LRS 30.61 
TF-HSS 26.85 
ESEL-neg - 
ESEL-PBS 28.75 
ESEL-LRS 31.07 
ESEL-HSS 21.68 
ICAM-neg - 
IL1B-LRS 29.67 
IL1B-HSS 27.73 
iNOS-neg - 
iNOS-PBS 28.44 
iNOS-LRS 28.32 
iNOS-HSS - 
TLR4-neg - 
TLR4-PBS 29.15 ICAMP-PBS 28.06 
TLR4-LRS 32.75 ICAM-LRS - 
TLR4-HSS - ICAM-HSS - 
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Melt data for cord 5 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.17. Melt data (cord 5) 
 
 
 
Table 3.25. Summary of genes and melt temperatures (cord 5) 
 
 
 
 
Name Melt temp° 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
B2M-neg - 
B2M-PBS 84.8 
B2M-HSS 85 89.7 
B2M-LRS 85.2 
IL1B-neg - 
IL1B-PBS - 
IL1B-HSS - 
IL1B-LRS - 
iNOS-neg - 
iNOS-PBS 82.5 87.3 
iNOS-HSS 83.7 
iNOS-LRS 83.3 
TLR4-neg - 
TLR4-PBS - 
TLR4-HSS - 
TLR4-LRS - 
Name Melt temp° 
TNFα-neg 89.3 
TNFα-PBS 83 89.7 
TNFα-HSS - 
TNFα-LRS 83.3 90 
TF-neg - 
TF-PBS - 
TF-LPS - 
TF-LRS - 
ESEL-neg 87.5 
ESEL-PBS - 
ESEL-HSS - 
ESEL-LRS 88.2 
ICAM-neg 82 91 
ICAMP-PBS 83 91.7 
ICAM-HSS - 
ICAM-LRS 82.8 91.5 
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Table 3.26. Summary of Gene Expression Profile Data (cord 5) 
 
 
 
 
Normalised 
ICN 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.18. Gene Expression Profile (cord 5) 
 
Gene Gene 
Normalised 
ICN 
ESel-
Control 
TF-
Control 0.0034 0.001789 
ESel-HSS 9.446954 TF-HSS 0.958624 
ESel-
Ringers 2634380
TF-
Ringers 977525 
ICAM-
Control 0.010927
TLR4-
Control 0.010607 
ICAM-HSS 0
TLR4-
HSS 0 
ICAM-
Ringers 0
TLR4-
Ringers 3854187 
IL1B-
Control 0.002452
TNFa-
Control 0.004521 
IL1B-HSS 0.083368
TNFa-
HSS 0 
IL1B-
Ringers 
TNFa-
Ringers 1367010 0.981007 
iNOS-
Control 0.006335   
iNOS-HSS 0   
iNOS-
Ringers 12.15964   
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The internal control standard (housekeeping gene) used in this Real Time PCR was 
Beta 2 Microglobulin. 
Evidence from the gene expression profile in Figure 3.18 shows an 8-fold up 
regulation of ESEL when endothelial cells are exposed to HSS and LRS. There is 
also an 8-fold up regulation of IL1B, iNOS and TF for LRS stimulation. TNF-α gene 
is also expressed 2-fold in the presence of LRS but is not expressed in resting 
endothelial cells or stimulation with HSS. The gene expression of ICAM is 
suppressed in all samples. 
The gene expression for the PBS (control) samples were suppressed, this result may 
of been due to gene heterogeneity of each individual umbilical cord.  
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3.8. DMXAA & TCM Responses for cord 6 
 
Table 3.27. Summary of umbilical cord 6 information. Segment weights, 
lengths, perfusate solutions used and time period 
 
Perfusion Experiment 
Perfused Time Length(mm) Weight(g) Section 
1 PBS (control) 4 hours 70 7.178 
2 TCM 4 hours 75 6.281 
3 TCM + 
DMXAA 
(250μg/ml) 
2 hours + 48  
     4 hours 6.545 
4 
 
 
DMXAA 
(250μg/ml) 
4 hours 56 7.808 
 
           100+  1     2      3     4    5      6     7    8      9 
         Ladder 
Description   
  
  Lane 
Number Size (bp)  
 100bp+   Ladder     - 
1 RNA Pol                                  100bp                                            90bp 
125bp                              
125 
90 2 β Actin   
3 PBS (RNA Pol) 125 
4 PBS (β actin) 
 
90  
 125 5 TCM (RNA Pol) 
6 TCM (β actin) 90  
 
                                                                                 
7 DMXAA(RNA Pol) 125 
                                                                                                              
                         
 
 
 
 
Figure 3.19.  cDNA gel elctrophoresis (cord 6) 
The agarose gel was loaded with 5μl 100bp+ molecular weight standard ladder, 
8μl of both housekeeping genes (RNA Pol & β Actin) were loaded into lanes 1 & 
2. Samples (8μl) were loaded into lanes 3-9.  
 
 
TCM
DMXAA + 
(RNA Pol) 
 
125 
DMXAA + TCM(β 
actin) 
 
9 90 
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The cord segments were perfused successfully with appropriate solutions stated in 
Table 3.27. Confirmation of. cDNA with 2 housekeeping genes (β Actin & RNA Pol 
II) was performed and quantitated by agarose gel electrophoresis method described in 
section 2.9.1. The cDNA produced as described in section 2.9 was run on a 1% 
acrylimide gel and bands visualized with ethidium bromide. In lanes 2 & 3 the bands 
are clearly visible in the gel. The β Actin detected at approximately 90bp and RNA 
Pol II detected at 125bp. The cDNA samples loaded into gel lanes 3-9 detected each 
housekeeping gene of interest with strong visual bands. The samples were then 
prepared for Real Time PCR as described in section 2.11. 
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3.8.1. Tumour conditioned Media Perfusion for cord 6 
 
cDNA sample from tumour conditioned media perfused segment was analysed for 
expression of specific genes. Primers used are previously described in Table 2.10. 
 
Quantitation Data for SYBR Green for cord 6 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.20. Quantitation data for SYBR Green (TCM cord 6) 
 
 
Table 3.28. Summary of Genes and Threshold cycle Ct (TCM cord 6) 
 
Name  Ct 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
*NTC=No template Control 
IL-8 neg 23.58 
IL-8 – TCM 27.89 
IL-8 - TCM 26.09 
TNF – neg - 
TNF – TCM - 
TNF – TCM - 
TF – neg - 
TF – TCM - 
TF – TCM - 
RNA Pol-neg - 
RNA Pol-TCM - 
RNA Pol-TCM - 
Name Ct 
HPSY - neg NTC 
HPSY –TCM 28..90 
HPSY- TCM NTC 
E-Sel -  neg 31.40 
E-Sel – TCM 31.49 
E-Sel – TCM 32.56 
ICAM - neg 37.76 
ICAM – TCM - 
ICAM – TCM - 
IL-1β – neg - 
IL-1β – TCM 34.04 
IL-1β - TCM - 
IL-6 – neg 29.99 
IL-6 – TCM - 
IL-6 – TCM 34.38 
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Melt data for cord 6 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.21. Melt data (TCM cord 6) 
           
           
Table 3.29. Summary o f Genes and Melt Temperatures (TCM cord 6) 
 
 
 
 
 
  
Name Melt temp ° Name Melt temp ° 
 
 
 
 
  
 
 
 
  
 
 
 
 
 
 
 
HPSY - neg 79.5 
HPSY- TCM 
IL-8 neg 83.0 
- IL-8 – TCM 82.7 
HPSY- TCM 81.7 IL-8 - TCM 82.5 
E-Sel -  neg 80.0 TNF – neg - 
E-Sel – TCM 79.6 TNF – TCM - 
E-Sel – TCM 79.5 TNF – TCM - 
ICAM - neg 81.7 TF – neg - 
ICAM – TCM - TF – TCM 79.7 
ICAM – TCM - TF – TCM - 
IL-1β – neg 80.3 RNA Pol-neg - 
IL-1β – TCM 81.5 RNA Pol-TCM - 
IL-1β - TCM 80.2 RNA Pol-TCM - 
IL-6 – neg 80.2 
IL-6 – TCM 80.3 
IL-6 – TCM 80.5 
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Table 3.30. Summary of Gene Expression Profile Data (TCM cord 6) 
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Normalised 
ICN 
log(2) 
ICN Gene 
-
28.3937 ESEL-TCM 2.83562E-09 
 
-
22.6326ICAM-TCM 1.53782E-07
 -
14.6017 
 
IL1B-TCM 4.02199E-05
-
17.9472IL6-TCM 3.95697E-06 
 
 IL8-TCM 6.82987E-15
-
47.0571
RNAPol-
TCM 0.000116602
-
13.0661 
 
 
-
55.6412TF-TCM 1.77965E-17
 
 
 
TNF-TCM 8.95688E-10
-
30.0563
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.22. Gene Expression Profile (TCM cord 6) 
 
 
 
 
 
 
Results 72
 
The internal control standard (housekeeping gene) used in this Real Time PCR was 
Human Proteosome subunit Y (HPSY). The Ct values for each gene were recorded in 
Table 3.28. It was observed that Ct results were recorded for negative controls of 
ESEL, IL8 and IL6, this indicates possible contamination, from observing the melt 
data in Table 3.29, specific products were detected cofirming reaction contamination 
for all 3 of these genes. 
The gene expression profile was produced by normalizing the genes to that of the 
primary housekeeping gene HPSY. It was clearly visible in Figure 3.22 that the 
response of endothelial cells when stimulated with tumour conditioned media (TCM) 
significantly effected the expression of all genes. TF gene expression was down 
regulated the most. The results from this perfusion experiment provided evidence of 
how effective TCM is on gene regulation in HUVEC.  The gene expression of the 
contaminated genes ESEL, IL6 and IL8 are inconclusive due to contamination. 
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3.8.2. Tumour conditioned Media Perfusion + DMXAA for cord 6 
cDNA sample from Tumour conditioned media + DMXAA perfused segment was 
analysed for expression of specific genes. 
 
 
 
Quantitaion data for SYBR Green for cord 6 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.23. Quantitation data for SYBR Green (TCM+DMXAA cord 6) 
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Table 3.31. Summary of Genes and Threshold cycles  
(TCM+DMXAA cord 6) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Name Ct Name Ct 
HPSY - neg - IL-8 neg 24.64 
HPSY –
TCM+DMXAA 
- IL-8 –  
TCM+DMXAA
27.1 
HPSY-  
TCM+DMXAA  
- IL-8 -  
TCM+DMXAA
27.95 
E-Sel -  neg 27.93 TNF – neg - 
E-Sel –  
TCM+DMXAA 
23.55 TNF –  
TCM+DMXAA
6.61 
E-Sel –  
TCM+DMXAA 
24.10 TNF –  
TCM+DMXAA
- 
TF – neg ICAM - neg - - 
ICAM –  
TCM+DMXAA 
32.22 TF –  
TCM+DMXAA
- 
TF –  
TCM+DMXAA
- 
RNA Pol-neg 23.84 
RNA Pol- 
TCM+DMXAA
- 
RNA Pol- 
TCM+DMXAA
- 
ICAM –  
TCM+DMXAA 
- 
IL-1β – neg - 
IL-1β –  
TCM+DMXAA 
31.28 
IL-1β -  
TCM+DMXAA 
29.87 
IL-6 – neg 30.53 
IL-6 –  
TCM+DMXAA 
- 
IL-6 –  
TCM+DMXAA 
- 
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Melt data for cord 6 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.24. Melt data (TCM+DMXAA cord 6) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Results 76
 
Table 3.32. Summary of Genes and Melt temperatures  
(TCM+DMXAA cord 6)            
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Name Melt Temp ° Name Melt temp ° 
HPSY - neg 80.0 IL-8 neg 82.7 
HPSY –
TCM+DMXAA 
79.3 IL-8 –  
TCM+DMXAA
82.5 
HPSY-  
TCM+DMXAA 
80.2 
E-Sel -  neg 
IL-8 -  
TCM+DMXAA
82.7 
79.3 TNF – neg - 
E-Sel –  
TCM+DMXAA 
78.7 86.8 TNF –  
TCM+DMXAA
- 
E-Sel –  
TCM+DMXAA 
78.0 86.5 TNF –  
TCM+DMXAA
- 
ICAM - neg 80.5 
ICAM –  
TCM+DMXAA 
80.5 
TF – neg - 
TF –  
TCM+DMXAA
- 
ICAM –  
TCM+DMXAA 
80.0 
IL-1β – neg 
TF –  
TCM+DMXAA
- 
- RNA Pol-neg 79.5 88.5 
IL-1β –  
TCM+DMXAA 
80.8 
IL-1β -  
TCM+DMXAA 
80.0 85.0 
RNA Pol- 
TCM+DMXAA
79.5 
RNA Pol- 
TCM+DMXAA
79.5 
IL-6 – neg 79.8 
IL-6 –  
TCM+DMXAA 
80.5 
IL-6 –  
TCM+DMXAA 
80.0 
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Table 3.33. Summary of Gene Expression Profile Data 
(TCM+DMXAA cord 6) 
 
 
 
 
 
Normalised 
ICN 
log(2) 
ICN Gene 
ESEL-
TCM/DMXAA 128.3869157 7.004354
ICAM-
TCM/DMXAA 4.66197E-05 -14.3887
IL1B-TCM/DMXAA 4.065873325 2.023565
IL6-TCM/DMXAA 1436.55199
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Figure 3.25. Gene Expression Profile (TCM+DMXAA cord 6) 
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The internal control standard (housekeeping gene) used in this Real Time PCR was 
RNA Polymerase II, this was the secondary housekeeping gene. The primary 
housekeeping gene Human Proteosome subunit Y was an unreliable internal control 
because there was no recorded Ct value for any of the samples. 
The impact of DMXAA is identified in the gene expression profile displayed in 
Figure 3.25. The TNF-α gene observed up regulated 8-fold. ICAM is the only gene 
that displayed down regulation. The results indicate, DMXAA is suppressing the 
effective action of TCM, and initiating genes to be expressed and up regulated. This 
experiment with samples from TCM perfusion and DMXAA perfusion provided an 
ideal within cord comparison limiting the factors influencing results (ie. heterogeneity 
between cords). 
TNF-α in particular is known to be induced by DMXAA and this is replicated in the 
results from Figure 3.25. However, the recorded Ct values for the controls of IL6 and 
IL8 and ESEL seen in Table 3.31 indicated contamination which had ultimately 
produced misleading results of gene expression for each of these genes shown in the 
gene expression profile (Figure 3.25.) 
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3.9. DMXAA & TCM Responses for cord 7 
 
Table 3.34. Summary of umbilical cord 7 information. Segment weights, 
lengths, perfusate solutions used and time period 
Experiment 
Section Perfused Time Length(mm) Weight(g) 
1 PBS 4 hours 50 9.90 
2 DMXAA 
(125μm) 
4 hours 45 16.6 
3 DMXAA 
(250μM) 
4 hours 50 10.28 
 
4 
TCM  /        
DMXAA 
(250μM) 
2 hours / 65 16.20 
     4 hours 
 
Table 3.35. Nanodrop Spectrometer Data: RNA quality check for each 
cord segment (cord 7) 
Experiment 
ng/μL A260 260/230 260/280 Const. Sample ID 
Concentration  
control 741.65 18.541 0.27 1.21 40 
DMXAA 
(125μM) 
2104.6 52.616 0.53 1.34 40 
DMXAA 
(250μM) 
 
  
1126.6 28.167 0.33 1.28 40 
TCM + 
DMXAA 
(250μM) 
484.72 12.188 0.87 1.52  
Table 3.36. Nanodrop Spectrometer Data 2: RNA quality check for each 
cord segment (cord 7) 
40 
Experiment - Nanodrop 
ng/μL A260 260/230 260/280 Const. Sample ID 
Concentration  
control 559.36 13.984 1.41 1.74 40 
DMXAA 
(125μM) 
419.79 12.245 0.92 1.66 40 
DMXAA 
(250μM) 
219.84 5.496 0.37 1.53 40 
TCM + 
DMXAA 
(250μM) 
548.23 13.706 1.27 1.77 40 
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                        100+     1      2        3        4 
                      Ladder 
Lane 
Number 
   
Description Size (bp)  
- 100bp+   Ladder  
- 1 PBS                          
- 2 DMXAA 125μM  
   
3 DMXAA 250μM -  
    100bp                                     A                 B 
 TCM + DMXAA 
(250μM) 
-  
4  
 
 
 
 
Figure 3.26. RNA Gel Electrophoresis (cord 7) 
The agarose gel was loaded with 4μl 100bp+ molecular weight standard Ladder,  
Samples (2μl) were loaded into lanes 1-4.  
 
 
The RNA isolated from each cord segment was assessed on an agarose gel to check 
the quality of extracted RNA. In Figure 3.26. only 1 band can be visualized in lane 1 
and lane 3. There are no sharp 18s or 28s bands so the  RNA was then checked with 
the Nanodrop spectrometer. The results in Table 3.35 indicate a low 260/280 ratio, 
with results for PBS, and both DMXAA perfusions < 1.50, so the RNA isolation 
procedure was repeated. The final RNA quality results are shown in Table 3.36, the 
260/280 ratio value of all 4 segments were > 1.5, this result was suitable to produce 
cDNA. The cDNA samples were run on an agarose gel for 30 mins (Figure 3.31) with 
housekeeping gene RNA Pol II. There were 2 bands seen for TCM+DMXAA only; 
however, there was no band identified for the housekeeping gene. This experimental 
procedure was inconclusive. 
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3.10. DMXAA & TCM Responses for cord 8 
 
 
Table 3.37. Summary of umbilical cord 8 information. Segment weights, 
lengths, perfusate solutions used and time period 
 
Experiment 
Perfused Time Length(mm) Weight(g) Section 
1 PBS (control) 4 hours 105 15.67 
2 DMXAA 
(250μM) 
2 hours 115 12.92 
3 TCM 2 hours  80 9.26 
    
 
 
 
 
 
            100+     1      2       3       4 
          Ladder 
 
 
  
Description            
 
Lane 
Number 
Size 
(bp) 
 
 
100bp                                                       100bp+  Ladder - 
1 β Actin                    90 
2 PBS(β-actin)           
     90bp                                                       
  
 90 
3 TCM(β-actin)         90 
4 DMXAA(β-actin)   
 
90  
 
 
 
 
 
 
 
 
 
Figure 3.27. cDNA Gel Electrophoresis (cord 8) 
The agarose gel was loaded with 8μl 100bp+ molecular weight standard ladder, 
then 8μl of housekeeping gene β -actin in lane 1. Samples (8μl) were loaded into 
lanes 2-4.  
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The gene expression was measured in response to DMXAA and TCM. 
The RNA was isolated from each sample successfully and used to produce cDNA. As 
described in section 2.9. The quality of cDNA was confirmed on an agarose gel 
performed with housekeeping gene β-actin as seen in Figure 3.27. 
The housekeeping gene β-actin was positively detected at 90bp. A single band was 
detected at approximately 90bp for each sample, indicating the cDNA quality was 
suitable to measure gene expression using Real Time PCR. 
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3.10.1 PBS (control) Perfusion for cord 8 
 
cDNA sample from PBS perfused segment was analysed for expression of specific 
genes. Primers used are previously described in Table 2.10. 
 
 
 
 
 
Quantitation data for SYBR Green for cord 8 
 
 
 
 
 
 
 
 
 
 
  
       
 
 
 
Figure 3.28. Quantitation data for SYBR Green (PBS cord 8) 
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Table 3.38. Summary of Genes and Threshold cycle Ct (PBS cord 8)  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
*NTC=No template Control 
 
  
 
 
 
 
 
 
 
 
 
 
 
Name Ct Name Ct 
HPSY - neg NTC IL-8 -  neg 25.22 
HPSY –PBS 19.91 IL-8 – PBS 16.95 
HPSY- PBS 21.77 
  
IL-8 – PBS 16.44 
  
E-Sel -  neg NTC TNF – neg - 
E-Sel – PBS 17.93 TNF – PBS - 
E-Sel – PBS 20.26 
  
ICAM – neg NTC 
ICAM – PBS 26.50 
ICAM – PBS 27.68 
  
IL-1β – neg NTC 
IL-1β – PBS 24.88 
IL-1β - PBS 20.85 
  
TNF – PBS - 
  
TF – neg - 
TF – PBS 23.85 
TF - PBS 23.54 
  
RNA Pol- neg - 
RNA Pol-PBS 20.77 
RNA Pol-PBS 21.26 
IL-6 - neg 33.64 
IL-6 -PBS 26.73 
IL-6 -PBS 25.76 
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Melt data for cord 8 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.29. Melt data (PBS cord 8) 
 
 
Table 3.39. Summary of Genes and Melt Temperatures  (PBS cord 8)  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Name Melt temp° Name 
IL-8 -  neg 82.2 
Melt temp° 
HPSY - neg - 
IL-8 – PBS 81.5 81.5 
IL-8 – PBS 81.5 81.5 
  
HPSY –PBS 88.8 
HPSY- PBS 88.7 
 
TNF – neg - 
TNF – PBS 
 
E-Sel -  neg - 
- E-Sel – PBS 86.0 
TNF – PBS - 
  
E-Sel – PBS 85.8 
 
TF– neg - 
TF – PBS 
 
ICAM – neg - 
84.0- ICAM – PBS 83.5 91.5 
TF - PBS 84.0- 
  
ICAM – PBS 84.5 91.2 
 
RNA Pol- neg - 
 
IL-1β – neg - 
RNA Pol-PBS 89.3 IL-1β – PBS 88.5 
RNA Pol-PBS 81.0 89.3 IL-1β – PBS 88.3 
  
IL-6 - neg - 
IL-6 –PBS 86.0 
IL-6- PBS 86.0 
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Table 3.40. Summary of Gene Expression Profile Data (PBS cord 8) 
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Figure 3.30 Gene Expression Profile (PBS cord 8) 
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The internal control standard (housekeeping gene) used for this Real Time PCR was 
Human Proteosome subunit Y. The results for gene expression measured in response 
to PBS perfusion are represented in Figure 3.30. 
The Ct values for each gene was recorded in Table 3.38 and revealed Ct values for 
negative controls for both IL6 and IL8, this is possible DNA contamination. From 
observing the melt temperatures values recorded in Table 3.39, IL6 had no recorded 
melt temperature for the negative but IL8 recorded an ideal melt temperature. This 
indicated the specific product was being detected and contamination was confirmed. 
The gene expression analysis for IL8 was unreliable. 
IL1β was expressed the most with a 3-fold up regulation. ESEL expression was up 
regulated 1-fold. TNF-α gene expression is not detected, providing evidence it is not 
induced in the resting endothelial cells of this cord. 
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3.10.2 Tumour Conditioned Media Perfusion for cord 8 
cDNA sample from Tumour conditioned media perfused segment was analysed for 
specific gene expression. 
 
Quantitation data for SYBR Green for cord 8 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.31. Quantitation data for SYBR Green (TCM cord 8) 
 
Table 3.41. Summary of Genes and Threshold cycle Ct (TCM cord 8) 
 
Name Ct  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
HPSY - neg - 
HPSY –TCM 23.16 
HPSY- TCM 19.41 
E-Sel -  neg - 
E-Sel – TCM 20.63 
E-Sel – TCM 20.01 
ICAM – neg - 
ICAM – TCM 31.70 
ICAM – TCM 30.29 
IL-1β – neg - 
IL-1β – TCM - 
IL-1β – TCM 24.20 
Name Ct 
IL-6 - neg 31.52 
IL-6 –TCM 24.96 
IL-6- TCM 25.92 
IL-8 -  neg 26.28 
IL-8 – TCM 18.98 
IL-8 – TCM 18.95 
TNF – neg - 
TNF – TCM - 
TNF – TCM - 
TF– neg - 
TF – TCM 24.60 
TF – TCM 24.66 
RNA Pol- neg 37.72 
RNA Pol-TCM 23.93 
RNA Pol-TCM 23.53 
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Melt data for cord 8 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.32. Melt data (TCM cord 8) 
 
 
 
 
 
Table 3.42. Summary of Genes and Melt Temperatures (TCM cord 8) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
*NTC=No template Control 
 
 
 
Name Melt temp° Name 
IL-6 - neg 81.3 
IL-6 –TCM 79.5 86.0 
IL-6- TCM 80.5 86.0 
IL-8 -  neg 81.7 
Melt temp ° 
HPSY - neg NTC 
HPSY –TCM 88.7 
HPSY- TCM 76.5 
E-Sel -  neg 79.0 86.3 
IL-8 – TCM 81.3 86.7 E-Sel – TCM 76.7 85.7 
IL-8 – TCM 81.5 86.5 E-Sel – TCM 78.3 85.7 
TNF – neg - 
TNF – TCM 
ICAM – neg 79.2 
- ICAM – TCM 84.7 89.5 
TNF – TCM - ICAM – TCM 77.8 85.8 
TF– neg 77.3 IL-1β – neg 79.8 
TF – TCM 84.0 IL-1β – TCM 79.8 
TF – TCM 83.8 91.5 IL-1β – TCM 79.5 88.2 
RNA Pol- neg - 
RNA Pol-TCM 76.2 83.5 89.2 
RNA Pol-TCM 83.0 89.2 
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Table 3.43. Summary of Gene Expression Profile data (TCM cord 8) 
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Figure 3.33. Gene Expression Profile (TCM cord 8) 
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The internal control standard (housekeeping gene) used for this Real Time PCR. 
The gene expression profile results of TCM perfusion are shown in Figure 3.33. 
There is evidence of an 8-fold up regulation of IL1B but the overall trend identifies 
the decreasing effect tumour conditioned media has on gene regulation.  ESEL, 
ICAM and TF, cytokines expressed in resting endothelial cells have all been 
significantly down regulated. 
The gene expression of TNF-α has been suppressed when HUVEC was stimulated 
with tumour conditioned media. 
Interleukin-6 (IL6), IL8 and RNA Pol showed reaction contamination and were 
excluded from gene expression analysis. 
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3.10.3. DMXAA Perfusion for cord 8 
cDNA sample from DMXAA perfused segment was analysed for expression of 
specific genes. 
 
Quantitation data for SYBR Green for cord 8 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.34. Quantitation data for SYBR Green (DMXAA cord 8) 
 
 
 
Table 3.44. Summary of Genes and Threshold cycles Ct (DMXAA cord 8) 
 
 
 
Name Ct 
HPSY - neg - 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
HPSY- DMXAA 21.13 
HPSY- DMXAA 21.90 
E-Sel -  neg 28.93 
E-Sel – DMXAA 22.08 
E-Sel – DMXAA 21.59 
ICAM – neg - 
ICAM -DMXAA 26.76 
ICAM–DMXAA 28.60 
IL-1β – neg  
IL-1β –DMXAA 25.99 
IL-1β –DMXAA 27.92 
Name Ct 
IL-6 - neg 31.94 
IL-6 - DMXAA 28.41 
IL-6 - DMXAA 27.57 
IL-8 -  neg 23.58 
IL-8 – DMXAA 23.78 
IL-8 – DMXAA  
TNF – neg - 
TNF – DMXAA - 
TNF – DMXAA - 
TF– neg - 
TF – DMXAA 28.16 
TF – DMXAA 29.38 
RNA Pol- neg - 
RNA Pol-DMXAA 22.78 
RNA Pol-DMXAA 22.62 
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Melt Data for cord 8 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.35. Melt data (DMXAA cord 8) 
 
 
Table 3.45. Summary of Genes and Melt Temperatures (DMXAA cord 8) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Name Melt temp° Name 
IL-6 - neg 79.0 
Melt temp° 
HPSY - neg 79.0 92.5 
HPSY- DMXAA 82.5 88.7 
HPSY- DMXAA 82.7 88.8 
E-Sel -  neg 79.0 
E-Sel – DMXAA 78.7 86.0 
E-Sel – DMXAA 78.5 85.8 
ICAM – neg - 
ICAM -DMXAA - 
ICAM–DMXAA - 
IL-6 - DMXAA 79.3 86.0 
IL-6 - DMXAA 78.8 
IL-8 -  neg 81.7 
IL-8 – DMXAA 81.7 
IL-8 – DMXAA 81.5 
TNF – neg - 
TNF – DMXAA - 
TNF – DMXAA - 
TF– neg 77.5 
TF – DMXAA 78.5 84.0 
TF – DMXAA 
IL-1β – neg 78.7 
IL-1β –DMXAA 79.3 88.5 
78.0 84.0 
RNA Pol- neg - 
IL-1β –DMXAA 81.3 88.3 
RNA Pol-DMXAA 77.2 89.3 
RNA Pol-DMXAA 89.0 
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The internal control standard (housekeeping gene) used in this Real Time PCR was 
Human Proteosome subunit Y. 
The Ct values for each gene are represented in Table 3.44 and showed adequate 
amounts of cDNA; however, for IL8 and ESEL control genes, a Ct value was 
recorded, this indicates contamination. This was also confirmed from observing the 
melt temperature results recorded in Table 3.35. IL8 produced a melt temperature 
matching the melt temperature of the 2 replicate samples. This indicated the correct 
product had been detected, confirming contamination. Gene expression analysis was 
inconclusive from these results. 
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3.11. DMXAA & TCM Responses for cord 9 
 
Table 3.46. Summary of umbilical cord 9 information: Segment 
weights, lengths, perfusate solutions used and time period 
Experiment 
Perfused Time Length(mm) Weight(g) Section 
1 PBS (control) 4 hours 50 16.057 
2 DMXAA 
(250μM) 
4 hours 45 9.943 
3 TCM / 
DMXAA 
(250μM) 
2 hours / 
     4 hours 
 
 
 
Table 3.47. Nanodrop Spectrometer Data: RNA quality check for each 
cord segment (cord 9) 
30 10.997 
Experiment 
Sample ID ng/μL 
Concentration
A260 260/230 260/280 
 
Const. 
control 385.87 9.647 0.66 1.43 
 
40 
DMXAA 
(250μM) 
273.05 6.826 0.44 1.37 40 
TCM + 
DMXAA 
(250μM) 
264.66 6.617 0.44 1.18 40 
 
Gene expression was measured in response to DMXAA and TCM+DMXAA. 
RNA was successfully isolated from all samples and purity assessed on the nanodrop 
spectrometer. The cord segment perfused with PBS (control) was shown to give the 
highest 260/280 ratio value of 1.43 seen in Table 3.47. indicating the purity of RNA 
extracted. However, the results from all 3 perfused segments were very low 
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100+     1       2       3      4        5       6      7       8      9 Lane 
Number Description 
 
Size (bp) Ladder 
 
 
 
100bp+  Ladder - 
1 - RNA Pol II 
2 - PBS (RNA Pol) 
 90 TCM + 
DMXAA(RNA Pol) 3  
 
 
90 4 DMXAA(RNA Pol) 
5 - - 
                                                           6 PBS(RNA Pol) - 
7 
TCM + 
DMXAA(RNA Pol) 
90 
8 
 
 DMXAA 
250μM(RNA Pol) 
- 
9 
 
 - DMXAA 
125μl(RNA Pol)  
 
 
 
 
Figure 3.36. cDNA Gel Electrophoresis (cord 9) 
The agarose was loaded with 5μl 100bp+ molecular weight standard ladder  and 
8μl of housekeeping gene (RNA Pol II) in lane 1. Samples (8μl) were loaded into 
lanes 2-4. cDNA samples from table 3.34 (cord 7) perfusion experiment were 
loaded into lanes 6-9.  
 
The RNA samples were used to produce cDNA as outlined in section 2.9. The cDNA 
samples were then quality assessed on an agarose gel shown in Figure 3.36 with 
housekeeping gene RNA Pol II. The brightest band in lane 3 was detected 
representing the cDNA sample for TCM+DMXAA (shown by the arrow) There was 
no visual band seen for the housekeeping gene which made it difficult to compare 
samples. The poor result produced from the agarose gel seen in Figure 3.36 prevented 
Real Time PCR gene expression analysis. 
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3.12. DMXAA & TCM Responses for cord 10 
Table 3.48. Summary of umbilical cord 10 information. Segment weights, 
lengths, perfusate solutions used and time period 
 
Experiment 
Perfused Time Length(mm) Weight(g) Section 
1 PBS (control) 4 hours 100 15.67 
2 DMXAA 
(250μM) 
2 hours 98 12.92 
3 TCM 2 hours  80 9.26 
   
 
Table 3.49. Nanodrop spectrometer data: RNA quality check for each 
cord segment (cord 10) 
Experiment 
Sample ID ng/μL A260 260/230 260/280 
Concentration  
Const. 
control 383.07 9.577 0.59 1.54 40 
DMXAA 
(250μM) 
499.2 12.481 0.73 1.70 40 
TCM + 
DMXAA 
(250μM) 
193.39 4.835 0.37 
 
 
 
1.36 40 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.37. Optical Density (OD) Measurements 
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100+       1     2      3     4      
Ladder 
 Lane 
Number 
Size  Description  
100bp+ Ladder               - 
1 RNA Pol 
 
125  
- 2 PBS(RNA Pol)                                                      
 
 
3 
TCM + 
DMXAA(RNA 
Pol) 
- 
4 
DMXAA(RNA 
Pol) 
        
-  
 
 
 
       
 
 
Figure 3.38. cDNA Gel Electrophoresis (cord 10) 
The agarose gel was loaded with 5μl 100bp+ molecular weight standard 
ladder.Lane 1 loaded with 8μl of both housekeeping genes (RNA Pol & β Actin). 
Samples (8μl) were loaded into lanes 2-4. 
 
The isolated RNA from perfused samples in table 3.48 was purity assessed with the 
Nanodrop spectrometer. RNA from TCM+DMXAA samples produced a low 260/280 
ratio value of <1.50. DMXAA gave an ideal reading for RNA purity with 260/280 
ratio value of >1.7, supported with 2 clear peaks (18s and 28s) in Figure 3.37. All 3 
RNA samples were used to produce cDNA and an agarose gel performed with RNA 
Pol II as an internal standard control (housekeeping gene). Only a single band was 
detected for DMXAA sample as indicated by the arrow; however, RNA Pol II was 
undetected. Only PBS and DMXAA cDNA samples were used for gene analysis in 
Real Time PCR. 
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3.12.1. PBS (control) Perfusion for cord 10 
 
cDNA sample from PBS perfused segment was analysed for expression of specific 
genes. Primers used are previously described in Table 2.10. 
 
Quantitation data for SYBR Green for cord 10 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.39. Quantitation data for SYBR Green (PBS cord 10)  
 
 
 
Table 3.50. Summary o f Genes and Threshold cycle Ct (PBS cord 10)  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Name Ct Name Ct 
HPSY - neg 19.49 IL-6 - neg - 
HPSY –PBS - IL-6 –PBS - 
HPSY- PBS - IL-6- PBS 3.51 
E-Sel -  neg - 
E-Sel – PBS 5.02 
E-Sel – PBS - 
ICAM – neg - 
ICAM – PBS 3.08 
IL-8 -  neg 16.74 
IL-8 – PBS - 
IL-8 – PBS - 
TNF – neg 10.57 
TNF – PBS - 
ICAM – PBS - 
IL-1β – neg 
TNF – PBS - 
17.24 TF– neg - 
IL-1β – PBS 3.14 TF – PBS 6.45 
IL-1β – PBS 5.56 TF - PBS - 
RNA Pol- neg 8.65 
RNA Pol-PBS 5.13 
RNA Pol-PBS 3.46 
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Melt data for cord 10 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.40. Melt data (PBS cord 10) 
 
 
 
 
 
 
Table 3.51. Summary of Genes and Temperatures (PBS cord 10) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Name Melt temp° Name 
IL-6 - neg 76.5 81.0 
Melt temp ° 
HPSY - neg 80.0 
IL-6 -PBS - HPSY –PBS - 
IL-6 -PBS 77.8 HPSY- PBS - 
IL-8 -  neg 81.8 E-Sel -  neg 78.7 
IL-8 – PBS 76.5 81.5 E-Sel – PBS 78.0 
IL-8 – PBS 77.2 81.5 E-Sel – PBS 78.0 
TNF – neg - ICAM – neg 78.5 
TNF – PBS - ICAM – PBS - 
TNF – PBS - ICAM – PBS - 
TF – neg - IL-1β – neg 78.2 
TF – PBS - IL-1β – PBS 80.0 
TF - PBS - IL-1β - PBS - 
RNA Pol- neg - 
RNA Pol-PBS - 
RNA Pol-PBS - 
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The cDNA from PBS perfused segments were prepared as described in section 2.92. 
Low Ct values of < 10 were recorded in Table 3.50. The poor recorded Ct values 
indicate clear contamination of the reaction. 
The melt curve produced displayed signs of DNA contamination and primer dimer.  
The results of this Real Time PCR are inconclusive preventing any gene expression 
analysis the PBS (control) sample.  
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3.12.2. DMXAA Perfusion for cord 10 
 
cDNA sample from DMXAA perfused segment was analysed for expression of 
specific genes. Primers used are previously described in Table 2.10. 
 
Quantitation data for SYBR Green for cord 10 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.41. Quantitation data for SYBR Green (DMXAA cord 10) 
 
 
 
Table 3.52. Summary of Genes and Threshold cycle (DMXAA cord 10) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Name Ct Name 
IL-6 - neg 26.57 
IL-6 –DMXAA 24.37 
Ct 
HPSY - neg - 
HPSY –DMXAA - 
HPSY- DMXAA 20.44 
E-Sel -  neg 28.86 
E-Sel – DMXAA 22.19 
E-Sel – DMXAA 22.41 
ICAM – neg 33.06 
IL-6- DMXAA 20.86 
IL-8 -  neg 25.96 
IL-8 – DMXAA 17.29 
IL-8 – DMXAA 16.71 
TNF – neg 8.40 
TNF – DMXAA 29.04 
TNF – DMXAA 29.04 
TF– neg - 
ICAM -DMXAA 27.29 
ICAM- DMXAA 28.13 
IL-1β – neg 32.59 
IL-1β –DMXAA TF – DMXAA 24.19 21.06 
IL-1β –DMXAA 24.62 TF – DMXAA 25.31 
RNA Pol-neg - 
RNA Pol-DMXAA - 
RNA Pol-DMXAA - 
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Melt data for cord 10 
 
 
 
Figure 3.42. Melt data (DMXAA cord 10) 
 
 
 
 
 
 
 
 
Table 3.53. Summary of Genes and Temperatures (DMXAA cord 10) 
 
 Name Melt temp ° 
 HPSY - neg - 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
HPSY –DMXAA 88.8 
HPSY- DMXAA 88.7 
E-Sel -  neg 79.0 
E-Sel – DMXAA 85.7 
E-Sel – DMXAA 78.2 85.5 
ICAM – neg 79.5 
ICAM -DMXAA 83.0 91.5 
ICAM -DMXAA - 
IL-1β – neg 80.0 
IL-1β – DMXAA 79.0 84.2 88.3
IL-1β - DMXAA 83.8 88.2 
Name Melt 
temp° 
IL-6 - neg 79.8 
IL-6 –DMXAA - 
IL-6 - DMXAA 80.5 85.7 
IL-8 -  neg 82.0 
IL-8 – DMXAA 81.5 86.7
IL-8 – DMXAA 83.8 88.2
TNF – neg - 
TNF – DMXAA 84.5 
TNF – DMXAA 84.5 
TF – neg - 
TF – DMXAA 79.2 84.0
TF – DMXAA 83.8 
RNA Pol- neg - 
RNA Pol-DMXAA 83.8 89.2
RNA Pol-DMXAA 83.5 89.0
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The internal control gene (housekeeping gene) used in this Real Time PCR was 
Human Proteome subunit Y (HPsY). The Ct values for each gene were recorded in 
Table 3.52. and produced suitable Ct values of < 33; however the negative control for 
each gene was detected indicating contamination of the reaction. There should be no 
Ct values recorded for any of the negative controls. A gene expression profile could 
not be produced from this Real Time PCR. 
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3.13. DMXAA & TCM Responses for cord 11 
 
Table 3.54. Summary of umbilical cord 11 information: Segment weights, 
lengths, perfusate solutions used and time period 
Experiment 
Perfused Time Length(mm) Weight(g) Section 
1 PBS (control) 4 hours 100 16.06 
2 TCM  2 hours 100 9.26 
 
3 DMXAA 
(250μg/ml) 
4 hours 80 11.78 
Table 3.55.Nanodrop Spectrometer Data: RNA quality check for each 
cord segment (cord 11) 
Experiment - Nanodrop 
ng/μL A260 260/230 260/280 Const. Sample ID 
Concentration  
PBS (control) 334.44 8.361 0.55 1.51 40 
TCM 643.34 16.083 0.28 1.07 40 
 
 
DMXAA 
(250μg/ml 
370.85 9.271 0.57 1.53 
      100+          1                2              3        
   Ladder 
 
      
  
40 
Lane 
Number Description 
 
Size 
100bp+ Ladder - 
1 PBS - 
 
 
 
 
 
                            100bp 
 
 
 
 
 
 
 
Figure 3.43. RNA Gel Electrophoresis (cord 11) 
The agarose gel was loaded with 4μl 100bp+ molecular weight standard ladder,  
RNA samples (2μl) were loaded into lanes 1-3.  
2 DMXAA - 
3 TCM  - 
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             100+     1        2       3       4       5      6      7       8        9 
           Ladder 
 
Lane 
Number 
       
   Description 
 
Size
100bp+  Ladder -  
90 1 β Actin          
2 PBS(β actin)       90 
3 DMXAA(β actin 
 
90                                                 
125 4 RNA Pol II                                                                                               125bp 
5 PBS(RNA Pol)      125  
125 6 DMXAA(RNAPol)100bp                                                   90bp 
 
 
 
 
 
 
 
Figure 3.44. cDNA Gel Electrophoresis (cord 11) 
The agarose was loaded with 5μl 100bp+ molecular weight standard ladder The 
housekeeping gene (β Actin) loaded in lane 1 & 8μl of housekeeping gene (RNA 
Pol II) in lane 4.  The cDNA samples (8μl) were loaded into lanes 2,3,5,6. 
 
Gene expression responses to TCM and DMXAA were measured using Real Time 
PCR. The RNA isolated from each sample were purity assessed on an agarose gel 
displayed in Figure 3.43. Each sample was loaded in lanes 1-3. No bands were 
detected in the gel, this indicated no RNA present or small amounts isolated 
undetectable on the gel. The RNA was reisolated as described in section 2.7. Re 
isolated RNA was the assessed using the Nanodrop spectrometer. The 260/280 ratio 
values for this isolation shown in Table 3.55 revealed low quality RNA. TCM RNA 
sample recorded the lowest 260/280 ratio value of 1.07. Only PBS and DMXAA 
samples were used to produce cDNA and quality confirmed on an agarose gel seen in 
Figure 3.44. Bands were positively identified for each housekeeping gene. 
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3.13.1. PBS (control) Perfusion for cord 11 
 
cDNA sample from PBS perfused segment was analysed for expression of specific 
genes. Primers used are previously described in Table 2.10. 
 
 
Quantitation Data for Cycling B.Green 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.45. Quantitation data for SYBR Green (PBS cord 11) 
 
 
 
Table 3.56. Table of Genes and Threshold cycle Ct (PBS cord 11) 
 
Name Ct  
HPSY - neg 37.80  
HPSY –PBS -  
 HPSY- PBS - 
 E-Sel -  neg 30.75 
 E-Sel – PBS 35.46 
 E-Sel – PBS 31.20 
 ICAM – neg 36.22  
ICAM – PBS -  
ICAM – PBS -  
 
 
 
 
IL-1β – neg 31.34 
IL-1β – PBS 35.93 
IL-1β – PBS 36.54 
Name Ct 
IL-6 - neg 30.55 
IL-6 –PBS 32.02 
IL-6- PBS 34.00 
IL-8 -  neg 26.32 
IL-8 – PBS 27.07 
IL-8 – PBS 27.13 
TNF – neg - 
TNF – PBS - 
TNF – PBS - 
TF– neg 37.18 
TF – PBS - 
TF - PBS - 
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Melt Data for Melt A.Green 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.46. Melt data (PBS cord 11) 
 
 
 
 
 
 
 
Table 3.57. Summary of Genes and Temperatures (PBS cord 11) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Name Melt temp ° Name Melt temp ° 
HPSY - neg 80.3 IL-6 - neg 80.0 
HPSY –PBS 77.2 IL-6 –PBS 80.0 
HPSY- PBS - IL-6- PBS 79.0 
E-Sel -  neg 78.8 IL-8 -  neg 81.2 
E-Sel – PBS 78.7 IL-8 – PBS 81.2 
E-Sel – PBS 78.8 IL-8 – PBS 81.0 
ICAM – neg - TNF – neg - 
ICAM – PBS - TNF – PBS - 
ICAM – PBS - TNF – PBS - 
IL-1β – neg 79.5 TF– neg 79.0 
IL-1β – PBS 80.0 TF – PBS - 
IL-1β – PBS 79.8 TF - PBS - 
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The internal control standard (housekeeping gene) used in this Real Time PCR was 
Human Proteosome subunit Y (HPSY) there was no secondary housekeeping gene 
used.. The recorded Ct values were represented in Table 3.56. The negative control 
for each gene except TNF-α, which was undetected, produced a Ct value which 
indicates DNA contamination or contamination with the reaction. Observation of the 
melt data presented in Table 3.57 confirms contamination, ultimately preventing any 
reliable gene analysis profile to be produced. The results from this Real Time PCR 
were unsuccessful and inconclusive. 
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3.13.2. Tumour Conditioned Media Perfusion for cord 11 
 
cDNA sample from Tumour conditioned media perfused segment was analysed for 
expression of specific genes. Primers used are previously described in table 2.10. 
 
 
Quantitation data for Cycling B.Green 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.47. Quantitation data for SYBR Green (TCM cord 11) 
 
 
Table .3.58. Summary of Genes and Threshold cycle Ct (TCM cord 11) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Name Ct 
IL-6 - neg 27.15 
IL-6 –TCM 23.83 
IL-6- TCM 39.26 
IL-8 -  neg 30.93 
IL-8 – TCM 19.97 
IL-8 – TCM 29.48 
TNF – neg - 
TNF – TCM 20.41 
TNF – TCM - 
TF– neg - 
TF – TCM 39.33 
TF - TCM - 
RNA Pol-neg 15.71 
RNA Pol-TCM - 
RNA-Pol-TCM - 
Name Ct 
HPSY - neg - 
HPSY –TCM - 
HPSY- TCM - 
E-Sel -  neg - 
E-Sel – TCM 21.19 
E-Sel – TCM 33.42 
ICAM – neg 13.15 
ICAM – TCM - 
ICAM – TCM - 
IL-1β – neg 18.49 
IL-1β – TCM 35.52 
IL-1β – TCM 32.47 
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Melt data for Cycling A.Green 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.48. Melt data (TCM cord 11) 
 
 
 
 
 
 
Table 3.59. Summary of Genes and Melt temperatures (TCM cord 11) 
 
 
 
Name Melt temp ° Name Melt temp ° 
HPSY - neg 77.5 82.5 88.0 93.5 IL-6 - neg 79.2 87.0 90.0 
HPSY –TCM 78.2 82.0 87.0 IL-6 –TCM 73.5 81.0 
HPSY- TCM 77.0 87.3 91.7 IL-6- TCM 73.8 78.7 88.3 
E-Sel -  neg 78.5 IL-8 -  neg 81.5 90.7 
E-Sel – TCM 78.5 90.3 IL-8 – TCM 81.5 
E-Sel – TCM 78.5 86.5 IL-8 – TCM 81.5 
ICAM – neg 78.0 84.3 89.0 93.5
ICAM – 
TCM 
78.0 85.0 
TNF – neg 76.8 82.5 89.5 
TNF – TCM 75.7 78.0 85.3 91.0
ICAM – 
TCM 
76.5 83.0 90.2 
TNF – TCM 73.8 80.0 82.8 87.7
TF– neg 79.7 
TF – TCM 78.0 84.0 91.5 
IL-1β – neg 79.5 TF – TCM 78.5 
IL-1β – TCM 80.0 RNA Pol-TCM 74.0 80.0 87.5 92.2
IL-1β – TCM 80.2 RNA Pol-TCM 75.0 83.5 89.0 
RNA Pol-TCM 75.5 80.7 88.2 
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The internal control standard used in this Real Time PCR was Human Proteosome 
subunit Y. The Ct value results recorded in Table 3.58 revealed no detection for the 
primary housekeeping gene HPSY and the secondary housekeeping gene RNA Pol II 
produced a result for the negative control. The melt data displayed in Table 3.59 
showed significant DNA contamination and primer dimer, all gene samples detected 
more than 1 peak suggesting more than the specific product is being detected. The 
result of an undetected primary housekeeping gene and contaminated secondary 
housekeeping gene prevented a reliable gene expression analysis. 
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Chapter Four 
Discussion 
 
 
 
4.1. Method Development 
 
The aim of this study was to develop an ex vivo method in order to characterise 
endothelial cell responses to inflammatory stimuli and DMXAA (presence and 
absence of tumour conditioned media) using whole human umbilical cords.  
 
4.2. Ex Vivo Perfusion Model 
The ex vivo perfusion model was compatible with each cord sample collected. The 
adjustable features were able to accommodate for different cord lengths and size. The 
advantage of using this model when exposing the cells to various stimuli was that the 
endothelial cells remained in their normal vascular anatomical relationship to other 
tissues while maintaining cell viability. Another advantage was the ability to perform 
within cord comparisons running three separate chambers together along with the 
continuous intravenous infusion of solutions which minimised handling 
contamination. This was an important factor because heterogeneity between  
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endothelial cells from different cords is evident due to differences in the history of the 
pregnancy which can make the critical interpretation of results difficult (Hughes S.E, 
1996).  
The antivascular effects of DMXAA seem to be mediated through direct and indirect 
effects on tumour vascular endothelial cells in vivo (Ching yet al, 2002). Replicating 
an in vivo environment with the ex vivo perfusion model allowed results to bear 
significant relevance to the antivascular activity of DMXAA in humans. 
 
4.3. MTT Viability Assay 
 
There are a number of methods that have been developed to study endothelial cell 
viability in cell populations. The modern assays have been developed in a microplate 
format (96-well plate) which allows many samples to be analysed rapidly and 
simultaneously. 
Trypan Blue also called ‘Dye Exclusion Method’ is another cell viability assay 
commonly used; this assay measures the number of dead cells in a sample. Trypan 
blue is a vital stain that selectively colours dead tissue and cells blue which is then 
quantitated under a microscope. Because cells are selective in compounds that pass 
through the membrane, viable cells do not absorb trypan blue, so the dead cells are 
measured exclusively. The limitation of this technique is high estimates of viable 
cells present in a sample (Cell isolation techniques, 2004). 
The viability assay chosen for this research had to be rapid and convenient for it to 
work well with the perfusion chamber set up. 
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Tetrazolium Salt MTT (3, (4,5-dimethylthiazol-2-yl)2,5-diphenyl-tetrazolium 
bromide) colourmetric viability assay was the preferred method. The succinate - 
tetrazolium reductase system which belongs to a cells mitochondria and only active in 
viable cells, cleaves MTT to form non-water soluble violet formazan crystals (Altman, 
1979).   
The purple formazan formed gives an estimate of the number of mitochondria present 
hence the number of living cells. This dye solution was measured using a 
spectrophotometer with a wavelength of 570nm. The OD Absorbance reading 
obtained was proportional to the amount of converted dye. 
This technique was suitable as it required no washing or harvesting of cells. 
 
Increased OD = Increased Active Cells 
 
In this research eight cords were collected and measured for cell viability. Only seven 
of these umbilical cords were perfused successfully. Each individual cord was 
divided into two segments to allow within cord comparison and perfused for various 
time periods to give an indication of a time frame in which the HUVEC would still be 
at a viable state (stationary phase). 
Each cord was perfused for the indicated time period in Table 3.1. The MTT solution 
was then added and perfused for an additional 2 hours. The cords length was recorded 
and the OD absorbance of the resultant solution was divided by this figure to help 
give a true and comparable result. 
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The graph seen in Figure 3.4. represents the OD absorbance measurements for each 
cord segment. The highest measurement (OD/mm(x10ֿ³) was recorded at 45, after 
only 2 hours perfusion in contrast to the low values recorded after 5 hours perfusion  
of  1.45 & 1.5 detailed in Table 3.1. 
The perfusion period needed to be long enough to allow combination perfusions to 
also take place (ie.TCM+DMXAA). Evidence from Figure 3.4 show that cells after 2 
hours are still in a metabolically active state, however, perfusion periods  
exceeding 5 hours show a decline in OD Absorbance readings indicating that fewer 
cells are capable of reducing MTT to a coloured formazan losing their viable state. 
However, the OD absorbance measurements of cord 4 question the consistency of 
using MTT assay as a method for testing cell viability. Cord 4, segment 1 in the MTT 
viability experiment recorded an OD of 0.052 after 2.5 hours perfusion, but within the 
same cord, segment 2 recorded an OD of 0.083 after 5 hours perfusion. This result 
indicates cell viability increased from 2 hours to 5 hours. A possible cause for this 
result could be experimental error or unusual perfusion history as the results from 
other perfused cord segments reflect the general trend that cell viability decreases 
over time. With these results it was estimated that endothelial cells within the 
umbilical cord are still alive and active after 2 hours perfusion but cell viability 
slowly declines with increasing time. 
The overall conclusion was that after 6 hours perfusion there are few viable cells 
remaining, capable of metabolizing MTT, so perfusion experiments did not exceed 6 
hours.  
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This assay method has been previously used in other studies to determine endothelial 
cell proliferation (Busby et al, 2003).  
One advantage to using the MTT assay was the cells ability to reduce the salt to give 
a coloured appearance which was easily observed through the chambers and any 
problems (ie.leakage) during the perfusion period of MTT could also be identified. 
It was important to establish a baseline to work from, and the generally consistent 
results for each cord were able to give an estimation of this time frame. 
 
4.4. Isolating HUVEC 
In this study a key objective was to characterise responses of endothelial cells to 
certain stimuli, and compare these results from an ex vivo perfusion model with the  
traditional in vitro HUVEC model. This was unsuccessful; a complete monolayer was 
difficult to maintain and cells were sensitive to subculturing treatment.  
HUVECs were isolated from seven separate umbilical cords by collagenase digestion 
method described in section 2.10 based on the HUVEC isolation method in Jaffe et al, 
1973.   
Due to the poor results seen with the first two isolations the method was altered to try 
and maximise cell yield. These changes included extended incubation periods with 
collagenase A solution still infused in the umbilical vein.  
Collagenase A is prepared from extracellular culture filtrate of Clostridium 
histolyticum containing other proteases including clostripain, a trypsin-like activity 
and a neutral protease. This mixture of enzymes allows gentle dissociation of tissue to 
generate single cells (In Vitro, 2004).  
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Another additional change was massaging the cord by hand for an extended period of 
time. This technique used by Galley et al, 1999, assisted in the release of the attached 
vein endothelial cells. Both of these techniques were used and contributed to an 
increase in endothelial cell yield. 
The endothelial cells extracted were identified as large polygonal cells, visualized 
through a phase contrast microscope (x40 objectives) and later confirmed from paper 
Culture of Human Endothelial Cells Derived from Umbillical Veins: Identification by  
and immunologic criteria, Jaffe et al, 1973. 
The isolated HUVEC were maintained for the first day on RPMI 1640 culture 
medium to establish cell growth thereafter passaged with HUVEC (Complete) 
medium which contained endothelial cell growth factors. The media was changed  
every two days or when required. After the second passage it was difficult to maintain 
cell confluence and cell numbers decreased eventually dying. 
This trend was observed with two additional HUVEC isolations. The medium 
previously used was changed to M199 (Wasserman S et al, 2002). There was a 
positive outcome from this media change resulting in an increase in cell numbers and 
a more confluent monolayer observed. These cells were maintained with HUVEC 
(complete) medium after the first passage; however, after the second passage cell 
confluence and cell numbers decreased again resulting in cell death. 
The isolation of human endothelial cells is known to be time consuming and yields 
can often be low, in addition, the use of primary cells have a number of disadvantages 
such as the presence of contaminating cells, progressive loss of viability and 
differences in the genetic background of the isolates. (Unger et al, 2002). 
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In this research the ability to maintain a working endothelial cell culture isolated from 
individual human umbilical cords was unsuccessful. 
 
4.5. Gene Expression Results 
 
4.5.1. RNA Extraction 
An important first step in RNA extraction was finding the appropriate method of 
cellular disruption for starting material to obtain maximum yield of RNA. In this 
study GiTC lysis solution was used for extraction of endothelial cells from the whole 
umbilical cords. This is a slow cellular disruption solution, ensuring that all RNA in  
the sample is collected for purification. However, in cord 7 RNA quality was poor or 
undetectable so re-isolation procedure was necessary (Table 3.36). 
There are a number of possibilities for poor quality RNA starting with choice of 
extracting solution used.  
GiTC solution, if left too long, is capable of degrading RNA by releasing 
endogeneous RNases internally before purification (The Basics: RNA Isolation, 
Ambion, 2007) however, if left for a short period it may result in incomplete 
disruption and decreased yield because some of the RNA in the sample will still  
remain in intact cells and therefore is unavailable for subsequent purification (Cell 
Disruption: Getting the RNA out, Ambion 2007). 
The RNA isolation procedure used in this research was very tedious but all steps were 
necessary, it was found that if RNA quality was poor, re-isolation was capable of 
purifying the RNA even more to give acceptable results. 
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4.5.2. DMXAA & Tumour Conditioned Media 
DMXAA was prepared as described in section 2.6.4.  
Tumour conditioned media was collected from NZM3 culture flasks once cells had 
reached confluence. This media was perfused through the umbilical cord veins prior 
to DMXAA perfusion. The addition of tumour conditioned media assisted in 
replicating a tumour microenvironment for the HUVECs and offered response 
differences to DMXAA. 
 
4.5.3. Real-Time PCR  
Real time PCR is one of the most sensitive and reproducible quantification methods 
for gene expression analysis. It provides simultaneous movement of gene expression 
in many different samples for a number of genes (Silver et al, 2006). 
Housekeeping genes can effect Real Time PCR results. The ideal housekeeping gene 
should be constantly transcribed in all cell types and tissues and remain stable  
between samples that are taken from different time points and under different 
experimental conditions. This is almost impossible so it is critical that an appropriate 
housekeeping gene is selected. 
Relative quantification was achieved by analyzing the Ct value, with data quality 
examined through a regression model. The approach identified the correlation 
between the Ct value and logrithm (Base 2) transformed concentration of template, 
giving a significant linear relationship for each standard curve (Yuan J, 2005) shown 
in Figure 4.1 & 4.2. This data was then was then interpreted in to a bar graph. 
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Figure 4.1. Linear Regression PCR data: All genes displayed for PBS 
perfusion 
 
 
 
 
 
 
 
 
 
 
Figure 4.2. Linear Regression PCR data: 
Individual sample (RNAPol II – PBS)  
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Beta-2 Microglobulin (B2M) was the initial housekeeping gene of choice for immune 
response experiments but was subsequently shown to be unreliable for endothelial 
cells. 
Human Proteosome Subunit Y (HPSY) was the housekeeping gene of choice for 
TCM and DMXAA perfusion experiments with RNA Pol II as the secondary 
housekeeping gene. 
Dissociation curves (melt temperatures) were also run to ensure that the desired 
amplicon was being detected. This curve data was also required because the 
methodology process included the use of SYBR green which is capable of detecting 
any double stranded DNA including primer dimers, contaminating DNA and PCR 
products from misannealed primers ( Real time PCR handbook, 2003). This could 
give false positive results in gene analysis. 
Ideally samples should yield a sharp peak at the melting temperature indicating the 
products are specific, if a melt curve reveals a series of peaks this indicates there is 
not enough discrimination between specific and non-specific reaction products 
(Ambion, 2004) 
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4.5.4. Immune Responses 
LPS induces a severe inflammatory response by initiating multiple intracellular 
signaling events including NF-κB which ultimately leads to synthesis and release of 
pro-inflammatory mediators and adhesion molecules, TNF-α and ICAM (Ulevitch R 
& Schletter J, 1995). 
Beta-2 Microglobulin (B2M) was used as the internal control standard (housekeeping 
gene) for all immune response gene analysis. 
 
4.5.4.1. Immune Response: Cord 1 
In this experiment gene response was measured for LPS induced inflammatory 
response. Isolated RNA from perfusion samples were quantitated using the Nanodrop  
spectrometer. Each section produced good quality RNA with suitable 260/280 ratio 
values. PBS gave the lowest reading of 1.51 but was still used to produce cDNA. 
Real Time PCR was performed with housekeeping gene B2M, quantitation data 
presented in table 3.5 indicate very little cDNA present in each sample with Ct values 
>34. The B2M (housekeeping gene) for LPS cDNA sample had the highest Ct 
(threshold cycle) value of 39.76. This indicated the need to use a higher concentration 
of cDNA in the Real Time PCR. 
A melt curve (dissociation curve) was also produced and data displayed in Table 3.6. 
The results reveal possible contamination as temperatures do not lie within 0.5-1°C of 
each other and also possible primer dimer for both IL8-PBS & IL8-LPS. Both of 
these gene samples reveal 2 peaks which can be a result of self-annealed primers. 
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The overall results from this Real Time PCR could not be used to evaluate gene 
expression efficiently and based on the cDNA control, PCR reaction, the 
concentration of cDNA was adjusted for cord 2. 
 
4.5.4.2. Immune Response: Cord 2 
In this experiment gene response to LPS stimuli and LPS +HSS combination was 
measured. The RNA was successfully isolated from each cord segment with all 
260/280 ratio values > 1.5. The cDNA was then produced from each RNA sample for 
Real Time PCR. All genes were successfully detected and Ct values recorded in 
Table 3.9. TLR4 gene samples recorded no conclusive Ct values. The genes 
expressed were normalized to housekeeping gene Beta-2 Microglobulin (B2M) and 
results  
represented in Figure 3.9. This revealed an 8-fold up regulation of E-SEL when 
stimulated with LPS but only a 2-fold increase in the presence of HSS. 
Tissue Factor (TF), ICAM & IL1B were also upregulated with LPS stimulation.  
A 6-fold decrease in expression of E-SEL when perfused with combination 
LPS+HSS indicates HSS has an effective impact on LPS stimulation, suppressing its 
action on endothelial cells. 
 
4.5.4.3. Immune Response: Cord 3 
Gene expression was measured in response to Lactated Ringers (LRS), LPS & 
combination LPS+HSS.The isolated RNA from each sample revealed suitable 
260/280 ratio values recorded in Table 3.13. The cord was divided into small  
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segments for 4 separate perfusion setups, this made the RNA isolation procedure 
difficult as there was minimal RNA to start with. The cDNA was produced from 
isolated RNA samples for Real Time PCR. 
The detected Ct values represented in Table 3.14. showed suitable amounts of cDNA, 
with only the TLR4 gene undetected. A melt curve was produced and data displayed 
in Table 3.15. The melt readings for IL1β, B2M and ESEL indicated the specific 
amplicon was being detected. 
 An 8-fold up regulation of E-SEL & ICAM is shown in Figure 3.12. for both LPS 
and LPS+HSS. HSS appears to have no effect on LPS for E-SEL in this cord. 
 
4.5.4.4. Immune Response: Cord 4 
Gene expression was measured in response to LPS and combination LPS+HSS. 
RNA was isolated from each sample and purity assessed with nanodrop spectrometer. 
The PBS (control) segment gave the lowest RNA 260/280 ratio value of 1.48. All 
samples were used to produce cDNA for Real Time PCR. 
The poor RNA quality from PBS (control) sample was evident in Table 3.19, Ct 
values for each gene were high indicating inadequate amounts of cDNA. The melt 
data represented in Table 3.20 show possible DNA contamination for iNOS and 
TNF-α. 
Ideally melt results should be identical or 0.5-1°C of each other. iNOS and TNF-α 
have a 2°C difference for each sample. This may be a result of DNA contamination, 
total RNA preparation or non specific amplification. 
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LPS stimulation reveals a 4-fold up regulation of E-SEL. In combination perfusion 
with HSS a 1-fold decrease in expression of E-SEL is observed. Control (PBS) 
samples show an 8-fold expression increase in E-SEL, ICAM & TF. These gene 
expression results indicate that ESEL, ICAM and TF genes are significantly being  
expressed in these HUVEC without any inflammatory stimulation, and which may 
represent a prior inflammatory history of the pregnant women or “problems” during 
delivery. 
 
4.5.4.5. Immune Response: Cord 5 
In this experiment gene expression responses to HSS and LRS were measured. All 3 
RNA samples were used to produce cDNA. The melt temperatures of each gene were 
recorded in Table 3.25., this showed possible DNA contamination or primer dimer 
for gene samples TNFα-PBS, TNF-α LRS, ICAM PBS and ICAM-LRS. 
Gene expression profile (Figure 3.18) shows an 8-fold up regulation of TLR4, TF, 
iNOS, IL1B and ESEL when stimulated by LRS. No genes were expressed for PBS 
(control) samples and stimulation with HSS revealed an 8-fold up regulation of E-
SEL. Intracellular Adehesion Molecule (ICAM) was the only gene response fully 
suppressed. 
 
Final Discussion 
There is evidence from cords 2, 3 and 4 that E-SEL is over expressed when 
stimulated with LPS, but down regulated with the combination of LPS+HSS. The  
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impact of HSS appears to suppress the full effectiveness of LPS stimulation on 
endothelial cells.The up regulation of genes in resting endothelial cells (control) was 
seen in cord 4. This presents evidence that prior inflammatory stimulation of the 
endothelial cells may have taken place before the cord was collected. This may be a 
reflection of the mother’s pregnancy or “problems” during the delivery of the baby.  
 
4.5.5. DMXAA & TCM Perfusion Responses  
The experimental results for DMXAA & Tumour Conditioned Media (TCM) 
perfusion samples were adjusted by normalizing them to housekeeping gene Human 
Proteasome subunit Y. A secondary housekeeping gene RNA POl II was also used in 
Real Time PCR analysis. 
 
4.5.5.1. DMXAA & TCM Responses: Cord 6 
Gene expression responses to TCM, DMXAA and combination TCM+DMXAA were 
measured. Isolated RNA from each sample was used to produce cDNA. The cDNA 
confirmation was performed on an agarose gel with 2 housekeeping genes, β-Actin & 
RNA Pol II. The β-actin gene was detected at 90 bp and RNA Pol II detected at 
125bp. All samples loaded into gel wells gave positive readings and gene can be 
clearly identified by bands in Figure 3.9.  
Tumour Conditioned Media (TCM) Perfusion 
Tumour Conditioned Media (TCM) cDNA samples was used in Real Time PCR. The 
Ct values for each gene were recorded in Table 3.28, and each gene was normalized  
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to the primary housekeeping gene there was no Ct value detected for the secondary 
housekeeping gene RNA Pol II. The negative controls for IL6 and IL8 recorded Ct  
values indicating possible DNA contamination. The melt data in Table 3.29 support 
the evidence of reaction contamination for both of these 2 genes. 
The gene expression profile represented in Figure 3.22 shows down regulation of all 
genes, excluding ESEL, IL6 and IL8 because of contamination in the control.. The 
impact of Tumour Conditioned Media (TCM) suggests that TCM causes down 
regulation of the genes investigated 
TCM & DMXAA Perfusion 
The combination perfusion samples with TCM+DMXAA were also used in Real 
Time PCR. The recorded Ct values in Table 3.31 revealed suitable Ct results < 32, 
but the housekeeping gene HPSY has no recorded Ct; however, the secondary 
housekeeping gene (RNA POl II) detected a Ct result. Using RNA Pol II as the 
internal control standard, a gene expression profile was produced shown in Figure 
3.22 An up regulation of genes was evident in the presence of DMXAA. ICAM is 
still down regulated, but TNF-α, showed an 8-fold up regulation. 
ESEL, IL8 and IL6 are contaminated so gene expression results are not conclusive for 
these genes. 
The experiment with cord 8 is an ideal within cord comparison on the effectiveness of 
both DMXAA and TCM. The initial down regulation of gene expression from TNF is 
effectively interrupted with addition of DMXAA.  
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4.5.5.2. DMXAA & TCM Responses: Cord 7 
In this experiment gene expression responses to DMXAA, TCM+DMXAA and 
DMXAA (125μM) were measured. The first round of isolated RNA was measured on  
an agarose gel shown in Figure 3.26. Only 2 bands were detected in lanes 1 & 3, but 
there are no signs of sharp 18S or 28S bands present. The RNA samples were then  
checked with the Nanodrop spectrometer. These results were recorded in Table 3.35. 
The 260/280 ratio values were < 1.5, RNA isolation was then repeated. The final 
results were recorded in Table 3.36. A significant increase in 260/280 ratio values 
>1.5 were observed. 
The cDNA was produced from each RNA sample and quality confirmed on an 
agarose gel shown in Figure 3.31 with housekeeping gene RNA Pol II. There were 2 
bands detected for TCM+DMXAA segment only, but no band was observed from the 
RNA Pol II control. This experimental procedure was unsuccessful. 
 
4.5.5.3. DMXAA & TCM Responses: Cord 8 
Gene responses to DMXAA and TCM were measured in this experiment. RNA was 
successfully isolated from each sample and was used to produce cDNA. The cDNA 
was then confirmed on an agarose gel shown in Figure 3.27with housekeeping gene 
β-actin. Three bright bands are positively identified with PBS, DMXAA and TCM 
samples for β-actin at 90bp. All cDNA samples were then used for Real Time PCR. 
PBS Perfusion 
PBS perfused cDNA samples were performed in Real Time PCR and Ct values 
displayed in Table 3.38. Overall there appeared to be significant amounts of detected  
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cDNA with Ct values of <33, to give conclusive gene expression results; however Ct 
values of negative control were recorded for IL6 and IL8, contamination of these  
genes was confirmed from the melt data presented in Table 3.39. The close 
temperature melts for IL8 indicate this specific amplicon is being detected. The melt 
temperatures observed also indicate possible contamination or primer dimer for gene 
samples I-CAM, IL1B & RNA Pol II. 
A gene expression profile shown in Figure 3.30.was produced by normalizing gene 
Ct values to the housekeeping gene HSPY. Results indicate IL1B gene expression 
was up regulated. TNF-α expression was suppressed suggesting it is not expressed in 
the resting endothelial cells of this cord. 
TCM Perfusion 
TCM perfused segments were used to produce cDNA for Real Time PCR. 
The gene expression analysis represented in Figure 3.33 clearly shows an overall 
down regulation of gene expression. IL1B is the only gene which has been  
upregulated 8-fold. The melt temperatures for each gene recorded in Table 3.42. show 
more than one value being recorded this could be possible primer dimer or 
contamination of the reaction. Another possibility is the temperature threshold was 
set too high, ultimately detecting more than one peak in the reaction. The genes IL6, 
IL8 and RNA Pol showed contamination revealed from Ct values recorded for each 
negative control. These genes were excluded from gene expression analysis. 
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DMXAA Perfusion 
The DMXAA perfused segment was used to produce cDNA for Real Time pCR. The 
Ct values were recorded in Table 3.44 and showed adequate cDNA for gene 
expression analysis; however, reaction contamination is evident from the negative  
control Ct values detected for genes ESEL, IL6 and IL8. Gene expression analysis 
was inconclusive from these results. 
 
4.5.5.4. DMXAA & TCM Responses: Cord 9 
Gene responses to DMXAA and TCM+DMXAA were measured in this experiment. 
RNA was successfully isolated and purity assessed on the Nanodrop spectrometer. 
The 260/280 ratio values were <1.50 which can indicate possible contamination or 
not enough RNA has been extracted from the sample. The cord segment lengths were 
very short in this experimental procedure and would account for the lack of extracted 
RNA. RNA samples were then used to produce cDNA and the quality was checked 
on an agarose gel shown in Figure 3.36. One band was detected for TCM+DMXAA 
the cDNA sample; however, there was no bands detected for the housekeeping gene 
RNA Pol II. This made it difficult to assess the quality of the cDNA. From the poor 
RNA purity results and cDNA results, Real Time PCR was not performed for gene 
expression analysis. 
 
4.5.5.5. DMXAA & TCM Responses: Cord 10 
Gene expression analysis was measured in response to TCM and TCM+DMXAA. 
RNA was successfully isolated and quantitated using the Nanodrop spectrometer as  
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described in section 2.8. The RNA for DMXAA sample recorded a good 260/280 
ratio value of 1.70, which is also displayed in Figure 3.37. The two sharp peaks in 
Figure 3.37 represent the 18S & 28S rRNA. The cDNA was produced from all 3 
samples and confirmed on an agarose gel run with housekeeping gene RNA Pol II.  
The control gene RNA Pol II was undetected, and only the DMXAA cDNA sample 
produced a small visual band in the gel. 
Due to the poor cDNA gel results, TCM+DMXAA samples were not used to perform 
Real Time PCR. 
PBS Perfusion 
The cDNA from PBS perfused segments were prepared as described in section 2.92. 
Low Ct values of < 10 were recorded in Table 3.50. and clearly indicated 
contamination. A gene expression profile was inconclusive for the PBS (control) 
perfused segment. 
DMXAA Perfusion 
The cDNA from DMXAA perfused samples were also used in Real Time PCR. 
The Ct values for each gene are recorded in Table 3.52. and indicate suitable amounts 
of cDNA with Ct values < 33 recorded; however, the Ct values for the negative 
control of each gene except RNA Pol which was undetected and TF were observed. 
This indicated reaction contamination so no gene analysis profile was produced as 
results would be inconclusive and misleading. 
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4.5.5.6. DMXAA & TCM Responses: Cord 11 
Gene expression was measured in response to DMXAA and TCM stimulation. 
RNA was isolated from each sample and assessed on an agarose gel to confirm RNA 
quality. No bands were detected from any of the samples seen in Figure 3.43. RNA 
was then re-isolated following the method described in section 2.7. All re isolated 
RNA samples were confirmed using the Nanodrop spectrometer. The isolated RNA  
from TCM sample gave a poor 260/280 ratio value of 1.07 seen in Table 3.55. PBS 
and DMXAA recorded low 260/280 ratio values of 1.51 and 1.53 respectively. 
Only PBS and DMXAA RNA samples were used to produce cDNA. The cDNA 
quality was confirmed in an agarose gel, performed with 2 housekeeping genes 
β-actin and RNA Poll II. The gene β-actin was successfully detected at 90 bp, and 2 
positive bands were identified from both PBS and DMXAA samples, seen in Figure 
3.44. The secondary housekeeping gene RNA Pol II was undetected in the gel, but 
single bands were detected for both PBS and DMXAA samples at approximately 
125bp. 
PBS Perfusion 
The cDNA from PBS (control) sample was used in Real Time PCR. The Ct values for 
the negative controls of each gene except TNF-α, which was undetected, was 
produced. This ultimately indicates reaction contamination. The results from this Real 
Time PCR were inconclusive and a gene expression profile could not be produced. 
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TCM Perfusion 
The TCM cDNA samples were also used in Real Time PCR. The Ct value results 
recorded in Table 3.58 revealed no detection of primary housekeeping gene HPSY, 
and secondary housekeeping gene RNA Pol II was contaminated, evidence given  
from a recorded Ct value for the negative control. Interleukin (IL6), IL8, ICAM and 
IL1B also produced Ct values for negative control samples indicating contamination. 
The melt data displayed in Table 3.59 also showed significant DNA contamination 
and primer dimer, all gene samples detected more than one peak suggesting more  
than the specific product is being detected. The results from this Real Time PCR 
prevented a reliable gene expression analysis. 
Final Discussion 
Gene expression analysis quantified with Real Time PCR was capable of producing 
reliable results only when the reaction conditions were correct, minimizing all 
possible contamination that could effect the results. Problems observed were reaction 
contamination possibly due to inadequate amounts of cDNA, primer contamination or 
DNA contamination in the cDNA preparation method.  
However, it was observed from TCM perfused experiments, the impact of tumour 
conditioned media on gene regulation, gene expression appear to be down regulated 
in the presence of TCM but in combination with DMXAA they are elevated. Also 
observed was the upregulation of TNF-α in the presence of DMXAA, which was not 
observed in TCM samples. This finding was also reported in paper Joseph et al, 1999 
& Ching et al, 1999, “feature of DMXAA activity is ability to stimulate production of 
TNF-α within tumour microenvironment”. 
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Possibilities for poor gene expression results. 
Changes in gene expression can occur as early as sample harvest/handling and during 
RNA isolation (McGarvey et al,). 
Stabilizing samples after isolation is critical in preventing artifacts and in preserving 
the gene expression patterns. Cell death and enzymatic degradation of RNA can limit 
the efficiency of Real Time and reduce yield. This results in specific genes being  
induced or down regulated, and non-specific and specific reduction in mRNA species 
(McGarvey et al,). 
 
4.6. Conclusion 
The aim of this study was to characterize responses of endothelial cells to 
inflammatory stimuli and DMXAA, and compare these results to two separate models: 
a traditional in vitro model using HUVEC and an ex vivo model using the intact 
umbilical vein. 
Isolating primary endothelial cells from whole umbilical cords was found to be a very 
tedious and very sensitive process. Failure to culture HUVEC successfully prevented 
experimental comparison between the two models. Focus was then directed towards 
the ex vivo model, employing the technique of a whole intact umbilical vein 
perfusion. 
Dividing the cord into a number of segments was successful in permitting control and 
experimental conditions in the same tissue. Each individual perfusion had limitations 
but it was overall successful. 
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Inflammatory agents and drug administration by intravenous perfusion provided an 
easy and reproducible method to cellular exposure minimizing cell contamination and 
sample handling. 
The gene expression profiles resulting from the immune response study successfully 
shows the impact of the inflammatory stimuli LPS on endothelial cells of the 
umbilical cord. The results show an upregulation of ESEL, ICAM and TF; however 
in the presence of Hypertonic Saline Solution, gene expressions are down regulated.  
This evidence suggests that HSS intercepts in the activation pathway of LPS 
ultimately suppressing its effect on endothelial cells. 
There is also evidence from gene regulation of unstimulated endothelial cells that 
supports the idea of heterogeneity between cords. This may be caused from 
inflammatory stimuli of the umbilical cord endothelial cells during pregnancy prior to 
receiving the cord for experimental manipulation. 
Enhanced induction of TNF-α was observed with combination of TCM + DMXAA 
perfusion; however not observed when TCM was perfused alone, suggesting that the 
enhancement of gene expression lies within the action of DMXAA. The limitations of 
the DMXAA and TCM perfusion experiments was avoiding contamination of each 
Real Time PCR reaction. This produced in some experiments, unreliable and 
misleading gene expression profiles, which could not give conclusive results. 
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4.7. Future Directions 
The biggest limitation for extended work in this research was the availability of 
whole umbilical cords. A fresh umbilical cord sample was required for each 
experimental procedure.  
Establishing a successful new system for ex vivo cell response analysis will open the 
door to new opportunities in cell biology in particular cancer gene therapy where 
there is an urgent need to develop robust human preclinical models. 
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Appendix 1 
 
DMXAA Requirements  
 
Assumptions: 
• To allow for assay development, replicates and additional endothelial cell 
analysis experiments, 25 cords will be required. 
• Each cord is divided into three segments (control + 2 different concentrations 
of DMXAA), plus additional extraction and culture of HUVEC. 
• Only one cord can be processed at a time due to limitations of the perfusion 
chamber. 
• Perfusate volume for each segment of cord is 100ml; volume of media 
required for HUVEC is minimal (a few ml) 
• DMXAA for each cord experiment will be taken from the same vial, which 
will only be used immediately upon opening in order to ensure sterility and 
stability. 
• A contingency allowance of 50% extra is included in requirements 
 
 
DMXAA Concentration Proposed 
 
• Zero (Control) 
• 25μM (peak plasma free drug concentration at doses used in current clinical 
trial) 
• 250 μM (peak plasma free drug concentration at higher doses used in trials) 
 
 
Formulation 
 
Clinical formulation = 200mg/ml, 10ml vial, 10 vials per box 
Molecular Weight: 304 
 
DMXAA Vial Requirement Calculations 
 
25μM x 100ml = 2.5μmol = 0.76mg 
250μM x 100ml = 25μmol = 7.6mg 
 
One vial will amply cover there requirements for each cord experimental procedure 
 
25 cords + 50% contingency allowance = 38 vials 
 
Conclusion 
 
4 Boxes x 10 vials each required 
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Appendix 2 
 
Real Time PCR Data 
 
Data for Cord 1 
 
 
Quantitation Report 
Experiment Information 
Run Name Joe LPS Run 2 2006-01-24 (1)
Run Start 24/01/2006 4:09:50 p.m. 
Run Finish 24/01/2006 6:20:57 p.m. 
Operator Joe 
Notes   
Run On Software Version Rotor-Gene 6.0.27 
Run Signature The Run Signature is valid. 
Gain Green 5. 
Quantitation Information 
Threshold 0.0251 
Left Threshold 28.000 
Standard Curve Imported No 
Standard Curve (1) N/A 
Standard Curve (2) N/A 
Start normalising from cycle 1 
Noise Slope Correction Yes 
No Template Control Threshold 2%  
Reaction Efficiency Threshold Disabled  
Normalisation Method Dynamic Tube Normalisation
Digital Filter Light 
Sample Page Page 1 
Imported Analysis Settings   
Messages 
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Profile 
Cycle Cycle Point 
Hold @ 95°c, 15 min 0 secs    
Cycling (40 repeats)  Step 1 @ 94°c, hold 20 secs 
  Step 2 @ 55°c, hold 20 secs 
  Step 3 @ 68°c, hold 30 secs, acquiring to 
Cycling A([Green][1][1]) 
  Step 4 @ 80°c, hold 15 secs, acquiring to 
Cycling B([Green][1][1]) 
Melt (50-95°c) , hold secs on the 1st step, hold 5 
secs on next steps, Melt A([Green][1][1]) 
  
Raw Data For Cycling B.Green 
 
Appendices 141
 
Standard Curve 
 
No. Colour Name Type Ct Given Conc (Copies) Calc Conc (Copies) % Var
1  B2M-Blank Unknown NEG (NTC)    
2  IL1B-Blank Unknown     
3  IL6-Blank Unknown     
4  IL8-Blank Unknown 34.44    
5  IL12-Blank Unknown     
6  iNOS-Blank Unknown NEG (NTC)    
7  PAI1-Blank Unknown     
8  TLR4-Blank Unknown     
(Continued on next page)...  
No. Colour Name Type Ct Given Conc (Copies) Calc Conc (Copies) % Var
9  TNFa-Blank Unknown     
10  TF-Blank Unknown NEG (NTC)    
11  ICAM1-Blank Unknown NEG (NTC)    
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12  ESel-Blank Unknown     
13  B2M-LPS Unknown 39.76    
14  IL1B-LPS Unknown 37.55    
15  IL6-LPS Unknown     
16  IL8-LPS Unknown 34.18    
17  IL12-LPS Unknown     
18  iNOS-LPS Unknown 37.02    
19  PAI1-LPS Unknown 37.29    
20  TLR4-LPS Unknown     
21  TNFa-LPS Unknown 39.34    
22  TF-LPS Unknown 37.45    
ICAM1-LPS Unknown   23    
24  ESel-LPS Unknown     
25  B2M-Control Unknown 32.32    
26  IL1B-Control Unknown     
 IL6-Control Unknown 37.18    27 
IL8-Control Unknown 33.56    28  
IL12-Control Unknown 39.41    29  
iNOS-Control Unknown 36.49    30  
PAI1-Control Unknown 37.55    31  
32  TLR4-Control Unknown     
33 TNFa-Control Unknown 36.55     
34  TF-Control Unknown 34.62    
35 ICAM1-Control Unknown NEG (NTC)     
36  ESel-Control Unknown     
Legend: 
NEG (NTC) - Sample cancelled due to NTC Threshold.  
NEG (R. Eff) - Sample cancelled as efficiency less than reaction efficiency threshold. 
 
 
This report generated by Rotor-Gene Real-Time Analysis Software Rotor-Gene 6000 Series Software 
1.7 (Build 25) 
Corbett Research 2005  
All Rights Reserved  
ISO 9001:2000 (Reg. No. QEC21313)  
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Melt Report 
Experiment Information 
Run Name Joe LPS Run 2 2006-01-24 (1)
Run Start 24/01/2006 4:09:50 p.m. 
Run Finish 24/01/2006 6:20:57 p.m. 
Operator Joe 
Notes   
Run On Software Version Rotor-Gene 6.0.27 
Run Signature The Run Signature is valid. 
Gain Green 5. 
Melt Information 
Digital Filter Light 
Imported Analysis Settings   
Sample Page Page 1
Temp. Threshold 76.7°c
Threshold 0.062 
Messages 
Message 
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Profile 
Cycle Cycle Point 
Hold @ 95°c, 15 min 0 secs    
Cycling (40 repeats)  Step 1 @ 94°c, hold 20 secs 
  Step 2 @ 55°c, hold 20 secs 
  Step 3 @ 68°c, hold 30 secs, acquiring to 
Cycling A([Green][1][1]) 
  Step 4 @ 80°c, hold 15 secs, acquiring to 
Cycling B([Green][1][1]) 
Melt (50-95°c) , hold secs on the 1st step, hold 5 
secs on next steps, Melt A([Green][1][1]) 
  
Melt data for Melt A.Green 
 
 
 
No. Name Genotype Peak 1 Peak 2
1 B2M-Blank    
2 IL1B-Blank  78.5  
3 IL6-Blank  80.7  
4 IL8-Blank  82.2  
5 IL12-Blank  81.5  
6 iNOS-Blank    
7 PAI1-Blank    
(Continued on next page)...  
No. Name Genotype Peak 1 Peak 2
8 TLR4-Blank  78.8  
9 TNFa-Blank  80.3  
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10 TF-Blank  77.5  
11 ICAM1-Blank    
12 ESel-Blank  79.0  
13 B2M-LPS  80.0  
14 IL1B-LPS  81.5  
15 IL6-LPS  80.5  
16 IL8-LPS  82.0 87.5 
17 IL12-LPS  81.2  
18 iNOS-LPS    
19 PAI1-LPS    
20 TLR4-LPS  80.2  
21 TNFa-LPS  81.0  
22 TF-LPS  80.0  
23 ICAM1-LPS    
24 ESel-LPS  79.5  
25 B2M-Control  86.3  
26 IL1B-Control    
27 IL6-Control  82.0  
28 IL8-Control  81.0 87.8 
29 IL12-Control    
30 iNOS-Control  84.0  
31 PAI1-Control  83.2  
32 TLR4-Control    
33 TNFa-Control  81.3  
34 TF-Control  85.0  
35 ICAM1-Control    
36 ESel-Control  78.7  
 
 
Bin Name Temperature Sample No. Sample Name Peak
 
 
(Continued on next page)...  
 
This report generated by Rotor-Gene Real-Time Analysis Software Rotor-Gene 6000 Series Software 
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Data for cord 2 
 
Quantitation Report 
Experiment Information 
Run Name Joe 13_02 LPS + HSS 2006-02-15 (2)
Run Start 15/02/2006 11:33:37 a.m. 
Run Finish 15/02/2006 1:43:55 p.m. 
Operator Joe 
Notes   
Run On Software Version Rotor-Gene 6.0.27 
Run Signature The Run Signature is valid. 
Gain Green 5. 
Quantitation Information 
Threshold 0.00483 
Left Threshold 19.000 
Standard Curve Imported No 
Standard Curve (1) N/A 
Standard Curve (2) N/A 
Start normalising from cycle 1 
Noise Slope Correction Yes 
No Template Control Threshold 2%  
Reaction Efficiency Threshold Disabled  
Normalisation Method Dynamic Tube Normalisation
Digital Filter Light 
Sample Page Page 1 
Imported Analysis Settings   
Messages 
Message 
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Profile 
Cycle Cycle Point 
Hold @ 95°c, 15 min 0 secs    
Cycling (40 repeats)  Step 1 @ 94°c, hold 20 secs 
  Step 2 @ 55°c, hold 20 secs 
  Step 3 @ 68°c, hold 30 secs, acquiring to 
Cycling A([Green][1][1]) 
  Step 4 @ 80°c, hold 15 secs, acquiring to 
Cycling B([Green][1][1]) 
Melt (50-95°c) , hold secs on the 1st step, hold 5 
secs on next steps, Melt A([Green][1][1]) 
  
Raw Data For Cycling B.Green 
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Standard Curve 
 
No. Colour Name Type Ct Given Conc (copies/ul) Calc Conc (copies/ul) % Var
1  B2M-Blank Unknown NEG (NTC)    
2  IL1B-Blank Unknown NEG (NTC)    
3  iNOS-Blank Unknown NEG (NTC)    
4  TLR4-Blank Unknown NEG (NTC)    
5  TNFa-Blank Unknown NEG (NTC)    
6  TF-Blank Unknown NEG (NTC)    
7  ESel-Blank Unknown NEG (NTC)    
8  ICAM-Blank Unknown NEG (NTC)    
(Continued on next page)...  
No. Colour Name Type Ct Given Conc (copies/ul) Calc Conc (copies/ul) % Var
9  B2M-Control Unknown 28.21    
10  IL1B-Control Unknown 33.02    
11  iNOS-Control Unknown 33.43    
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12  TLR4-Control Unknown NEG (NTC)    
13  TNFa-Control Unknown 33.61    
14  TF-Control Unknown NEG (NTC)    
15  ESel-Control Unknown NEG (NTC)    
16  ICAM-Control Unknown NEG (NTC)    
17  B2M-LPS Unknown 26.80    
18  IL1B-LPS Unknown 26.91    
19  iNOS-LPS Unknown 31.00    
20  TLR4-LPS Unknown NEG (NTC)    
21  TNFa-LPS Unknown 30.12    
22  TF-LPS Unknown 22.88    
ESel-LPS Unknown 20.01    23  
ICAM-LPS Unknown 29.78    24  
B2M-LPS+HSS Unknown 28.08    25  
IL1B-LPS+HSS Unknown 29.67  26    
27  iNOS-LPS+HSS Unknown 32.54    
TLR4-LPS+HSS Unknown NEG (NTC)    28  
 TNFa-LPS+HSS Unknown 28.75    29 
 TF-LPS+HSS Unknown 29.78    30 
 ESel-LPS+HSS Unknown 28.30  31   
32 ICAM-LPS+HSS Unknown NEG (NTC)     
33  Empty Unknown NEG (NTC)    
34  Empty Unknown NEG (NTC)    
35  Empty Unknown NEG (NTC)    
36 Empty Unknown NEG (NTC)     
Legend: 
NEG (NTC) - Sample cancelled due to NTC Threshold.  
NEG (R. Eff) - Sample cancelled as efficiency less than reaction efficiency threshold. 
 
 
This report generated by Rotor-Gene Real-Time Analysis Software Rotor-Gene 6000 Series Software 
1.7 (Build 25) 
Corbett Research 2005  
All Rights Reserved  
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Melt Report 
Experiment Information 
Run Name Joe 13_02 LPS + HSS 2006-02-15 (2)
Run Start 15/02/2006 11:33:37 a.m. 
Run Finish 15/02/2006 1:43:55 p.m. 
Operator Joe 
Notes   
Run On Software Version Rotor-Gene 6.0.27 
Run Signature The Run Signature is valid. 
Gain Green 5. 
Melt Information 
Digital Filter Light 
Imported Analysis Settings   
Sample Page Page 1 
Temp. Threshold 83.2°c 
Threshold 0.31773
Messages 
Message 
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Profile 
Cycle Cycle Point 
Hold @ 95°c, 15 min 0 secs    
Cycling (40 repeats)  Step 1 @ 94°c, hold 20 secs 
  Step 2 @ 55°c, hold 20 secs 
  Step 3 @ 68°c, hold 30 secs, acquiring to 
Cycling A([Green][1][1]) 
  Step 4 @ 80°c, hold 15 secs, acquiring to 
Cycling B([Green][1][1]) 
Melt (50-95°c) , hold secs on the 1st step, hold 5 
secs on next steps, Melt A([Green][1][1]) 
  
Melt data for Melt A.Green 
 
 
 
No. Name Genotype Peak 1
1 B2M-Blank   
2 IL1B-Blank   
3 iNOS-Blank   
4 TLR4-Blank   
5 TNFa-Blank   
6 TF-Blank   
7 ESel-Blank   
(Continued on next page)...  
No. Name Genotype Peak 1
8 ICAM-Blank   
9 B2M-Control  87.2 
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10 IL1B-Control   
11 iNOS-Control   
12 TLR4-Control   
13 TNFa-Control   
14 TF-Control   
15 ESel-Control   
16 ICAM-Control   
17 B2M-LPS  87.3 
18 IL1B-LPS  90.5 
19 iNOS-LPS   
20 TLR4-LPS   
21 TNFa-LPS  92.0 
22 TF-LPS  85.8 
23 ESel-LPS  88.0 
24 ICAM-LPS   
25 B2M-LPS+HSS  87.3 
26 IL1B-LPS+HSS  91.0 
27 iNOS-LPS+HSS   
28 TLR4-LPS+HSS   
29 TNFa-LPS+HSS  92.8 
30 TF-LPS+HSS  86.3 
31 ESel-LPS+HSS  88.0 
32 ICAM-LPS+HSS   
33 Empty   
34 Empty   
35 Empty   
36 Empty   
 
 
Bin Name Temperature Sample No. Sample Name Peak
 
(Continued on next page)...  
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Data for Normalized ICN (Cord 2) 
No. Gene Sample Ct Avg Ct No PCR eff Avg Eff R2 ICN GOI/B2M
9 B2M Control 28.21 - 1.26E-09 1.78176 - 0.995626 939.2092 HK 
17 B2M LPS 26.8 - 1.12E-08 1.700212 - 0.99637 7442.775 HK 
25 B2M LPS+HSS 28.08 - 1.13E-09 1.798595 - 0.997176 777.4815 HK 
15 ESel Control  - 0.00338 1.064516 - 0.356879 0 0
23 ESel LPS 20.01 - 3.32E-07 1.731798 - 0.992513 189186.6 25.41882
31 ESel LPS+HSS 28.3 - 1.08E-09 1.793066 - 0.996362 745.4934 0.958857
16 ICAM Control  - 0.005607 1.014962 - 0.026406 0 0
24 ICAM LPS 29.78 - 1.27E-08 1.627005 - 0.998088 5676.183 0.762643
32 ICAM LPS+HSS - 0.009618 0.996541 - 0.016295 0 0
10 IL1B Control 33.02 - 1.15E-10 1.76554 - 0.987599 78.94462 0.084054
18 IL1B LPS 26.91 - 2.49E-08 1.648048 - 0.907754 16238.87 2.18183
26 IL1B LPS+HSS 29.67 - 1.83E-09 1.692727 - 0.945766 1849.464 2.378788
11 iNOS Control 33.43 - 1.37E-10 1.734211 - 0.992872 113.773 0.121137
19 iNOS LPS 31 - 1.68E-11 1.869857 - 0.998463 41.99131 0.005642
27 iNOS LPS+HSS 32.54 - 1.91E-10 1.750844 - 0.993907 136.1287 0.175089
14 TF Control  - 0.00124 1.084359 - 0.263305 0 0
22 TF LPS 22.88 - 8.42E-09 1.85391 - 0.996439 8229.041 1.105642
30 TF LPS+HSS 29.78 - 8.94E-11 1.850263 - 0.999345 123.3113 0.158604
12 TLR4 Control  - 0.056649 0.981779 - 0.0382 0 0
20 TLR4 LPS  - 0.013683 1.012378 - 0.023781 0 0
28 TLR4 LPS+HSS - 0.020666 0.988244 - 0.027114 0 0
13 TNFa Control 33.61 - 8.89E-10 1.657381 - 0.994438 472.529 0.503114
21 TNFa LPS 30.12 - 2.91E-09 1.679553 - 0.9972 1846.65 0.248113
29 TNFa LPS+HSS 28.75 - 4.54E-10 1.78706 - 0.995395 631.2691 0.811941
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Data for cord 3 
 
 
Quantitation Report 
Experiment Information 
Run Name 20_02 Full expt 2006-02-21 (1)
Run Start 21/02/2006 4:35:33 p.m. 
Run Finish 21/02/2006 6:47:36 p.m. 
Operator Joe 
Notes   
Run On Software Version Rotor-Gene 6.0.27 
Run Signature The Run Signature is valid. 
Gain Green 5. 
Quantitation Information 
Threshold 0.00597 
Left Threshold 20.000 
Standard Curve Imported No 
Standard Curve (1) N/A 
Standard Curve (2) N/A 
Start normalising from cycle 1 
Noise Slope Correction Yes 
No Template Control Threshold 2%  
Reaction Efficiency Threshold Disabled  
Normalisation Method Dynamic Tube Normalisation
Digital Filter Light 
Sample Page Page 1 
Imported Analysis Settings   
Messages 
Message 
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Profile 
Cycle Cycle Point 
Hold @ 95°c, 15 min 0 secs    
Cycling (40 repeats)  Step 1 @ 94°c, hold 20 secs 
  Step 2 @ 55°c, hold 20 secs 
  Step 3 @ 68°c, hold 30 secs, acquiring to 
Cycling A([Green][1][1]) 
  Step 4 @ 80°c, hold 15 secs, acquiring to 
Cycling B([Green][1][1]) 
Melt (50-95°c) , hold secs on the 1st step, hold 5 
secs on next steps, Melt A([Green][1][1]) 
  
Raw Data For Cycling B.Green 
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Standard Curve 
 
No. Colour Name Type Ct Given Conc (copies/ul) Calc Conc (copies/ul) % Var
1  B2M-Blank Unknown NEG (NTC)    
2  IL1B-Blank Unknown NEG (NTC)    
3  ESel-Blank Unknown NEG (NTC)    
4  ICAM-Blank Unknown NEG (NTC)    
5  B2M-Control Unknown 24.28    
6  IL1B-Control Unknown 32.94    
7  iNOS-Control Unknown 31.73    
8  TLR4-Control Unknown NEG (NTC)    
(Continued on next page)...  
No. Colour Name Type Ct Given Conc (copies/ul) Calc Conc (copies/ul) % Var
9  TNFa-Control Unknown NEG (NTC)    
10  TF-Control Unknown 30.84    
11  ESel-Control Unknown 31.24    
Appendices 157
12  ICAM-Control Unknown 33.53    
13  B2M-LRS Unknown 26.40    
14  IL1B-LRS Unknown 29.54    
15  iNOS-LRS Unknown NEG (NTC)    
16  TLR4-LRS Unknown NEG (NTC)    
17  TNFa-LRS Unknown NEG (NTC)    
18  TF-LRS Unknown 25.24    
19  ESel-LRS Unknown 22.72    
20  ICAM-LRS Unknown 29.86    
21  B2M-LPS Unknown 28.39    
22  IL1B-LPS Unknown 29.22    
iNOS-LPS Unknown NEG (NTC)  23    
24  TLR4-LPS Unknown NEG (NTC)    
25  TNFa-LPS Unknown 32.50    
26  TF-LPS Unknown 23.89    
 ESel-LPS Unknown 21.63    27 
ICAM-LPS Unknown 27.87    28  
B2M-LPS+HSS Unknown 28.33    29  
IL1B-LPS+HSS Unknown 30.26    30  
iNOS-LPS+HSS Unknown 33.03    31  
32  TLR4-LPS+HSS Unknown NEG (NTC)    
33 TNFa-LPS+HSS Unknown NEG (NTC)     
34  TF-LPS+HSS Unknown 26.65    
35 ESel-LPS+HSS Unknown 22.78     
36  ICAM-LPS+HSS Unknown 28.10    
Legend: 
NEG (NTC) - Sample cancelled due to NTC Threshold.  
NEG (R. Eff) - Sample cancelled as efficiency less than reaction efficiency threshold. 
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Melt Report 
Experiment Information 
Run Name 20_02 Full expt 2006-02-21 (1)
Run Start 21/02/2006 4:35:33 p.m. 
Run Finish 21/02/2006 6:47:36 p.m. 
Operator Joe 
Notes   
Run On Software Version Rotor-Gene 6.0.27 
Run Signature The Run Signature is valid. 
Gain Green 5. 
Melt Information 
Digital Filter Light 
Imported Analysis Settings   
Sample Page Page 1 
Temp. Threshold 81.2°c 
Threshold 0.13391
Messages 
Message 
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Profile 
Cycle Cycle Point 
Hold @ 95°c, 15 min 0 secs    
Cycling (40 repeats)  Step 1 @ 94°c, hold 20 secs 
  Step 2 @ 55°c, hold 20 secs 
  Step 3 @ 68°c, hold 30 secs, acquiring to 
Cycling A([Green][1][1]) 
  Step 4 @ 80°c, hold 15 secs, acquiring to 
Cycling B([Green][1][1]) 
Melt (50-95°c) , hold secs on the 1st step, hold 5 
secs on next steps, Melt A([Green][1][1]) 
  
Melt data for Melt A.Green 
 
 
 
No. Name Genotype Peak 1 Peak 2
1 B2M-Blank    
2 IL1B-Blank    
3 ESel-Blank    
4 ICAM-Blank    
5 B2M-Control  87.0  
6 IL1B-Control  89.0  
7 iNOS-Control    
(Continued on next page)...  
No. Name Genotype Peak 1 Peak 2
8 TLR4-Control    
9 TNFa-Control    
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10 TF-Control  83.7  
11 ESel-Control  88.0  
12 ICAM-Control    
13 B2M-LRS  87.0  
14 IL1B-LRS  81.5 88.7 
15 iNOS-LRS    
16 TLR4-LRS    
17 TNFa-LRS    
18 TF-LRS  85.7  
19 ESel-LRS  87.7  
20 ICAM-LRS  87.8  
21 B2M-LPS  87.2  
22 IL1B-LPS  88.8  
23 iNOS-LPS    
24 TLR4-LPS    
25 TNFa-LPS  81.5  
26 TF-LPS  85.5  
27 ESel-LPS  87.7  
28 ICAM-LPS  88.0  
29 B2M-LPS+HSS  87.2  
30 IL1B-LPS+HSS  88.5  
31 iNOS-LPS+HSS    
32 TLR4-LPS+HSS  81.3  
33 TNFa-LPS+HSS    
34 TF-LPS+HSS  85.7  
35 ESel-LPS+HSS  87.5  
36 ICAM-LPS+HSS  88.0  
 
 
Bin Name Temperature Sample No. Sample Name Peak
 
(Continued on next page)...  
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Data for Normalized ICN (Cord 3) 
No. Gene Sample Ct Avg Ct No PCR eff Avg Eff R2 ICN GOI/B2M 
5 B2M Control 24.28 - 1.77E-09 1.876198 - 0.99624 2594.264 HK 
21 B2M LPS 28.39 - 7.56E-11 1.939046 - 1 76.66357 HK 
29 B2M LPS+HSS 28.33 - 8.84E-11 1.918146 - 0.996617 108.437 HK 
13 B2M LRS 26.4 - 4.19E-10 1.902005 - 0.991418 476.4622 HK 
11 ESel Control 31.24 - 2.28E-10 1.781098 - 0.998544 165.0947 0.063638
27 ESel LPS 21.63 - 1.34E-08 1.901532 - 0.99579 10284.99 134.1575
35 ESel LPS+HSS 22.78 - 6.29E-08 1.701971 - 0.994204 61394.36 566.1752
19 ESel LRS 22.72 - 8.21E-09 1.860306 - 0.994198 8399.685 17.62928
12 ICAM Control 33.53 - 5.49E-11 1.749913 - 0.999597 79.59341 0.030681
28 ICAM LPS 27.87 - 5.36E-10 1.819201 - 0.995664 640.2456 8.351366
36 ICAM LPS+HSS 28.1 - 3.11E-09 1.708866 - 0.993007 3236.864 29.85016
20 ICAM LRS 29.86 - 2.77E-09 1.674373 - 0.997155 2317.343 4.863645
6 IL1B Control 32.94 - 3.74E-12 1.880357 - 0.929668 10.36916 0.003997
22 IL1B LPS 29.22 - 4.42E-11 1.916498 - 0.990651 62.27679 0.812339
30 IL1B LPS+HSS 30.26 - 1.38E-09 1.723873 - 0.996375 780.854 7.200989
14 IL1B LRS 29.54 - 2.25E-10 1.82902 - 0.999527 201.0396 0.421942
7 iNOS Control 31.73 - 1.4E-11 1.827385 - 0.998652 55.12499 0.021249
23 iNOS LPS  - 0.026669 1.017908 - 0.096116 0 0
31 iNOS LPS+HSS 33.03 - 1.86E-09 1.623397 - 1 1255.696 11.57995
15 iNOS LRS  - 0.003848 1.035147 - 0.05218 0 0
10 TF Control 30.84 - 4.28E-12 1.981234 - 0.993348 7.793277 0.003004
26 TF LPS 23.89 - 1.77E-09 1.916116 - 0.99248 2005.212 26.156
34 TF LPS+HSS 26.65 - 0.000392 1.220099 - 0.651009 55819799 514766.9
18 TF LRS 25.24 - 1.21E-09 1.88209 - 0.993044 1310.063 2.749562
8 TLR4 Control  - 0.015083 1.020842 - 0.038403 0 0
24 TLR4 LPS  - 4.54E-14 2.000911 - 0.732345 0 0
32 TLR4 LPS+HSS - 3.28E-11 1.761961 - 0.888133 0 0
16 TLR4 LRS  - 0.026571 1.012551 - 0.02076 0 0
9 TNFa Control  - 0.021785 0.977704 - 0.059534 0 0
25 TNFa LPS 32.5 - 1.91E-12 1.966608 - 0.999628 3.187054 0.041572
33 TNFa LPS+HSS - 0.007067 1.007046 - 0.00251 0 0
17 TNFa LRS  - 0.01229 0.98441 - 0.097089 0 0
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Data for cord 4 
 
 
 
Quantitation Report 
Experiment Information 
Run Name Joe HSS+LPS 02_02 2005 2006-02-08 (2)
Run Start 8/02/2006 11:35:05 a.m. 
Run Finish 8/02/2006 1:45:47 p.m. 
Operator Joe 
Notes   
Run On Software Version Rotor-Gene 6.0.27 
Run Signature The Run Signature is valid. 
Gain Green 5. 
Quantitation Information 
Threshold 0.0055 
Left Threshold 14.000 
Standard Curve Imported No 
Standard Curve (1) N/A 
Standard Curve (2) N/A 
Start normalising from cycle 1 
Noise Slope Correction Yes 
No Template Control Threshold 2%  
Reaction Efficiency Threshold Disabled  
Normalisation Method Dynamic Tube Normalisation
Digital Filter Light 
Sample Page Page 1 
Imported Analysis Settings   
Messages 
Message 
Appendices 163
Profile 
Cycle Cycle Point 
Hold @ 95°c, 15 min 0 secs    
Cycling (40 repeats)  Step 1 @ 94°c, hold 20 secs 
  Step 2 @ 55°c, hold 20 secs 
  Step 3 @ 68°c, hold 30 secs, acquiring to 
Cycling A([Green][1][1]) 
  Step 4 @ 80°c, hold 15 secs, acquiring to 
Cycling B([Green][1][1]) 
Melt (50-95°c) , hold secs on the 1st step, hold 5 
secs on next steps, Melt A([Green][1][1]) 
  
Raw Data For Cycling B.Green 
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Standard Curve 
 
No. Colour Name Type Ct Given Conc (Copies) Calc Conc (Copies) % Var
1  B2M-Blank Unknown NEG (NTC)    
2  IL1B-Blank Unknown NEG (NTC)    
3  iNOS-Blank Unknown 33.54    
4  TLR4-Blank Unknown     
5  TNFa-Blank Unknown NEG (NTC)    
6  TF-Blank Unknown NEG (NTC)    
7  ESel-Blank Unknown NEG (NTC)    
8  ICAM-Blank Unknown NEG (NTC)    
(Continued on next page)...  
No. Colour Name Type Ct Given Conc (Copies) Calc Conc (Copies) % Var
9  B2M-Control Unknown 18.99    
10  IL1B-Control Unknown 32.48    
11  iNOS-Control Unknown 29.73    
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12  TLR4-Control Unknown 33.09    
13  TNFa-Control Unknown 30.75    
14  TF-Control Unknown 33.83    
15  ESel-Control Unknown 32.51    
16  ICAM-Control Unknown 31.99    
17  B2M-LPS Unknown 20.53    
18  IL1B-LPS Unknown 24.68    
19  iNOS-LPS Unknown 35.94    
20  TLR4-LPS Unknown NEG (NTC)    
21  TNFa-LPS Unknown NEG (NTC)    
22  TF-LPS Unknown 23.90    
ESel-LPS Unknown 19.79    23  
 ICAM-LPS Unknown 27.38    24 
 B2M-LPS+HSS Unknown 16.63    25 
IL1B-LPS+HSS Unknown 19.53    26  
iNOS-LPS+HSS Unknown 32.06    27  
TLR4-LPS+HSS Unknown 30.05  28    
29  TNFa-LPS+HSS Unknown 29.20    
30  TF-LPS+HSS Unknown 19.50    
31  ESel-LPS+HSS Unknown 16.21    
32  ICAM-LPS+HSS Unknown 20.95    
33  Empty Unknown NEG (NTC)    
34  Empty Unknown NEG (NTC)    
35  Empty Unknown NEG (NTC)    
36  Empty Unknown NEG (NTC)    
Legend: 
NEG (NTC) - Sample cancelled due to NTC Threshold.  
NEG (R. Eff) - Sample cancelled as efficiency less than reaction efficiency threshold. 
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Melt Report 
Experiment Information 
Run Name Joe HSS+LPS 02_02 2005 2006-02-08 (2)
Run Start 8/02/2006 11:35:05 a.m. 
Run Finish 8/02/2006 1:45:47 p.m. 
Operator Joe 
Notes   
Run On Software Version Rotor-Gene 6.0.27 
Run Signature The Run Signature is valid. 
Gain Green 5. 
Melt Information 
Digital Filter Light 
Imported Analysis Settings   
Sample Page Page 1 
Temp. Threshold 81.5°c 
Threshold 0.10453
Messages 
Message 
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Profile 
Cycle Cycle Point 
Hold @ 95°c, 15 min 0 secs    
Cycling (40 repeats)  Step 1 @ 94°c, hold 20 secs 
  Step 2 @ 55°c, hold 20 secs 
  Step 3 @ 68°c, hold 30 secs, acquiring to 
Cycling A([Green][1][1]) 
  Step 4 @ 80°c, hold 15 secs, acquiring to 
Cycling B([Green][1][1]) 
Melt (50-95°c) , hold secs on the 1st step, hold 5 
secs on next steps, Melt A([Green][1][1]) 
  
Melt data for Melt A.Green 
 
 
 
No. Name Genotype Peak 1 Peak 2
1 B2M-Blank    
2 IL1B-Blank    
3 iNOS-Blank  85.3  
4 TLR4-Blank    
5 TNFa-Blank    
6 TF-Blank    
7 ESel-Blank    
(Continued on next page)...  
No. Name Genotype Peak 1 Peak 2
8 ICAM-Blank    
9 B2M-Control  86.5  
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10 IL1B-Control    
11 iNOS-Control  86.3  
12 TLR4-Control    
13 TNFa-Control  84.0  
14 TF-Control    
15 ESel-Control  87.7  
16 ICAM-Control    
17 B2M-LPS  86.5  
18 IL1B-LPS  90.0  
19 iNOS-LPS    
20 TLR4-LPS    
21 TNFa-LPS    
22 TF-LPS  85.2  
23 ESel-LPS  87.3  
24 ICAM-LPS    
25 B2M-LPS+HSS  86.5  
26 IL1B-LPS+HSS  90.0  
27 iNOS-LPS+HSS  88.5  
28 TLR4-LPS+HSS  87.7  
29 TNFa-LPS+HSS  86.0 91.5 
30 TF-LPS+HSS  85.0 89.5 
31 ESel-LPS+HSS  87.3  
32 ICAM-LPS+HSS    
33 Empty    
34 Empty    
35 Empty    
36 Empty    
 
 
Bin Name Temperature Sample No. Sample Name Peak
 
(Continued on next page)...  
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Data for Normalized ICN (cord 4) 
No. Gene Sample Ct Avg Ct No PCR eff Avg Eff R2 ICN GOI/B2M
9 B2M Control 18.99 - 3.94E-07 1.7562 - 0.999762 253957.2 HK 
17 B2M LPS 20.53 - 1.45E-07 1.729365 - 0.990288 146353.6 HK 
25 B2M LPS+HSS 16.63 - 1.99E-06 1.723149 - 0.993131 1315743 HK 
15 ESel Control 32.51 - 0.000975 1.134163 - 0.635693 1.87E+08 736.1406
23 ESel LPS 19.79 - 4E-07 1.69247 - 0.991273 336348.9 2.298194
31 ESel LPS+HSS 16.21 - 3.33E-06 1.690181 - 0.990027 2261626 1.718896
16 ICAM Control 31.99 - 0.002773 1.09298 - 0.434829 6.52E+08 2566.006
24 ICAM LPS 27.38 - 7.34E-09 1.696327 - 0.942547 5824.313 0.039796
32 ICAM LPS+HSS 20.95 - 3.98E-07 1.640939 - 0.978397 349165.9 0.265375
10 IL1B Control 32.48 - 4.31E-08 1.47196 - 0.986898 39441.58 0.155308
18 IL1B LPS 24.68 - 5.73E-08 1.661645 - 0.998611 40395.33 0.276012
26 IL1B LPS+HSS 19.53 - 3.62E-07 1.713995 - 0.957488 301307.2 0.229002
11 iNOS Control 29.73 - 1.43E-08 1.631108 - 0.997915 5396.455 0.021249
19 iNOS LPS 35.94 - 5.2E-08 1.456074 - 1 15289.91 0.104472
27 iNOS LPS+HSS 32.06 - 3.86E-10 1.709072 - 0.999995 386.2952 0.000294
14 TF Control 33.83 - 0.003882 1.051144 - 0.103672 2.07E+09 8158.893
22 TF LPS 23.9 - 2.52E-08 1.724263 - 0.995058 24796.67 0.16943
30 TF LPS+HSS 19.5 - 9.36E-07 1.658458 - 0.997532 582078.7 0.442395
12 TLR4 Control 33.09 - 5.45E-10 1.640059 - 0.991642 870.0027 0.003426
20 TLR4 LPS  - 0.001585 1.094295 - 0.462626 0 0
28 TLR4 LPS+HSS 30.05 - 2.03E-08 1.591632 - 0.994594 9634.789 0.007323
13 TNFa Control 30.75 - 2.65E-08 1.537948 - 0.619017 19987.74 0.078705
21 TNFa LPS  - 0.007691 1.045466 - 0.294483 0 0
29 TNFa LPS+HSS 29.2 - 1.9E-09 1.706186 - 0.966102 1879.529 0.001428
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Data for cord 5 
 
Quantitation Report 
Experiment Information 
Run Name 2006-02-07 (1) 
Run Start 7/02/2006 5:43:17 p.m. 
Run Finish 7/02/2006 7:54:30 p.m. 
Operator Joe 
Notes   
Run On Software Version Rotor-Gene 6.0.27 
Run Signature The Run Signature is valid.
Gain Green 5. 
Quantitation Information 
Threshold 0.00224 
Left Threshold 17.000 
Standard Curve Imported No 
Standard Curve (1) N/A 
Standard Curve (2) N/A 
Start normalising from cycle 1 
Noise Slope Correction Yes 
No Template Control Threshold 2%  
Reaction Efficiency Threshold Disabled  
Normalisation Method Dynamic Tube Normalisation
Digital Filter Light 
Sample Page Page 1 
Imported Analysis Settings   
Messages 
Message 
Appendices 
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Profile 
Cycle Cycle Point 
Hold @ 95°c, 15 min 0 secs    
Cycling (40 repeats)  Step 1 @ 94°c, hold 20 secs 
  Step 2 @ 55°c, hold 20 secs 
  Step 3 @ 68°c, hold 30 secs, acquiring to 
Cycling A([Green][1][1]) 
  Step 4 @ 80°c, hold 15 secs, acquiring to 
Cycling B([Green][1][1]) 
Melt (50-95°c) , hold secs on the 1st step, hold 5 
secs on next steps, Melt A([Green][1][1]) 
  
Raw Data For Cycling B.Green 
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Standard Curve 
 
No. Colour Name Type Ct Given Conc (copies/ml) Calc Conc (copies/ml) % Var
1  B2M-Blank Unknown NEG (NTC)    
2  IL1B-Blank Unknown NEG (NTC)    
3  iNOS-Blank Unknown NEG (NTC)    
4  TLR4-Blank Unknown NEG (NTC)    
5  TNFa-Blank Unknown NEG (NTC)    
6  TF-Blank Unknown NEG (NTC)    
7  ESel-Blank Unknown NEG (NTC)    
8  ICAM-Blank Unknown NEG (NTC)    
(Continued on next page)...  
No. Colour Name Type Ct Given Conc (copies/ml) Calc Conc (copies/ml) % Var
9  B2M-Control Unknown 17.81    
10  IL1B-Control Unknown 27.57    
11  iNOS-Control Unknown 28.44    
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12  TLR4-Control Unknown 29.15    
13  TNFa-Control Unknown 29.23    
14  TF-Control Unknown 27.49    
15  ESel-Control Unknown 28.75    
16  ICAM-Control Unknown 28.06    
17  B2M-Ringers Unknown 30.82    
18  IL1B-Ringers Unknown 29.67    
19  iNOS-Ringers Unknown 28.32    
20  TLR4-Ringers Unknown 32.75    
21  TNFa-Ringers Unknown 32.45    
22  TF-Ringers Unknown 30.61    
ESel-Ringers Unknown 31.07    23  
ICAM-Ringers Unknown NEG (NTC)    24  
B2M-HSS Unknown 24.46    25  
IL1B-HSS Unknown 27.73  26    
27  iNOS-HSS Unknown NEG (NTC)    
TLR4-HSS Unknown NEG (NTC)    28  
 TNFa-HSS Unknown NEG (NTC)    29 
 TF-HSS Unknown 26.85    30 
 ESel-HSS Unknown 21.68   31  
32  ICAM-HSS Unknown NEG (NTC)    
 Empty Unknown NEG (NTC)   33  
34  Empty Unknown NEG (NTC)    
 Empty Unknown NEG (NTC)   35  
36  Empty Unknown NEG (NTC)    
Legend: 
NEG (NTC) - Sample cancelled due to NTC Threshold.  
NEG (R. Eff) - Sample cancelled as efficiency less than reaction efficiency threshold. 
 
 
This report generated by Rotor-Gene Real-Time Analysis Software Rotor-Gene 6000 Series Software 
1.7 (Build 25) 
Corbett Research 2005  
All Rights Reserved  
ISO 9001:2000 (Reg. No. QEC21313)  
 
Appendices 
 
174
 
 
Melt Report 
Experiment Information 
Run Name 2006-02-07 (1) 
Run Start 7/02/2006 5:43:17 p.m. 
Run Finish 7/02/2006 7:54:30 p.m. 
Operator Joe 
Notes   
Run On Software Version Rotor-Gene 6.0.27 
Run Signature The Run Signature is valid.
Gain Green 5. 
Melt Information 
Digital Filter Light 
Imported Analysis Settings   
Sample Page Page 1 
Temp. Threshold 81°c 
Threshold 0.21494
Messages 
Message 
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Profile 
Cycle Cycle Point 
Hold @ 95°c, 15 min 0 secs    
Cycling (40 repeats)  Step 1 @ 94°c, hold 20 secs 
  Step 2 @ 55°c, hold 20 secs 
  Step 3 @ 68°c, hold 30 secs, acquiring to 
Cycling A([Green][1][1]) 
  Step 4 @ 80°c, hold 15 secs, acquiring to 
Cycling B([Green][1][1]) 
Melt (50-95°c) , hold secs on the 1st step, hold 5 
secs on next steps, Melt A([Green][1][1]) 
  
Melt data for Melt A.Green 
 
 
 
No. Name Genotype Peak 1 Peak 2
1 B2M-Blank    
2 IL1B-Blank    
3 iNOS-Blank    
4 TLR4-Blank    
5 TNFa-Blank    
6 TF-Blank    
7 ESel-Blank    
(Continued on next page)...  
No. Name Genotype Peak 1 Peak 2
8 ICAM-Blank    
9 B2M-Control  86.5  
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10 IL1B-Control  85.3 89.5 
11 iNOS-Control  86.0  
12 TLR4-Control  88.0  
13 TNFa-Control  83.0  
14 TF-Control  85.3  
15 ESel-Control  87.3  
16 ICAM-Control    
17 B2M-Ringers  86.5  
18 IL1B-Ringers    
19 iNOS-Ringers    
20 TLR4-Ringers    
21 TNFa-Ringers  81.7  
22 TF-Ringers  86.0  
23 ESel-Ringers    
24 ICAM-Ringers    
25 B2M-HSS  86.5  
26 IL1B-HSS  89.7  
27 iNOS-HSS    
28 TLR4-HSS    
29 TNFa-HSS    
30 TF-HSS  85.0  
31 ESel-HSS  81.5 87.0 
32 ICAM-HSS    
33 Empty    
34 Empty    
35 Empty    
36 Empty    
 
 
Bin Name Temperature Sample No. Sample Name Peak
 
(Continued on next page)...  
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Data for Normalized ICN (Cord 5) 
No. Gene Sample Ct Avg Ct No PCR eff Avg Eff R2 ICN GOI/B2M
9 B2M Control 17.81 - 1.76E-07 1.817155 - 0.981978 268809.8 HK 
25 B2M HSS 24.46 - 6.19E-09 1.781602 - 0.98013 8210.902 HK 
17 B2M Ringers 30.82 - 5.71E-10 1.695236 - 0.98909 964.5948 HK 
15 ESel Control 28.75 - 4.23E-10 1.764214 - 0.999972 913.8329 0.0034
31 ESel HSS 21.68 - 4.94E-08 1.72976 - 0.979593 77568.02 9.446954
23 ESel Ringers 31.07 - 0.006231 1.048899 - 0.179867 2.54E+09 2634380
16 ICAM Control 28.06 - 1.43E-09 1.716102 - 0.979824 2937.239 0.010927
32 ICAM HSS  - 0.008431 0.998161 - 0.000546 0 0
24 ICAM Ringers  - 0.015428 1.002578 - 0.002365 0 0
10 IL1B Control 27.57 - 3.74E-10 1.829152 - 0.991189 659.1605 0.002452
26 IL1B HSS 27.73 - 4.37E-10 1.82031 - 0.987545 684.5226 0.083368
18 IL1B Ringers 29.67 - 0.002591 1.074767 - 0.25483 1.32E+09 1367010
11 iNOS Control 28.44 - 1.44E-09 1.736738 - 0.9974 1702.85 0.006335
27 iNOS HSS  - 0.015412 1.004069 - 0.007726 0 0
19 iNOS Ringers 28.32 - 1.67E-09 1.626135 - 0.995635 11729.13 12.15964
14 TF Control 27.49 - 3.58E-10 1.853491 - 0.995654 481.0175 0.001789
30 TF HSS 26.85 - 4.36E-09 1.694996 - 0.891614 7871.165 0.958624
22 TF Ringers 30.61 - 0.005627 1.084204 - 0.566989 9.43E+08 977525
12 TLR4 Control 29.15 - 1.7E-09 1.683511 - 0.993727 2851.153 0.010607
28 TLR4 HSS  - 0.019146 0.990066 - 0.02005 0 0
20 TLR4 Ringers 32.75 - 0.005739 1.034247 - 0.099425 3.72E+09 3854187
13 TNFa Control 29.23 - 7.67E-10 1.730885 - 0.998424 1215.175 0.004521
29 TNFa HSS  - 0.011109 0.984088 - 0.055493 0 0
21 TNFa Ringers 32.45 - 4.69E-10 1.651856 - 0.988181 946.2747 0.981007
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Data for cord 6 
 
 
Quantitation Report 
Experiment Information 
Run Name Tumour conditoned cord 10.04.07
Run Start 29/04/2007 12:40:46 p.m. 
Run Finish 29/04/2007 2:39:17 p.m. 
Operator Kiri 
Notes   
Run On Software Version Rotor-Gene 1.7.61 
Run Signature The Run Signature is valid. 
Gain Green 5.33 
Quantitation Information 
Threshold 0.0025 
Left Threshold 23.000 
Standard Curve Imported No 
Standard Curve (1) N/A 
Standard Curve (2) N/A 
Start normalising from cycle 1 
Noise Slope Correction Yes 
No Template Control Threshold 2%  
Reaction Efficiency Threshold Disabled  
Normalisation Method Dynamic Tube Normalisation
Digital Filter Light 
Sample Page Page 1 
Imported Analysis Settings   
Messages 
Message 
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Profile 
Cycle Cycle Point 
Hold @ 95°c, 15 min 0 secs    
Cycling (40 repeats)  Step 1 @ 94°c, hold 20 secs 
  Step 2 @ 55°c, hold 20 secs 
  Step 3 @ 68°c, hold 30 secs, acquiring to 
Cycling A([Green][1][1]) 
  Step 4 @ 80°c, hold 10 secs, acquiring to 
Cycling B([Green][1][1]) 
Melt (72-95°c) , hold secs on the 1st step, hold 5 
secs on next steps, Melt A([Green][1][1]) 
  
Raw Data For Cycling B.Green 
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Standard Curve 
 
No. Colour Name Type Ct Given Conc (Copies) Calc Conc (Copies) % Var
1  HSPY-negative Unknown NEG (NTC)    
2  ESEL-Neg Unknown 31.40    
3  ICAM-Neg Unknown 37.76    
4  IL1B-Neg Unknown NEG (NTC)    
5  IL6-Neg Unknown 29.99    
6  IL8-Neg Unknown 23.58    
7  TNF-Neg Unknown NEG (NTC)    
8  TF-Neg Unknown NEG (NTC)    
(Continued on next page)...  
No. Colour Name Type Ct Given Conc (Copies) Calc Conc (Copies) % Var
9  RNAPol-Neg Unknown NEG (NTC)    
10  HSPY-TCM Unknown NEG (NTC)    
11  ESEL-TCM Unknown 31.49    
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12  ICAM-TCM Unknown NEG (NTC)    
13  IL1B-TCM Unknown 34.04    
14  IL6-TCM Unknown NEG (NTC)    
15  IL8-TCM Unknown 27.89    
16  TNF-TCM Unknown NEG (NTC)    
17  TF-TCM Unknown NEG (NTC)    
18  RNAPol-TCM Unknown NEG (NTC)    
19  HSPY-TCM Unknown NEG (NTC)    
20  ESEL-TCM Unknown 32.56    
21  ICAM-TCM Unknown NEG (NTC)    
22  IL1B-TCM Unknown NEG (NTC)    
IL6-TCM Unknown 34.38  23    
24  IL8-TCM Unknown 26.09    
25  TNF-TCM Unknown NEG (NTC)    
26  TF-TCM Unknown NEG (NTC)    
 RNAPol-TCM Unknown NEG (NTC)    27 
 Unknown NEG (NTC)    28  
 Unknown NEG (NTC)    29  
 Unknown NEG (NTC)    30  
 Unknown NEG (NTC)   31   
32   Unknown NEG (NTC)    
33   Unknown NEG (NTC)    
34   Unknown NEG (NTC)    
  Unknown NEG (NTC)   35  
36   Unknown NEG (NTC)    
Legend: 
NEG (NTC) - Sample cancelled due to NTC Threshold.  
NEG (R. Eff) - Sample cancelled as efficiency less than reaction efficiency threshold. 
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Melt Report 
Experiment Information 
Run Name Tumour conditoned cord 10.04.07
Run Start 29/04/2007 12:40:46 p.m. 
Run Finish 29/04/2007 2:39:17 p.m. 
Operator Kiri 
Notes   
Run On Software Version Rotor-Gene 1.7.61 
Run Signature The Run Signature is valid. 
Gain Green 5.33 
Melt Information 
Digital Filter Light 
Imported Analysis Settings   
Sample Page Page 1 
Temp. Threshold 76°c 
Threshold 0.13886
Messages 
Message 
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Profile 
Cycle Cycle Point 
Hold @ 95°c, 15 min 0 secs    
Cycling (40 repeats)  Step 1 @ 94°c, hold 20 secs 
  Step 2 @ 55°c, hold 20 secs 
  Step 3 @ 68°c, hold 30 secs, acquiring to 
Cycling A([Green][1][1]) 
  Step 4 @ 80°c, hold 10 secs, acquiring to 
Cycling B([Green][1][1]) 
Melt (72-95°c) , hold secs on the 1st step, hold 5 
secs on next steps, Melt A([Green][1][1]) 
  
Melt data for Melt A.Green 
 
 
 
No. Name Genotype Peak 1
1 HSPY-negative  79.5 
2 ESEL-Neg  80.0 
3 ICAM-Neg  81.7 
4 IL1B-Neg  80.3 
5 IL6-Neg  80.2 
6 IL8-Neg  83.0 
7 TNF-Neg   
(Continued on next page)...  
No. Name Genotype Peak 1
8 TF-Neg   
9 RNAPol-Neg   
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10 HSPY-TCM   
11 ESEL-TCM  79.7 
12 ICAM-TCM   
13 IL1B-TCM  81.5 
14 IL6-TCM  80.3 
15 IL8-TCM  82.7 
16 TNF-TCM   
17 TF-TCM  79.7 
18 RNAPol-TCM   
19 HSPY-TCM  81.7 
20 ESEL-TCM  79.5 
21 ICAM-TCM   
22 IL1B-TCM  80.2 
23 IL6-TCM  80.5 
24 IL8-TCM  82.5 
25 TNF-TCM   
26 TF-TCM   
27 RNAPol-TCM   
28    
29    
30    
31    
32    
33    
34    
35    
36    
 
 
Bin Name Temperature Sample No. Sample Name Peak
 
 
(Continued on next page)...  
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Data for Normalized ICN (TCM cord  6) 
 
Gene Sample Ct Avg Ct No PCR eff Avg Eff R2 ICN GOI/B2M
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
No. 
11 ESEL TCM 31.49 32.025 3.53E-14 2.148814 1.903401 0.907601 12.51001 2.84E-09
20 ESEL TCM 32.56 32.025 3.82E-10 1.657988 1.903401 0.966717 12.51001 2.84E-09
10 HSPY TCM 40 40 0.01093 1.003365 1.023565 0.004595 4.41E+09 HK 
19 HSPY TCM 40 40 0.003481 1.043764 1.023565 0.26127 4.41E+09 HK 
12 ICAM TCM 40 40 0.015959 0.977959 1.515104 0.028607 678.4448 1.54E-07
21 ICAM TCM 40 40 2.33E-13 2.05225 1.515104 0.779946 678.4448 1.54E-07
13 IL1B TCM 34.04 37.02 4.4E-09 1.535843 1.34792 0.936597 177439.3 4.02E-05
22 IL1B TCM 40 37.02 0.003453 1.159997 1.34792 0.827689 177439.3 4.02E-05
14 IL6 TCM 40 37.19 0.008246 1.021085 1.432685 0.287702 17457.12 3.96E-06
23 IL6 TCM 34.38 37.19 6.94E-12 1.844285 1.432685 0.985744 17457.12 3.96E-06
15 IL8 TCM 27.89 26.99 2.49E-24 4.862226 3.466066 0.98279 3.01E-05 6.83E-15
24 IL8 6.83E-15TCM 26.09 26.99 2.62E-11 2.069906 3.466066 0.99122 3.01E-05
18 RNAPol TCM 40 40 0.016631 0.982478 1.283653 0.072747 514418.1 0.000117
27 RNAPol TCM 40 40 1.28E-05 1.584827 1.283653 0.872758 514418.1 0.000117
1.78E-17
1.78E-17
8.96E-10
17 TF TCM 40 40 1.84E-19 4.123758 2.68446 0.583222 7.85E-08
26 TF TCM 40 40 1.67E-05 1.245161 2.68446 0.715686 7.85E-08
0.985099 3.9515381.51E-10 1.950443 1.723103
1.495764 1.723103 0.736823 3.951538 8.96E-100.000737
40
40
TCM 40
40TCM 
16 TNF 
25 TNF 
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Data for cord 6 
 
Quantitation Report 
Experiment Information 
Run Name TCM-DMXAA cord 10.4.07
Run Start 29/04/2007 3:04:45 p.m. 
Run Finish 29/04/2007 5:00:58 p.m. 
Operator Kiri 
Notes   
Run On Software Version Rotor-Gene 1.7.61 
Run Signature The Run Signature is valid.
Gain Green 8. 
Quantitation Information 
Threshold 0.00314 
Left Threshold 6.000 
Standard Curve Imported No 
Standard Curve (1) N/A 
Standard Curve (2) N/A 
Start normalising from cycle 1 
Noise Slope Correction Yes 
No Template Control Threshold 2%  
Reaction Efficiency Threshold Disabled  
Normalisation Method Dynamic Tube Normalisation
Digital Filter Light 
Sample Page Page 1 
Imported Analysis Settings   
Messages 
Message 
Appendices 
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Profile 
Cycle Cycle Point 
Hold @ 95°c, 15 min 0 secs    
Cycling (40 repeats)  Step 1 @ 94°c, hold 20 secs 
  Step 2 @ 55°c, hold 20 secs 
  Step 3 @ 68°c, hold 30 secs, acquiring to 
Cycling A([Green][1][1]) 
  Step 4 @ 80°c, hold 10 secs, acquiring to 
Cycling B([Green][1][1]) 
Melt (72-95°c) , hold secs on the 1st step, hold 5 
secs on next steps, Melt A([Green][1][1]) 
  
Raw Data For Cycling B.Green 
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Standard Curve 
 
No. Colour Name Type Ct Given Conc (Copies) Calc Conc (Copies) % Var
1  HSPY-negative Unknown NEG (NTC)    
2  ESEL-Neg Unknown NEG (Multi Ct)    
3  ICAM-Neg Unknown NEG (NTC)    
4  IL1B-Neg Unknown NEG (NTC)    
5  IL6-Neg Unknown 30.53    
6  IL8-Neg Unknown 24.64    
7  TNF-Neg Unknown NEG (NTC)    
8  TF-Neg Unknown NEG (NTC)    
(Continued on next page)...  
No. Colour Name Type Ct Given Conc (Copies) Calc Conc (Copies) % Var
9  RNAPol-Neg Unknown 23.84    
10  HSPY-TCM/DMXAA Unknown NEG (NTC)    
11  ESEL-TCM/DMXAA Unknown 23.55    
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12  ICAM-TCM/DMXAA Unknown 32.22    
13  IL1B-TCM/DMXAA Unknown 31.28    
14  IL6-TCM/DMXAA Unknown NEG (NTC)    
15  IL8-TCM/DMXAA Unknown NEG (Multi Ct)    
16  TNF-TCM/DMXAA Unknown 6.61    
17  TF-TCM/DMXAA Unknown NEG (NTC)    
18  RNAPol-TCM/DMXAA Unknown NEG (NTC)    
19  HSPY-TCM/DMXAA Unknown NEG (NTC)    
20  ESEL-TCM/DMXAA Unknown 24.10    
21  ICAM-TCM/DMXAA Unknown NEG (NTC)    
22  IL1B-TCM/DMXAA Unknown 29.86    
IL6-TCM/DMXAA Unknown NEG (NTC)    23  
IL8-TCM/DMXAA Unknown 27.95    24  
TNF-TCM/DMXAA Unknown NEG (NTC)    25  
TF-TCM/DMXAA Unknown NEG (NTC)  26    
27  RNAPol-TCM/DMXAA Unknown NEG (NTC)    
 Unknown NEG (NTC)    28  
  Unknown NEG (NTC)    29 
  Unknown NEG (NTC)    30 
  Unknown NEG (NTC)    31 
32   Unknown NEG (NTC)    
33   Unknown NEG (NTC)    
34   Unknown NEG (NTC)    
35   Unknown NEG (NTC)    
36   Unknown NEG (NTC)    
Legend: 
NEG (NTC) - Sample cancelled due to NTC Threshold.  
NEG (R. Eff) - Sample cancelled as efficiency less than reaction efficiency threshold. 
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Melt Report 
Experiment Information 
Run Name TCM-DMXAA cord 10.4.07
Run Start 29/04/2007 3:04:45 p.m. 
Run Finish 29/04/2007 5:00:58 p.m. 
Operator Kiri 
Notes   
Run On Software Version Rotor-Gene 1.7.61 
Run Signature The Run Signature is valid.
Gain Green 8. 
Melt Information 
Digital Filter Light 
Imported Analysis Settings   
Sample Page Page 1 
Temp. Threshold 77°c 
Threshold 0.24167
Messages 
Message 
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Profile 
Cycle Cycle Point 
Hold @ 95°c, 15 min 0 secs    
Cycling (40 repeats)  Step 1 @ 94°c, hold 20 secs 
  Step 2 @ 55°c, hold 20 secs 
  Step 3 @ 68°c, hold 30 secs, acquiring to 
Cycling A([Green][1][1]) 
  Step 4 @ 80°c, hold 10 secs, acquiring to 
Cycling B([Green][1][1]) 
Melt (72-95°c) , hold secs on the 1st step, hold 5 
secs on next steps, Melt A([Green][1][1]) 
  
Melt data for Melt A.Green 
 
 
 
No. Name Peak 1 Peak 2Genotype Peak 3
1 HSPY-negative  80.0   
2 ESEL-Neg  79.3   
3 ICAM-Neg  80.5   
4 IL1B-Neg     
5 IL6-Neg  79.8   
6 IL8-Neg  82.7   
7 TNF-Neg     
(Continued on next page)...  
No. Name Genotype Peak 1 Peak 2 Peak 3
8 TF-Neg     
9 RNAPol-Neg  79.5 88.5 94.0 
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10 HSPY-TCM/DMXAA  79.3   
11 ESEL-TCM/DMXAA  78.7 86.8  
12 ICAM-TCM/DMXAA  80.5   
13 IL1B-TCM/DMXAA  80.8   
14 IL6-TCM/DMXAA  80.5   
15 IL8-TCM/DMXAA  82.5   
16 TNF-TCM/DMXAA     
17 TF-TCM/DMXAA     
18 RNAPol-TCM/DMXAA  79.5   
19 HSPY-TCM/DMXAA  80.2   
20 ESEL-TCM/DMXAA  78.0 86.5  
21 ICAM-TCM/DMXAA  80.0   
22 IL1B-TCM/DMXAA  80.0 85.0  
23 IL6-TCM/DMXAA  80.0   
24 IL8-TCM/DMXAA  82.7   
25 TNF-TCM/DMXAA     
26 TF-TCM/DMXAA     
27 RNAPol-TCM/DMXAA  79.5   
28      
29      
30      
31      
32      
33      
34      
35      
36      
 
 
Bin Name Temperature Sample No. Sample Name Peak
 
 
(Continued on next page)...  
 
This report generated by Rotor-Gene Real-Time Analysis Software Rotor-Gene 6000 Series Software 
1.7 (Build 25) Corbett Research 2005 All Rights Reserved ISO 9001:2000 (Reg. No. QEC21313)  
 
List of Abbreviations 
 
 
 
Data for Normalized ICN (TCM+DMXAA cord 6) 
 No. Gene Sample Ct Avg Ct No PCR eff Avg Eff R2 ICN GOI/B2M 
11 ESEL TCM/DMXAA 23.55 23.825 4.42E-10 1.998925 1.83035 0.999403 6227.876 128.3869
20 ESEL TCM/DMXAA 24.1 23.825 1.58E-07 1.661775 1.83035 0.97975 6227.876 128.3869
10 HSPY TCM/DMXAA 40 40 0.019301 0.986577 1.618397 0.157757 48.50865 HK 
19 HSPY TCM/DMXAA 40 40 2.68E-15 2.250217 1.618397 0.798706 48.50865 HK 
12 ICAM TCM/DMXAA 32.22 36.11 2.27E-20 3.153533 2.246777 0.966377 0.002261 4.66E-05
21 ICAM TCM/DMXAA 40 36.11 7.23E-07 1.340021 2.246777 0.928804 0.002261 4.66E-05
13 IL1B TCM/DMXAA 31.28 30.57 1.87E-11 1.823823 1.79331 0.927223 197.23 4.065873
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
22 IL1B TCM/DMXAA 29.86 30.57 2.53E-10 1.762797 1.79331 0.993672 197.23 4.065873
14 IL6 TCM/DMXAA 40 40 0.009012 1.059099 1.349435 0 69685.2 1436.552
23 IL6 TCM/DMXAA 40 40 0.00082 1.639771 1.349435 0.684768 69685.2 1436.552
15 IL8 TCM/DMXAA 40 33.975 7.01E-09 1.683603 1.657239 0.989131 394.1011 8.124346
24 IL8 TCM/DMXAA 27.95 33.975 4.38E-09 1.630875 1.657239 0.953473 394.1011 8.124346
84881841
84881841
18 RNAPol TCM/DMXAA 40 40 0.007405 1.020714 1.025332 0.26322 4.12E+09
27 RNAPol TCM/DMXAA 40 40 0.004533 1.029951 1.025332 0.206485 4.12E+09
17 TF TCM/DMXAA 40 40 0.046825 0.763657 1.586236 1 108.2707 2.231987
26 TF TCM/DMXAA 40 40 2.23E-11 2.408814 1.586236 0.74503 108.2707 2.231987
4.39E+111 2.13E+1316 TNF TCM/DMXAA 6.61 23.305 0.211885 0.334199 0.723299
1.1124 0.723299 0.701517 2.13E+13 4.39E+110.00814723.30540TNF TCM/DMXAA25
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Data for cord 8 
 
Quantitation Report 
Experiment Information 
Run Name control cord 2007-03-05 
Run Start 5/03/2007 1:09:54 p.m. 
Run Finish 5/03/2007 3:06:52 p.m. 
Operator KM 
Notes   
Run On Software Version Rotor-Gene 1.7.61 
Run Signature The Run Signature is valid.
Gain Green 8. 
Quantitation Information 
Threshold 0.01015 
Left Threshold 14.000 
Standard Curve Imported No 
Standard Curve (1) N/A 
Standard Curve (2) N/A 
Start normalising from cycle 1 
Noise Slope Correction Yes 
No Template Control Threshold 2%  
Reaction Efficiency Threshold Disabled  
Normalisation Method Dynamic Tube Normalisation
Digital Filter Light 
Sample Page Page 1 
Imported Analysis Settings   
Messages 
Message 
Appendices 
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Profile 
Cycle Cycle Point 
Hold @ 95°c, 15 min 0 secs    
Cycling (40 repeats)  Step 1 @ 94°c, hold 20 secs 
  Step 2 @ 55°c, hold 20 secs 
  Step 3 @ 68°c, hold 30 secs, acquiring to 
Cycling A([Green][1][1]) 
  Step 4 @ 80°c, hold 10 secs, acquiring to 
Cycling B([Green][1][1]) 
Melt (72-95°c) , hold secs on the 1st step, hold 5 
secs on next steps, Melt A([Green][1][1]) 
  
Raw Data For Cycling B.Green 
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Standard Curve 
 
No. Colour Name Type Ct Given Conc (Copies) Calc Conc (Copies) % Var
1  HSPY-negative Unknown NEG (NTC)    
2  ESEL-Negative Unknown NEG (NTC)    
3  ICAM-Negative Unknown NEG (NTC)    
4  IL1B-Negative Unknown NEG (NTC)    
5  IL6-Negative Unknown 33.64    
6  IL8-Negative Unknown 25.22    
7  TNF-Negative Unknown NEG (NTC)    
8  TF-Negative Unknown NEG (NTC)    
(Continued on next page)...  
No. Colour Name Type Ct Given Conc (Copies) Calc Conc (Copies) % Var
9  RNAPol-Negative Unknown NEG (NTC)    
10  HSPY-PBS Unknown 19.91    
11  ESEL-PBS Unknown 17.93    
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ICAM-PBS 12  Unknown 26.50    
13  IL1B-PBS Unknown 24.88    
14  IL6-PBS Unknown 26.73    
15  IL8-PBS Unknown 16.95    
16  TNF-PBS Unknown NEG (NTC)    
17  TF-PBS Unknown 23.58    
18  RNAPol-PBS Unknown 20.77    
19  HSPY-PBS Unknown 21.77    
20  ESEL-PBS Unknown 20.26    
21  ICAM-PBS Unknown 27.68    
22  IL1B-PBS Unknown 20.85    
IL6-PBS Unknown 25.76    23  
 IL8-PBS Unknown 16.44    24 
 TNF-PBS Unknown NEG (NTC)    25 
TF-PBS Unknown 23.54    26  
RNAPol-PBS Unknown 21.26    27  
Blank Unknown NEG (NTC)  28    
29  Blank Unknown NEG (NTC)    
30  Blank Unknown NEG (NTC)    
31  Blank Unknown NEG (NTC)    
32  Blank Unknown NEG (NTC)    
33  Blank Unknown NEG (NTC)    
34  Blank Unknown NEG (NTC)    
35  Blank Unknown NEG (NTC)    
36  Blank Unknown NEG (NTC)    
Legend: 
NEG (NTC) - Sample cancelled due to NTC Threshold.  
NEG (R. Eff) - Sample cancelled as efficiency less than reaction efficiency threshold. 
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Melt Report 
Experiment Information 
Run Name control cord 2007-03-05 
Run Start 5/03/2007 1:09:54 p.m. 
Run Finish 5/03/2007 3:06:52 p.m. 
Operator KM 
Notes   
Run On Software Version Rotor-Gene 1.7.61 
Run Signature The Run Signature is valid.
Gain Green 8. 
Melt Information 
Digital Filter Light 
Imported Analysis Settings   
Sample Page Page 1 
Temp. Threshold 80°c 
Threshold 0.10241
Messages 
Message 
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Profile 
Cycle Cycle Point 
Hold @ 95°c, 15 min 0 secs    
Cycling (40 repeats)  Step 1 @ 94°c, hold 20 secs 
  Step 2 @ 55°c, hold 20 secs 
  Step 3 @ 68°c, hold 30 secs, acquiring to 
Cycling A([Green][1][1]) 
  Step 4 @ 80°c, hold 10 secs, acquiring to 
Cycling B([Green][1][1]) 
Melt (72-95°c) , hold secs on the 1st step, hold 5 
secs on next steps, Melt A([Green][1][1]) 
  
Melt data for Melt A.Green 
 
 
 
No. Name Genotype Peak 1 Peak 2
1 HSPY-negative    
2 ESEL-Negative    
3 ICAM-Negative    
4 IL1B-Negative    
5 IL6-Negative    
6 IL8-Negative  82.2  
7 TNF-Negative    
(Continued on next page)...  
No. Name Genotype Peak 1 Peak 2
8 TF-Negative    
9 RNAPol-Negative    
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10 HSPY-PBS  88.8  
11 ESEL-PBS  86.0  
12 ICAM-PBS  83.5 91.5 
13 IL1B-PBS  88.5  
14 IL6-PBS  86.0  
15 IL8-PBS  81.5 86.8 
16 TNF-PBS    
17 TF-PBS  84.0  
18 RNAPol-PBS  89.3  
19 HSPY-PBS  88.7  
20 ESEL-PBS  85.8  
21 ICAM-PBS  84.5 91.2 
22 IL1B-PBS  88.3  
23 IL6-PBS  86.0  
24 IL8-PBS  81.5 86.7 
25 TNF-PBS    
26 TF-PBS  84.0  
27 RNAPol-PBS  81.0 89.3 
28 Blank    
29 Blank    
30 Blank    
31 Blank    
32 Blank    
33 Blank    
34 Blank    
35 Blank    
36 Blank    
 
 
Bin Name Temperature Sample No. Sample Name Peak
 
(Continued on next page)...  
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Data for Normalized ICN (PBS  Cord 8) 
 
No. Gene Sample Ct Avg Ct No PCR eff Avg Eff R2 ICN GOI/B2M
11 ESEL PBS 17.93 19.095 1.54E-06 1.739152 1.712735 0.98587 386283 1.57525
20 ESEL PBS 20.26 19.095 5.52E-07 1.686317 1.712735 0.893893 386283 1.57525
10 HSPY PBS 19.91 20.84 1.6E-06 1.660688 1.673371 0.997106 245220.1 HK 
19 HSPY PBS 21.77 20.84 1.55E-07 1.686054 1.673371 0.986496 245220.1 HK 
12 ICAM PBS 26.5 27.09 6.81E-08 1.633209 1.574158 0.977819 51425.86 0.209713
21 ICAM PBS 27.68 27.09 2.36E-07 1.515106 1.574158 0.999929 51425.86 0.209713
13 IL1B PBS 24.88 22.865 9.81E-06 1.387226 1.524627 0.993785 726414.7 2.962296
22 IL1B PBS 20.85 22.865 1.04E-06 1.662028 1.524627 0.999362 726414.7 2.962296
14 IL6 PBS 26.73 26.245 4.33E-09 1.771743 1.753397 0.996124 4452.285 0.018156
23 IL6 PBS 25.76 26.245 3.49E-08 1.73505 1.753397 0.999384 4452.285 0.018156
15 IL8 PBS 16.95 16.695 1.17E-07 1.962544 1.948927 0.994419 162584.7 0.663015
24 IL8 PBS 16.44 16.695 2.73E-07 1.935311 1.948927 0.999735 162584.7 0.663015
18 RNAPol PBS 20.77 21.015 1.58E-07 1.761302 1.804885 0.984133 45701.53 0.186369
27 RNAPol PBS 21.26 21.015 3.67E-08 1.848468 1.804885 0.971414 45701.53 0.186369
17 TF PBS 23.58 23.56 1.21E-07 1.671715 1.694399 0.967036 45041.33 0.183677
26 TF PBS 23.54 23.56 5.74E-08 1.717082 1.694399 0.93655 45041.33 0.183677
16 TNF PBS   0 28.0127 0.820429 0.92936 0.758613 0 0
25 TNF PBS   0 0.023061 1.038291 0.92936 0.41115 0 0
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Data for cord 8 
 
Quantitation Report 
Experiment Information 
Run Name Tumour conditoned cord 2007-03-06 (1)
Run Start 6/03/2007 12:03:20 p.m. 
Run Finish 6/03/2007 1:59:31 p.m. 
Operator Kiri 
Notes   
Run On Software Version Rotor-Gene 1.7.61 
Run Signature The Run Signature is valid. 
Gain Green 8. 
Quantitation Information 
Threshold 0.00419 
Left Threshold 15.000 
Standard Curve Imported No 
Standard Curve (1) N/A 
Standard Curve (2) N/A 
Start normalising from cycle 1 
Noise Slope Correction Yes 
No Template Control Threshold 2%  
Reaction Efficiency Threshold Disabled  
Normalisation Method Dynamic Tube Normalisation
Digital Filter Light 
Sample Page Page 1 
Imported Analysis Settings   
Messages 
Message 
Appendices 
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Profile 
Cycle Cycle Point 
Hold @ 95°c, 15 min 0 secs    
Cycling (40 repeats)  Step 1 @ 94°c, hold 20 secs 
  Step 2 @ 55°c, hold 20 secs 
  Step 3 @ 68°c, hold 30 secs, acquiring to 
Cycling A([Green][1][1]) 
  Step 4 @ 80°c, hold 10 secs, acquiring to 
Cycling B([Green][1][1]) 
Melt (72-95°c) , hold secs on the 1st step, hold 5 
secs on next steps, Melt A([Green][1][1]) 
  
Raw Data For Cycling B.Green 
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Standard Curve 
 
No. Colour Name Type Ct Given Conc (Copies) Calc Conc (Copies) % Var
1  HSPY-Neg Unknown NEG (NTC)    
2  ESEL-Neg Unknown NEG (Multi Ct)    
3  ICAM-Neg Unknown NEG (NTC)    
4  IL1B-Neg Unknown NEG (NTC)    
5  IL6-Neg Unknown 31.52    
6  IL8-Neg Unknown 26.52    
7  TNF-Neg Unknown NEG (NTC)    
8  TF-Neg Unknown NEG (NTC)    
(Continued on next page)...  
No. Colour Name Type Ct Given Conc (Copies) Calc Conc (Copies) % Var
9  RNAPol-Neg Unknown 37.72    
10  HSPY-TCM Unknown 23.16    
11  ESEL-TCM Unknown 20.63    
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ICAM-TCM 12  Unknown 31.70    
13  IL1B-TCM Unknown NEG (NTC)    
14  IL6-TCM Unknown 24.96    
15  IL8-TCM Unknown 18.98    
16  TNF-TCM Unknown NEG (NTC)    
17  TF-TCM Unknown 24.60    
18  RNAPol-TCM Unknown 23.93    
19  HSPY-TCM Unknown 19.41    
20  ESEL-TCM Unknown 20.01    
21  ICAM-TCM Unknown 30.29    
22  IL1B-TCM Unknown 24.20    
IL6-TCM Unknown 25.92    23  
 IL8-TCM Unknown 18.95    24 
 TNF-TCM Unknown NEG (NTC)    25 
TF-TCM Unknown 24.66    26  
RNAPol-TCM Unknown 23.53    27  
Blank Unknown NEG (NTC)  28    
29  Blank Unknown     
30  Blank Unknown     
31  Blank Unknown     
32  Blank Unknown NEG (NTC)    
33  Blank Unknown 39.05    
 Blank Unknown NEG (NTC)    34 
35  Blank Unknown NEG (NTC)    
36  Blank Unknown NEG (NTC)    
Legend: 
NEG (NTC) - Sample cancelled due to NTC Threshold.  
NEG (R. Eff) - Sample cancelled as efficiency less than reaction efficiency threshold. 
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Melt Report 
Experiment Information 
Run Name Tumour conditoned cord 2007-03-06 (1)
Run Start 6/03/2007 12:03:20 p.m. 
Run Finish 6/03/2007 1:59:31 p.m. 
Operator Kiri 
Notes   
Run On Software Version Rotor-Gene 1.7.61 
Run Signature The Run Signature is valid. 
Gain Green 8. 
Melt Information 
Digital Filter Light 
Imported Analysis Settings   
Sample Page Page 1 
Temp. Threshold 76°c 
Threshold 0.03331
Messages 
Message 
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Profile 
Cycle Cycle Point 
Hold @ 95°c, 15 min 0 secs    
Cycling (40 repeats)  Step 1 @ 94°c, hold 20 secs 
  Step 2 @ 55°c, hold 20 secs 
  Step 3 @ 68°c, hold 30 secs, acquiring to 
Cycling A([Green][1][1]) 
  Step 4 @ 80°c, hold 10 secs, acquiring to 
Cycling B([Green][1][1]) 
Melt (72-95°c) , hold secs on the 1st step, hold 5 
secs on next steps, Melt A([Green][1][1]) 
  
Melt data for Melt A.Green 
 
 
 
No. Name Genotype Peak 1 Peak 2 Peak 3
1 HSPY-Neg     
2 ESEL-Neg  79.0 86.3  
3 ICAM-Neg  79.2   
4 IL1B-Neg  79.8   
5 IL6-Neg  81.3   
6 IL8-Neg  81.7   
7 TNF-Neg     
(Continued on next page)...  
No. Name Genotype Peak 1 Peak 2 Peak 3
8 TF-Neg  77.3   
9 RNAPol-Neg     
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10 HSPY-TCM  88.7   
11 ESEL-TCM  76.7 85.7  
12 ICAM-TCM  84.7 89.5  
13 IL1B-TCM  79.8   
14 IL6-TCM  79.5 86.0  
15 IL8-TCM  81.3 86.7  
16 TNF-TCM     
17 TF-TCM  84.0   
18 RNAPol-TCM  76.2 83.5 89.2 
19 HSPY-TCM  76.5 81.5 88.5 
20 ESEL-TCM  78.3 85.7  
21 ICAM-TCM  77.8 85.8  
22 IL1B-TCM  79.5 88.2  
23 IL6-TCM  80.5 86.0  
24 IL8-TCM  81.5 86.5  
25 TNF-TCM     
26 TF-TCM  83.8 91.5  
27 RNAPol-TCM  83.0 89.2  
28 Blank     
29 Blank     
30 Blank     
31 Blank     
32 Blank     
33 Blank     
34 Blank     
35 Blank     
36 Blank     
 
 
Bin Name Temperature Sample No. Sample Name Peak
 
 
(Continued on next page)...  
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Data for Normalized ICN (TCM cord 8) 
GOI/B2M
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
No. Gene Sample Ct Avg Ct No PCR eff Avg Eff R2 ICN 
11 ESEL TCM 20.63 20.32 1.67E-08 1.865021 1.839834 0.990516 46656.74 0.000915
20 ESEL TCM 20.01 20.32 5.02E-08 1.814648 1.839834 0.998467 46656.74 0.000915
10 HSPY TCM 23.16 21.285 2.47E-06 1.454046 1.288286 0.974374 51004438 HK 
19 HSPY TCM 19.41 21.285 0.019735 1.122526 1.288286 0.99761 51004438 HK 
2.66E-0612 ICAM TCM 31.7 30.995 4.43E-10 1.713912 1.80064 0.992937 135.5996
21 ICAM TCM 30.29 30.995 4.41E-11 1.887368 1.80064 0.99495 135.5996 2.66E-06
7.162358
7.162358
13 IL1B TCM 24.2 24.2 0.00982 0.971315 1.151935 0.179718 3.65E+08
22 IL1B TCM 24.2 24.2 4.4E-05 1.332554 1.151935 0.965509 3.65E+08
14 IL6 TCM 24.96 25.44 3.03E-09 1.767732 1.667141 0.992458 25248.78 0.000495
23 IL6 TCM 25.92 25.44 1.53E-07 1.56655 1.667141 0.991629 25248.78 0.000495
15 IL8 TCM 18.98 18.965 2.9E-07 1.705652 1.711061 0.996677 422023.6 0.008274
24 IL8 TCM 18.95 18.965 3.32E-07 1.716471 1.711061 0.994601 422023.6 0.008274
18 RNAPol TCM 23.93 23.73 1.01E-06 1.520943 1.519166 0.99996 549193.6 0.010768
27 RNAPol TCM 23.53 23.73 1.35E-06 1.517389 1.519166 0.99935 549193.6 0.010768
17 TF TCM 24.6 24.63 0.00047 1.268197 1.501996 0.998948 498731.6 0.009778
26 TF TCM 24.66 24.63 1.34E-08 1.735795 1.501996 0.995724 498731.6 0.009778
001.431257 1.421308 0.794202
1.411359 1.421308 0.603733 0 0
0 8.29E-05
2.1E-060
 
 
16 TNF TCM 
TCM 25 TNF 
List of Abbreviations 
 
 
Data for cord 8 
 
Quantitation Report 
Experiment Information 
Run Name DMXAA cord 2007-03-06 (1)
Run Start 6/03/2007 2:08:49 p.m. 
Run Finish 6/03/2007 4:04:55 p.m. 
Operator Kiri 
Notes   
Run On Software Version Rotor-Gene 1.7.61 
Run Signature The Run Signature is valid. 
Gain Green 8. 
Quantitation Information 
Threshold 0.00315 
Left Threshold 20.000 
Standard Curve Imported No 
Standard Curve (1) N/A 
Standard Curve (2) N/A 
Start normalising from cycle 1 
Noise Slope Correction Yes 
No Template Control Threshold 2%  
Reaction Efficiency Threshold Disabled  
Normalisation Method Dynamic Tube Normalisation
Digital Filter Light 
Sample Page Page 1 
Imported Analysis Settings   
Messages 
Message 
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Profile 
Cycle Cycle Point 
Hold @ 95°c, 15 min 0 secs    
Cycling (40 repeats)  Step 1 @ 94°c, hold 20 secs 
  Step 2 @ 55°c, hold 20 secs 
  Step 3 @ 68°c, hold 30 secs, acquiring to 
Cycling A([Green][1][1]) 
  Step 4 @ 80°c, hold 10 secs, acquiring to 
Cycling B([Green][1][1]) 
Melt (72-95°c) , hold secs on the 1st step, hold 5 
secs on next steps, Melt A([Green][1][1]) 
  
Raw Data For Cycling B.Green 
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Standard Curve 
 
No. Colour Name Type Ct Given Conc (Copies) Calc Conc (Copies) % Var
1  HSPY-Neg Unknown NEG (NTC)    
2  ESEL-Neg Unknown 28.93    
3  ICAM-Neg Unknown NEG (NTC)    
4  IL1B-Neg Unknown NEG (NTC)    
5  IL6-Neg Unknown 31.94    
6  IL8-Neg Unknown 23.58    
7  TNF-Neg Unknown NEG (NTC)    
8  TF-Neg Unknown NEG (NTC)    
(Continued on next page)...  
No. Colour Name Type Ct Given Conc (Copies) Calc Conc (Copies) % Var
9  RNAPol-Neg Unknown NEG (NTC)    
10  HSPY-DMXAA Unknown 21.13    
11  ESEL-DMXAA Unknown 22.08    
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12  ICAM-DXMAA Unknown 26.76    
13  IL1BDMXAA Unknown 25.99    
14  IL6-DMXAA Unknown 28.41    
15  IL8-DMXAA Unknown 23.78    
16  TNF-DMXAA Unknown NEG (NTC)    
17  TF-DMXAA Unknown 28.16    
18  RNAPol-DMXAA Unknown 22.78    
19  HSPY-DMXAA Unknown 21.90    
20  ESEL-DMXAA Unknown 21.59    
21  ICAM-DXMAA Unknown 28.60    
22 IL1BDMXAA Unknown 27.92     
IL6-DMXAA Unknown 27.57  23    
24  IL8-DMXAA Unknown 24.38    
25  TNF-DMXAA Unknown NEG (NTC)    
 TF-DMXAA Unknown 29.38    26 
 RNAPol-DMXAA Unknown 22.62    27 
 Unknown NEG (NTC)    28  
 Unknown NEG (NTC)    29  
 Unknown NEG (NTC)    30  
31   Unknown NEG (NTC)    
32   Unknown NEG (NTC)    
33   Unknown NEG (NTC)    
34   Unknown NEG (NTC)    
35   Unknown NEG (NTC)    
36   Unknown NEG (NTC)    
Legend: 
NEG (NTC) - Sample cancelled due to NTC Threshold.  
NEG (R. Eff) - Sample cancelled as efficiency less than reaction efficiency threshold. 
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Melt Report 
Experiment Information 
Run Name DMXAA cord 2007-03-06 (1)
Run Start 6/03/2007 2:08:49 p.m. 
Run Finish 6/03/2007 4:04:55 p.m. 
Operator Kiri 
Notes   
Run On Software Version Rotor-Gene 1.7.61 
Run Signature The Run Signature is valid. 
Gain Green 8. 
Melt Information 
Digital Filter Light 
Imported Analysis Settings   
Sample Page Page 1 
Temp. Threshold 77°c 
Threshold 0.11868
Messages 
Message 
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Profile 
Cycle Cycle Point 
Hold @ 95°c, 15 min 0 secs    
Cycling (40 repeats)  Step 1 @ 94°c, hold 20 secs 
  Step 2 @ 55°c, hold 20 secs 
  Step 3 @ 68°c, hold 30 secs, acquiring to 
Cycling A([Green][1][1]) 
  Step 4 @ 80°c, hold 10 secs, acquiring to 
Cycling B([Green][1][1]) 
Melt (72-95°c) , hold secs on the 1st step, hold 5 
secs on next steps, Melt A([Green][1][1]) 
  
Melt data for Melt A.Green 
 
 
 
No. Name Genotype Peak 1 Peak 2 Peak 3
1 HSPY-Neg  79.0   
2 ESEL-Neg  79.0   
3 ICAM-Neg     
4 IL1B-Neg  78.7   
5 IL6-Neg  79.0   
6 IL8-Neg  81.7   
7 TNF-Neg     
(Continued on next page)...  
No. Name Genotype Peak 1 Peak 2 Peak 3
8 TF-Neg  77.5   
9 RNAPol-Neg     
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10 HSPY-DMXAA  82.5 88.7  
11 ESEL-DMXAA  78.7 86.0  
12 ICAM-DXMAA     
13 IL1BDMXAA  79.3 88.5  
14 IL6-DMXAA  79.2 86.0  
15 IL8-DMXAA  81.7   
16 TNF-DMXAA     
17 TF-DMXAA  78.5 84.0  
18 RNAPol-DMXAA  77.2 89.3  
19 HSPY-DMXAA  77.3 82.7 88.8 
20 ESEL-DMXAA  78.5 85.8  
21 ICAM-DXMAA     
22 IL1BDMXAA  81.3 88.3  
23 IL6-DMXAA  78.8   
24 IL8-DMXAA  81.5   
25 TNF-DMXAA     
26 TF-DMXAA  78.0 84.0  
27 RNAPol-DMXAA  89.0   
28      
29      
30      
31      
32      
33      
34      
35      
36      
 
 
Bin Name Temperature Sample No. Sample Name Peak
 
 
(Continued on next page)...  
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Data for cord 10 
 
Quantitation Report 
Experiment Information 
Run Name Control cord 2007-03-12 
Run Start 12/03/2007 3:24:29 p.m. 
Run Finish 12/03/2007 5:23:15 p.m. 
Operator Kiri 
Notes   
Run On Software Version Rotor-Gene 1.7.61 
Run Signature The Run Signature is valid.
Gain Green 8. 
Quantitation Information 
Threshold 0.00169 
Left Threshold 3.000 
Standard Curve Imported No 
Standard Curve (1) N/A 
Standard Curve (2) N/A 
Start normalising from cycle 1 
Noise Slope Correction No 
No Template Control Threshold 0%  
Reaction Efficiency Threshold Disabled  
Normalisation Method Dynamic Tube Normalisation
Digital Filter Light 
Sample Page Page 1 
Imported Analysis Settings   
Messages 
Message 
Appendices 
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Profile 
Cycle Cycle Point 
Hold @ 95°c, 15 min 0 secs    
Cycling (40 repeats)  Step 1 @ 94°c, hold 20 secs 
  Step 2 @ 55°c, hold 20 secs 
  Step 3 @ 68°c, hold 30 secs, acquiring to 
Cycling A([Green][1][1]) 
  Step 4 @ 80°c, hold 10 secs, acquiring to 
Cycling B([Green][1][1]) 
Melt (72-95°c) , hold secs on the 1st step, hold 5 
secs on next steps, Melt A([Green][1][1]) 
  
Raw Data For Cycling B.Green 
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Standard Curve 
 
No. Colour Name Type Ct Given Conc (Copies) Calc Conc (Copies) % Var
1  HSPY-Neg Unknown 19.49    
2  ESel-Neg Unknown NEG (Multi Ct)    
3  ICam-Neg Unknown NEG (Multi Ct)    
4  IL1B-Neg Unknown 17.24    
5  IL6-Neg Unknown NEG (Multi Ct)    
6  IL8-Neg Unknown 16.74    
7  TNF-Neg Unknown 10.57    
8  TF-Neg Unknown NEG (Multi Ct)    
(Continued on next page)...  
No. Colour Name Type Ct Given Conc (Copies) Calc Conc (Copies) % Var
9  RNAPol-Neg Unknown 8.65    
10  HSPY-Control Unknown NEG (Multi Ct)    
11  ESel-Control Unknown 5.02    
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12  ICam-Control Unknown 3.08    
13  IL1B-Control Unknown 3.14    
14  IL6-Control Unknown NEG (Multi Ct)    
15  IL8-Control Unknown NEG (Multi Ct)    
16  TNF-Control Unknown     
17  TF-Control Unknown 6.45    
18  RNAPol-Control Unknown 5.13    
19  HSPY-Control Unknown NEG (Multi Ct)    
20  ESel-Control Unknown NEG (Multi Ct)    
21  ICam-Control Unknown NEG (Multi Ct)    
22 IL1B-Control Unknown 5.56     
IL6-Control Unknown 3.51  23    
24  IL8-Control Unknown NEG (Multi Ct)    
25  TNF-Control Unknown NEG (Multi Ct)    
 TF-Control Unknown     26 
 RNAPol-Control Unknown 3.46    27 
 Unknown 16.03    28  
 Unknown 14.74    29  
 Unknown 17.34    30  
31   Unknown 13.22    
32  Unknown 12.62     
33   Unknown 17.08    
34  Unknown NEG (Multi Ct)     
35   Unknown 9.31    
36   Unknown NEG (Multi Ct)    
Legend: 
NEG (NTC) - Sample cancelled due to NTC Threshold.  
NEG (R. Eff) - Sample cancelled as efficiency less than reaction efficiency threshold. 
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Melt Report 
Experiment Information 
Run Name Control cord 2007-03-12 
Run Start 12/03/2007 3:24:29 p.m. 
Run Finish 12/03/2007 5:23:15 p.m. 
Operator Kiri 
Notes   
Run On Software Version Rotor-Gene 1.7.61 
Run Signature The Run Signature is valid.
Gain Green 8. 
Melt Information 
Digital Filter Light 
Imported Analysis Settings   
Sample Page Page 1 
Temp. Threshold 76°c 
Threshold 0.09738
Messages 
Message 
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Profile 
Cycle Cycle Point 
Hold @ 95°c, 15 min 0 secs    
Cycling (40 repeats)  Step 1 @ 94°c, hold 20 secs 
  Step 2 @ 55°c, hold 20 secs 
  Step 3 @ 68°c, hold 30 secs, acquiring to 
Cycling A([Green][1][1]) 
  Step 4 @ 80°c, hold 10 secs, acquiring to 
Cycling B([Green][1][1]) 
Melt (72-95°c) , hold secs on the 1st step, hold 5 
secs on next steps, Melt A([Green][1][1]) 
  
Melt data for Melt A.Green 
 
 
 
No. Name Genotype Peak 1 Peak 2
1 HSPY-Neg  80.0  
2 ESel-Neg  78.7  
3 ICam-Neg  78.5  
4 IL1B-Neg  78.2  
5 IL6-Neg  76.5 81.0 
6 IL8-Neg  81.8  
7 TNF-Neg    
(Continued on next page)...  
No. Name Genotype Peak 1 Peak 2
8 TF-Neg    
9 RNAPol-Neg    
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10 HSPY-Control    
11 ESel-Control  78.0  
12 ICam-Control    
13 IL1B-Control  80.0  
14 IL6-Control    
15 IL8-Control  76.5 81.5 
16 TNF-Control    
17 TF-Control    
18 RNAPol-Control    
19 HSPY-Control    
20 ESel-Control  78.0  
21 ICam-Control    
22 IL1B-Control    
23 IL6-Control  77.8  
24 IL8-Control  77.2 81.5 
25 TNF-Control    
26 TF-Control    
27 RNAPol-Control    
28     
29     
30     
31     
32     
33     
34     
35     
36     
 
 
Bin Name Temperature Sample No. Sample Name Peak
 
 
(Continued on next page)...  
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Data for cord 10 
 
Quantitation Report 
Experiment Information 
Run Name DMXAA cord 2007-03-14 (1)
Run Start 14/03/2007 3:21:04 p.m. 
Run Finish 14/03/2007 5:19:00 p.m. 
Operator Kiri 
Notes   
Run On Software Version Rotor-Gene 1.7.61 
Run Signature The Run Signature is valid. 
Gain Green 8. 
Quantitation Information 
Threshold 0.0069 
Left Threshold 1.000 
Standard Curve Imported No 
Standard Curve (1) N/A 
Standard Curve (2) N/A 
Start normalising from cycle 1 
Noise Slope Correction No 
No Template Control Threshold 0%  
Reaction Efficiency Threshold Disabled  
Normalisation Method Dynamic Tube Normalisation
Digital Filter Light 
Sample Page Page 1 
Imported Analysis Settings   
Messages 
Message 
Appendices 
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Profile 
Cycle Cycle Point 
Hold @ 95°c, 15 min 0 secs    
Cycling (40 repeats)  Step 1 @ 94°c, hold 20 secs 
  Step 2 @ 55°c, hold 20 secs 
  Step 3 @ 68°c, hold 30 secs, acquiring to 
Cycling A([Green][1][1]) 
  Step 4 @ 80°c, hold 10 secs, acquiring to 
Cycling B([Green][1][1]) 
Melt (72-95°c) , hold secs on the 1st step, hold 5 
secs on next steps, Melt A([Green][1][1]) 
  
Raw Data For Cycling B.Green 
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Standard Curve 
 
No. Colour Name Type Ct Given Conc (Copies) Calc Conc (Copies) % Var
1  HSPY-Neg Unknown NEG (Multi Ct)    
2  ESel-Neg Unknown 29.86    
3  ICam-Neg Unknown 33.06    
4  IL1B-Neg Unknown 32.59    
5  IL6-Neg Unknown 26.57    
6  IL8-Neg Unknown 25.96    
7  TNF-Neg Unknown 8.40    
8  TF-Neg Unknown NEG (Multi Ct)    
(Continued on next page)...  
No. Colour Name Type Ct Given Conc (Copies) Calc Conc (Copies) % Var
9  RNAPol-Neg Unknown 16.57    
10  HSPY-DMXAA Unknown NEG (Multi Ct)    
11  ESel-DMXAA Unknown 22.19    
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12  ICam-DMXAA Unknown 27.29    
13  IL1B-DMXAA Unknown 21.06    
14  IL6-DMXAA Unknown 24.37    
15  IL8-DMXAA Unknown 17.29    
16  TNF-DMXAA Unknown 29.04    
17  TF-DMXAA Unknown 24.19    
18  RNAPol-DMXAA Unknown 25.99    
19  HSPY-DMXAA Unknown 20.44    
20  ESel-DMXAA Unknown 22.41    
21  ICam-DMXAA Unknown 28.13    
22 IL1B-DMXAA Unknown 24.62     
IL6-DMXAA Unknown 20.86  23    
24  IL8-DMXAA Unknown 16.71    
25  TNF-DMXAA Unknown 29.34    
 TF-DMXAA Unknown 25.31    26 
 RNAPol-DMXAA Unknown 25.29    27 
Blank Unknown NEG (Multi Ct)    28  
Blank Unknown 33.15    29  
Blank Unknown 22.79    30  
31  Blank Unknown 18.23    
32  Blank Unknown 37.54    
33  Blank Unknown 18.27    
34  Blank Unknown 14.33    
35  Blank Unknown 20.20    
36 Blank Unknown NEG (Multi Ct)     
Legend: 
NEG (NTC) - Sample cancelled due to NTC Threshold.  
NEG (R. Eff) - Sample cancelled as efficiency less than reaction efficiency threshold. 
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Melt Report 
Experiment Information 
Run Name DMXAA cord 2007-03-14 (1)
Run Start 14/03/2007 3:21:04 p.m. 
Run Finish 14/03/2007 5:19:00 p.m. 
Operator Kiri 
Notes   
Run On Software Version Rotor-Gene 1.7.61 
Run Signature The Run Signature is valid. 
Gain Green 8. 
Melt Information 
Digital Filter Light 
Imported Analysis Settings   
Sample Page Page 1 
Temp. Threshold 78°c 
Threshold 0.29299
Messages 
Message 
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Profile 
Cycle Cycle Point 
Hold @ 95°c, 15 min 0 secs    
Cycling (40 repeats)  Step 1 @ 94°c, hold 20 secs 
  Step 2 @ 55°c, hold 20 secs 
  Step 3 @ 68°c, hold 30 secs, acquiring to 
Cycling A([Green][1][1]) 
  Step 4 @ 80°c, hold 10 secs, acquiring to 
Cycling B([Green][1][1]) 
Melt (72-95°c) , hold secs on the 1st step, hold 5 
secs on next steps, Melt A([Green][1][1]) 
  
Melt data for Melt A.Green 
 
 
 
No. Name Genotype Peak 1 Peak 2 Peak 3 Peak 4
1 HSPY-Neg      
2 ESel-Neg  79.0    
3 ICam-Neg  79.5    
4 IL1B-Neg  80.0    
5 IL6-Neg  79.8    
6 IL8-Neg  82.0    
7 TNF-Neg      
(Continued on next page)...  
No. Name Genotype Peak 1 Peak 2 Peak 3 Peak 4
8 TF-Neg      
9 RNAPol-Neg      
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10 HSPY-DMXAA  88.8    
11 ESel-DMXAA  85.7    
12 ICam-DMXAA  83.0 91.5   
13 IL1B-DMXAA  79.0 84.2 88.3  
14 IL6-DMXAA      
15 IL8-DMXAA  81.5 86.7   
16 TNF-DMXAA  84.5    
17 TF-DMXAA  79.2 84.0   
18 RNAPol-DMXAA  83.8 89.2   
19 HSPY-DMXAA  78.2 82.0 84.2 88.7 
20 ESel-DMXAA  78.2 85.5   
21 ICam-DMXAA      
22 IL1B-DMXAA  83.8 88.2   
23 IL6-DMXAA  80.5 85.7   
24 IL8-DMXAA  81.7 86.5   
25 TNF-DMXAA  84.5    
26 TF-DMXAA  83.8    
27 RNAPol-DMXAA  83.5 89.0   
28 Blank      
29 Blank      
30 Blank      
31 Blank      
32 Blank      
33 Blank      
34 Blank      
35 Blank      
36 Blank      
 
 
Bin Name Temperature Sample No. Sample Name Peak
 
 
(Continued on next page)...  
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Data for cord 11 
 
Quantitation Report 
Experiment Information 
Run Name control cord 2007-03-01 (1)
Run Start 1/03/2007 12:03:43 p.m. 
Run Finish 1/03/2007 2:11:37 p.m. 
Operator KM 
Notes   
Run On Software Version Rotor-Gene 1.7.61 
Run Signature The Run Signature is valid.
Gain Green 9.33 
Quantitation Information 
Threshold 0.0069 
Left Threshold 25.000 
Standard Curve Imported No 
Standard Curve (1) N/A 
Standard Curve (2) N/A 
Start normalising from cycle 1 
Noise Slope Correction Yes 
No Template Control Threshold 2%  
Reaction Efficiency Threshold Disabled  
Normalisation Method Dynamic Tube Normalisation
Digital Filter Light 
Sample Page Page 1 
Imported Analysis Settings   
Messages 
Message 
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Profile 
Cycle Cycle Point 
Hold @ 95°c, 15 min 0 secs    
Cycling (45 repeats)  Step 1 @ 94°c, hold 20 secs 
  Step 2 @ 55°c, hold 20 secs 
  Step 3 @ 68°c, hold 30 secs, acquiring to 
Cycling A([Green][1][1]) 
  Step 4 @ 80°c, hold 10 secs, acquiring to 
Cycling B([Green][1][1]) 
Melt (72-95°c) , hold secs on the 1st step, hold 5 
secs on next steps, Melt A([Green][1][1]) 
  
Raw Data For Cycling B.Green 
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Standard Curve 
 
No. Colour Name Type Ct Given Conc (Copies) Calc Conc (Copies) % Var
1  HPSY-Neg Unknown 37.80    
2  ESel-Neg Unknown 30.75    
3  ICAM-Neg Unknown 36.22    
4  IL1B-Neg Unknown 31.34    
5  IL6-Neg Unknown 30.55    
6  IL8-Neg Unknown 26.32    
7  TNF-Neg Unknown NEG (NTC)    
8  TF-Neg Unknown 37.18    
(Continued on next page)...  
No. Colour Name Type Ct Given Conc (Copies) Calc Conc (Copies) % Var
9  HPSY-pbs Unknown NEG (NTC)    
10  Esel-pbs Unknown 35.46    
11  ICAM-pbs Unknown NEG (NTC)    
12  IL1B-pbs Unknown 35.93    
13  IL6-pbs Unknown 32.02    
14  IL8-pbs Unknown 27.07    
15  TNF-pbs Unknown NEG (NTC)    
16  TF-pbs Unknown NEG (NTC)    
17  HPSY-pbs Unknown NEG (NTC)    
18  Esel-pbs Unknown 31.20    
19  ICAM-pbs Unknown NEG (NTC)    
20  IL1B-pbs Unknown 36.54    
21  IL6-pbs Unknown 34.00    
22 IL8-pbs Unknown 27.13     
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TNF-pbs Unknown NEG (NTC)    23  
TF-pbs Unknown NEG (NTC)    24  
 Blank Unknown NEG (NTC)    25 
 Blank Unknown NEG (NTC)    26 
27  Blank Unknown NEG (NTC)    
28 Blank Unknown NEG (NTC)     
29 Blank Unknown NEG (NTC)     
30  Blank Unknown NEG (NTC)    
31  Blank Unknown NEG (NTC)    
32  Blank Unknown NEG (NTC)    
33  Blank Unknown NEG (NTC)    
34  Blank Unknown NEG (NTC)    
35  Blank Unknown NEG (NTC)    
36  Blank Unknown NEG (NTC)    
Legend: 
NEG (NTC) - Sample cancelled due to NTC Threshold.  
NEG (R. Eff) - Sample cancelled as efficiency less than reaction efficiency threshold. 
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Melt Report 
Experiment Information 
Run Name control cord 2007-03-01 (1)
Run Start 1/03/2007 12:03:43 p.m. 
Run Finish 1/03/2007 2:11:37 p.m. 
Operator KM 
Notes   
Run On Software Version Rotor-Gene 1.7.61 
Run Signature The Run Signature is valid.
Gain Green 9.33 
Melt Information 
Digital Filter Light 
Imported Analysis Settings   
Sample Page Page 1 
Temp. Threshold 76°c 
Threshold 1.13183
Messages 
Message 
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Profile 
Cycle Cycle Point 
Hold @ 95°c, 15 min 0 secs    
Cycling (45 repeats)  Step 1 @ 94°c, hold 20 secs 
  Step 2 @ 55°c, hold 20 secs 
  Step 3 @ 68°c, hold 30 secs, acquiring to 
Cycling A([Green][1][1]) 
  Step 4 @ 80°c, hold 10 secs, acquiring to 
Cycling B([Green][1][1]) 
Melt (72-95°c) , hold secs on the 1st step, hold 5 
secs on next steps, Melt A([Green][1][1]) 
  
Melt data for Melt A.Green 
 
 
 
No. Name Genotype Peak 1 Peak 2
1 HPSY-Neg  80.3  
2 ESel-Neg  78.8 87.0 
3 ICAM-Neg    
4 IL1B-Neg  79.5  
5 IL6-Neg  80.0  
6 IL8-Neg  81.2 88.8 
7 TNF-Neg    
(Continued on next page)...  
No. Name Genotype Peak 1 Peak 2
8 TF-Neg  79.0  
9 HPSY-pbs    
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10 Esel-pbs  78.7  
11 ICAM-pbs    
12 IL1B-pbs  80.0  
13 IL6-pbs  80.0  
14 IL8-pbs  81.2 93.5 
15 TNF-pbs    
16 TF-pbs    
17 HPSY-pbs  77.2  
18 Esel-pbs  78.8  
19 ICAM-pbs    
20 IL1B-pbs  79.8  
21 IL6-pbs  79.0  
22 IL8-pbs  81.0  
23 TNF-pbs    
24 TF-pbs    
25 Blank    
26 Blank    
27 Blank    
28 Blank    
29 Blank    
30 Blank    
31 Blank    
32 Blank    
33 Blank    
34 Blank    
35 Blank    
36 Blank    
 
 
Bin Name Temperature Sample No. Sample Name Peak
 
 
(Continued on next page)...  
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Data for cord 11 
 
Quantitation Report 
Experiment Information 
Run Name tumour conditioned cord 2007-03-01
Run Start 1/03/2007 4:47:36 p.m. 
Run Finish 1/03/2007 6:43:35 p.m. 
Operator KM 
Notes   
Run On Software Version Rotor-Gene 1.7.61 
Run Signature The Run Signature is valid. 
Gain Green 9.33 
Quantitation Information 
Threshold 0.00487 
Left Threshold 12.000 
Standard Curve Imported No 
Standard Curve (1) N/A 
Standard Curve (2) N/A 
Start normalising from cycle 1 
Noise Slope Correction No 
No Template Control Threshold 0%  
Reaction Efficiency Threshold Disabled  
Normalisation Method Dynamic Tube Normalisation
Digital Filter Light 
Sample Page Page 1 
Imported Analysis Settings   
Messages 
Message 
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Profile 
Cycle Cycle Point 
Hold @ 95°c, 15 min 0 secs    
Cycling (40 repeats)  Step 1 @ 94°c, hold 20 secs 
  Step 2 @ 55°c, hold 20 secs 
  Step 3 @ 68°c, hold 30 secs, acquiring to 
Cycling A([Green][1][1]) 
  Step 4 @ 80°c, hold 10 secs, acquiring to 
Cycling B([Green][1][1]) 
Melt (72-95°c) , hold secs on the 1st step, hold 5 
secs on next steps, Melt A([Green][1][1]) 
  
Raw Data For Cycling B.Green 
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Standard Curve 
 
No. Colour Name Type Ct Given Conc (Copies) Calc Conc (Copies) % Var
1  HPSY-negative Unknown NEG (Multi Ct)    
2  ESel-negative Unknown NEG (Multi Ct)    
3  ICam-negative Unknown 13.15    
4  IL1B-negative Unknown 18.49    
5  IL6-negative Unknown 27.15    
6  Il8-negative Unknown 30.93    
7  TNF-negative Unknown     
8  TF-negative Unknown NEG (Multi Ct)    
(Continued on next page)...  
No. Colour Name Type Ct Given Conc (Copies) Calc Conc (Copies) % Var
9  RNAPol-negative Unknown 15.71    
10  HPSY-TCM Unknown     
11  ESel-TCM Unknown 21.19    
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12  ICam-TCM Unknown     
13  IL1B-TCM Unknown 35.52    
14  IL6-TCM Unknown 23.83    
15  Il8-TCM Unknown 19.97    
16  TNFTCM Unknown 20.41    
17  TF-TCM Unknown 39.33    
18  RNAPol-TCM Unknown     
19  HPSY-TCM Unknown     
20  ESel-TCM Unknown 33.42    
21  ICam-TCM Unknown     
22 IL1B-TCM Unknown 32.47     
IL6-TCM Unknown 39.26  23    
24  Il8-TCM Unknown 29.48    
25  TNFTCM Unknown NEG (Multi Ct)    
 TF-TCM Unknown     26 
 RNAPol-TCM Unknown     27 
Blank Unknown 14.20    28  
Blank Unknown 17.71    29  
Blank Unknown 17.65    30  
31  Blank Unknown 12.77    
32  Blank Unknown 23.35    
33  Blank Unknown NEG (Multi Ct)    
34  Blank Unknown 17.52    
35  Blank Unknown 15.80    
36  Blank Unknown 14.47    
Legend: 
NEG (NTC) - Sample cancelled due to NTC Threshold.  
NEG (R. Eff) - Sample cancelled as efficiency less than reaction efficiency threshold. 
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Melt Report 
Experiment Information 
Run Name tumour conditioned cord 2007-03-01
Run Start 1/03/2007 4:47:36 p.m. 
Run Finish 1/03/2007 6:43:35 p.m. 
Operator KM 
Notes   
Run On Software Version Rotor-Gene 1.7.61 
Run Signature The Run Signature is valid. 
Gain Green 9.33 
Melt Information 
Digital Filter Light 
Imported Analysis Settings   
Sample Page Page 1
Temp. Threshold 0°c 
Threshold 0. 
Messages 
Message 
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Profile 
Cycle Cycle Point 
Hold @ 95°c, 15 min 0 secs    
Cycling (40 repeats)  Step 1 @ 94°c, hold 20 secs 
  Step 2 @ 55°c, hold 20 secs 
  Step 3 @ 68°c, hold 30 secs, acquiring to 
Cycling A([Green][1][1]) 
  Step 4 @ 80°c, hold 10 secs, acquiring to 
Cycling B([Green][1][1]) 
Melt (72-95°c) , hold secs on the 1st step, hold 5 
secs on next steps, Melt A([Green][1][1]) 
  
Melt data for Melt A.Green 
 
 
 
No. Name Genotype Peak 1 Peak 2 Peak 3 Peak 4 Peak 5
1 HPSY-negative  77.5 82.5 88.0 93.5  
2 ESel-negative  78.5     
3 ICam-negative  78.0 84.3 89.0 92.5  
4 IL1B-negative  79.5     
5 IL6-negative  79.2 87.0 90.0   
6 Il8-negative  81.5 90.7    
7 TNF-negative  76.8 82.5 89.5   
(Continued on next page)...  
No. Name Genotype Peak 1 Peak 2 Peak 3 Peak 4 Peak 5 
8 TF-negative  79.7     
9 RNAPol-negative  74.0 80.0 87.5 92.2  
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10 HPSY-TCM  78.2 82.0 87.0   
11 ESel-TCM  78.5 90.3    
12 ICam-TCM  78.0 85.0    
13 IL1B-TCM  80.0     
14 IL6-TCM  73.5 81.0    
15 Il8-TCM  81.5     
16 TNFTCM  75.7 78.0 85.3 91.0  
17 TF-TCM  78.0 84.0 91.5   
18 RNAPol-TCM  75.0 83.5 89.0   
19 HPSY-TCM  77.0 87.3 91.7   
20 ESel-TCM  78.5 86.5    
21 ICam-TCM  76.5 83.0 90.2   
22 IL1B-TCM  80.2     
23 IL6-TCM  73.8 78.7 88.3   
24 Il8-TCM  81.5     
25 TNFTCM  73.8 80.0 82.8 87.7 90.5 
26 TF-TCM  78.5     
27 RNAPol-TCM  75.5 80.7 88.2   
28 Blank  75.0 79.7 84.2 87.5  
29 Blank  77.2 82.7 87.7 92.8  
30 Blank       
31 Blank  77.7 82.3 88.0   
32 Blank  75.3 79.7 84.0 88.3  
33 Blank  75.5 81.5 86.7 92.5  
34 Blank  72.8 78.2 83.0 87.5 92.8 
35 Blank  77.5 82.5    
36 Blank  81.0 88.5    
 
 
Bin Name Temperature Sample No. Sample Name Peak
 
 
(Continued on next page)...  
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